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Summary.
The enteric adenoviruses show a restricted host range in tissue culture. Adenovirus 
type 40 (Ad40) can not be passaged in conventional human cell lines used for other 
adenovirus serotypes, but will grow in cells constitutively expressing Ad2 or Ad5 E1B 
55K function (KB 16 & 293 cells respectively). Preliminary experiments showed that 
Ad40 could also be propagated in INT407 cells which were not known to express El 
proteins. The aim of the work described here was to characterise the growth of Ad40 in 
INT407 cells by examining virus replication and gene expression compared to other 
permissive (KB 16) and semi-permissive cell lines (HeLa & A549).
A timecourse of DNA replication confirmed that INT407 cells were permissive for 
Ad40. The pattern of DNA replication was similar on KB 16 and INT407 cells although 
the yield from KB 16 cells was slightly higher than INT407 cells; the lowest yield was 
from HeLa. In addition INT407 cells could partially complement the growth of an Ad2/5 
55K mutant virus. These results suggest that E1B 55K may be complemented or that the 
requirement for 55K may vary in INT407 cells.
The kinetics of Ad40 growth were studied by fluorescent focus assay using a 
monoclonal antibody against Ad5 hexon. Ad40 exhibited one hit kinetics on permissive 
cells (INT407 & KB 16) and two hit kinetics on semi-permissive cells (A549 & HeLa). 
There was a marked difference in the number of productively infected cells between cell 
types with fewer cells productively infected at 48h p.i. on semi-permissive cell lines.
The entry events of the Ad40 replicative cycle (i.e. attachment and internalisation) 
were investigated to determine if any defects at this stage might contribute to the Ad40 
growth phenotype on the different cell lines. A similar number of Ad40 particles attached 
and were internalised on INT407 and HeLa cells. These results could not explain why 
INT407 cells were more permissive for Ad40 growth than HeLa cells. In a parallel
experiment the attachment and internalisation of dl309 was found to be comparable to 
Ad40 on these cell lines.
In order to explain the Ad40 growth phenotype in the different cell types E1B 
gene expression was analysed by Northern blotting and SI nuclease digestion on the 
different cell lines. E1B 22S mRNA was observed at early times before the onset of DNA 
replication in INT407 and KB 16 cells, with the 14S mRNA predominantly late in 
infection in these cell types. In HeLa cells E1B mRNA was detected coincident with the 
onset of DNA replication at much reduced levels. A similar pattern to HeLa was seen on 
A549 cells. The pattern of E1B transcription on INT407 cells was comparable to that 
reported previously on KB 16 cells which is similar to Adl2 with 14S, 22S and 9S 
mRNA.
The lower levels of E1B mRNA and later detection in HeLa cells may indicate 
that the transcription from the EIB promoter is inefficient or absent early in infection in 
these cells. Even in permissive cells Ad40 E1B mRNA transcription is poor compared to 
Ad5 which may indicate inefficient promoter usage. Therefore the Ad40 E1B 
transcriptional regulatory region in particular the Spl binding site was studied by gel 
retardation assay. The ability of Ad40 and Ad2 GC box sequences (Spl binding sites) to 
bind either partially purified Spl or proteins from INT407 and HeLa extracts were 
compared. The Ad40 Spl binding site bound the Spl transcription factor but with lower 
affinity than the Ad2.
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1. INTRODUCTION
1.1. The Adenoviridae.
1.1.1. Classification.
The Adenoviridae family is divided into two genera, Mastadenovirus and 
Aviadenovirus. The Mastadenovirus genus includes: human, simian, bovine, equine, 
porcine, ovine and canine viruses. Human adenoviruses were first discovered by Rowe et 
al, (1953), in explants of adenoid tissue. There are currently 47 serotypes of human 
adenoviruses (Hierholzer et al., 1991) and possibly more, with two candidate serotypes 
identified by Schnurr and Dondero et al, (1993). The human adenoviruses were 
classified into six subgenera (A-F) based on the following criteria: immunological 
properties, oncogenicity in rodents, DNA homologies and morphological properties 
(Table 1.1.1.). Human adenoviruses are associated with a number of infections including 
respiratory, ocular, urinary and gastrointestinal, although symptoms are rarely fatal. 
Adenoviruses are widely used as model systems in molecular biology, and their use as 
important biological tools (reviewed in Horwitz, 1990) particularly as vectors in gene 
therapy has been extensively reported (reviewed in Haddada et al., 1995). Much of our 
current understanding of human adenoviruses comes from extensive studies with Ad2 and 
the closely related Ad5 serotypes and this is reflected in the following sections.
1.1.2. Morphology.
Adenoviruses are nonenveloped, icosahedral particles, approximately 50-80nm in 
diameter (Home et al, 1959). The virion has a dense central core comprising of a tightly 
packed DNA-protein complex (Nermut, 1984) and an outer protein capsid (see Fig 
1.1.1a.). The capsid is composed of 252 capsomers, consisting of 240 hexons (virion 
protein II) on the facets and 12 penton bases (virion protein HI) at the vertices (Ginsberg 
et al, 1966). Fibre (virion protein IV) is noncovalently attached to each penton base.
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Figure 1.1.1a. A Schematic View of the Adenovirus Particle.
A schematic view of the adenovirus particle based on current understanding of its 
polypeptide components and viral DNA. No real section of the icosahedral virion would 
contain all these components. (Reproduced from Stewart and Burnett, 1995).
Figure 1.1.1b. A Diagram of the Icosahedral Adenovirus Capsid.
The 240 copies of the hexon trimer are organised so that 12 lie on each of the 20 
facets. The penton complex formed from the penton base and fibre lies at each of the 12 
vertices. The central 9 hexons in a facet are cemented together by 12 copies of polypeptide 
DC. Dissociation of the virion releases the pentons, peripentonal hexons and the planar 
groups-of-nine hexons. (Reproduced from Burnett et al., 1985 ).
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Hexon is the major structural component of the virus capsid; it is a trimer of three 
identical polypeptide chains (Grutter and Franklin, 1974; Akusjarvi et al., 1984) and its 
structure has been solved to 2.9A resolution by X-ray crystallography (Athappilly et al.,
1994). The overall shape of the trimeric hexon molecule consists of a pseudo-hexagonal 
base with a triangular top. With mild disruption of virions, hexons were subdivided 
depending on their location in the capsid, into peripentonal hexons or groups of nine 
hexons (GONs) (see Fig 1.1.1b.). GONs make up the facets with peripentonal hexons the 
link between the facets and pentons. The minor capsid protein, polypeptide DC was shown 
to extend along hexon-hexon interfaces of GONs and is involved in stabilising the capsid 
(van Oostrum and Burnett, 1985; Furcinitti et al., 1989; Stewart et al., 1993). Hexon has 
a complex array of antigenic determinants, including those with genus, type, 
intersubgenus and intrasubgenus specificities (Norrby 1969a, b; Norrby and Wadell, 
1969). Type-specific determinants of hexon have been demonstrated on the surface of the 
virion (Willcox and Mautner 1976a, b; Toogood et al., 1992) and group-specific 
determinants appear to be buried internally (Mautner and Willcox, 1974; Norrby, 1969a; 
Willcox and Mautner, 1976a, b).
The complex of penton base and fibre polypeptide is called the penton capsomere. 
The penton base is composed of five subunits (van Oostrum and Burnett, 1985; Furcinitti 
et al., 1989; Stewart et al., 1993), and the fibre has been shown to comprise of three 
subunits each of 62K (Devaux et al, 1990; Stouten et al., 1992). The fibre consists of 
three domains (Green et al., 1983), the amino terminal tail that interacts with the penton 
base, an intervening shaft region and the carboxy terminus which contains type-specific 
antigenic determinants and is responsible for binding to the cell surface receptor 
(Pettersson et al., 1968; Hughes and Mautner, 1973; Devaux et al., 1990; Ruigrok et al., 
1990; Louis et al 1994). Most human adenoviruses have one fibre gene with the 
exception of Ad40 and Ad41 which have two. These fibre genes encode proteins of 
different shaft length and different knob sequence (Pieniazek et al., 1989; Kidd and 
Erasmus, 1989; Kidd etal., 1990, 1993; Davison etal., 1993; Yeh etal., 1994).
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The virion proteins Ilia, VI, VDI and IX are also associated with the major capsid 
proteins and are thought to act as "cement proteins" interacting with each other, hexons, 
pentons and possibly some of the core proteins (Stewart et al, 1993).
The core consists of genomic DNA tightly complexed with two highly basic 
proteins, virion proteins VII and V, also associated are the virion proteins VI and p 
(Russell and Precious, 1982). Protein V also binds penton base and is associated with 
protein Ilia (Everitt et al., 1975). The organisation of adenovirus DNA inside the capsid 
is not well understood. It has been suggested that the DNA is organised into 12 globular 
domains (Brown et al., 1975; Newcombe et al., 1984), which would fit into the 12 
vertices of the icosahedral capsid of the virus. A second model, involves the DNA wound 
around protein VII in the form of nucleosomes (Corden et al., 1976; Chatteijee et al., 
1986). Wong and Hsu (1989) suggested the viral DNA is organised into eight supercoiled 
loops, which are anchored to the centre of the virus core. This model was consistent with 
the results of Brown etal., (1975) and Newcombe eta l, (1984).
1.1.3. Genome Structure.
The adenovirus genome consists of a linear double stranded DNA molecule. The 
deoxycytidine at the 5' end of each strand is covalently linked to a 55K terminal protein 
(TP), through a serine phosphoryl bond (Robinson et al, 1973; Rekosh et al., 1977; 
Desideiro and Kelly, 1981). This protein is generated late in infection by the action of a 
virus protease (Webster et al, 1993), on an 80K precursor terminal protein (pTP). The 
ends of the virus genome have an inverted terminal repetition (Garon et al, 1972; 
Wolfson and Dressier, 1972). The inverted terminal repeats (ITRs) of human 
adenoviruses vary in length from 102 to 165bp, depending on the serotype (Tamanoi and 
Stillman, 1983; Shinagawa et al., 1987). Located within the first 51bp of the ITR is the 
origin of DNA replication. The terminal 18bp represent a minimal origin of DNA 
replication and contained within this is a lObp region (nt 9 to 18), which is highly 
conserved among different adenovirus serotypes (Stillman et al, 1982; Tamanoi and 
Stillman, 1983; Wides et al, 1987; Harris and Hay, 1988). This minimal origin has been
found to bind a heterodimer of the virion proteins, pTP and adenovirus DNA polymerase 
(Miralles et al, 1989; Chen et al., 1990; Temperley and Hay, 1992). Separated from the 
minimal origin by a defined spacer region (Wides et al, 1987), are binding sites for two 
host cell proteins, these factors stimulate the initiation of replication by different 
mechanisms (reviewed in Hay et al, 1995; van der Vliet, 1995), and will be discussed in 
more detail in section 1.1.4.3.
The complete nucleotide sequences for four human adenoviruses are now 
available: Ad2 (Roberts et al, 1986), Ad5 (Chroboczek et al, 1992), Ad40 (Davison et 
al, 1993) and Adl2 (Sprengel et al, 1994). The organisation of the Ad2 genome 
(35,937bp) is shown in Figure 1.1.2. By convention the genome is divided into 100 map 
units (m.u.) and the two strands denoted r and 1 for rightward and leftward transcription; 
genes are expressed from both strands. The viral genes are expressed in two broadly 
defined phases which are termed early and late, separated by the onset of DNA 
replication; a few genes are expressed at intermediate times (reviewed in Akusjarvi et al, 
1986). El A genes are the first to be expressed during infection and are sometimes 
referred to as "immediate early" genes (Berk, 1986). The late genes are transcribed from 
the same promoter, the major late promoter (MLP). All the major late mRNAs have a 
common 201nt long 5' leader sequence which consists of three short exons (Berget et al, 
1977; Akusjarvi and Pettersson, 1979; Shaw and Ziff, 1989). The replication cycle can 
therefore really be divided into four stages: Immediate Early, Early, Intermediate and 
Late.
1.1.4. The Lytic Cycle.
I.I .4 .I . Viral E ntry  into Cells.
This section outlines how adenoviruses enter cells, however a more detailed 
description of attachment and internalisation can be found in section 1.2. Initial 
attachment of adenoviruses is mediated by the fibre protein (Philipson et al, 1968; Henry 
et al, 1994; Louis et al, 1994). Although the cell receptor is unknown, some candidate 
cellular proteins have been shown to bind fibre (Hennache and Boulanger, 1977;
Figure 1.1.2. Organisation of the Ad2 Genome.
The parallel lines indicate the linear duplex DNA genome, which is divided into 100 
map units (m.u.). Rightward and leftward transcription is indicated by r and 1, respectively. 
Vertical brackets indicate position of promoter sites and the arrow heads show the location 
of 3' ends. The split arrows indicate the spliced structure of the mRNAs. Thick lines 
represent mRNAs expressed early after infection and thin lines mRNAs expressed at 
intermediate times. The open arrows show sequences present in mRNAs expressed late 
after infection. Polypeptides assigned to different regions are also shown (Reproduced from 
Akusjarvi and Wadell, 1993).
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Svensson et al., 1981; Belin and Boulanger, 1993). Adenoviruses from subgroups B and 
C use different cell receptors for virus attachment (Defer et al, 1990; Di Guilmi et al., 
1995; Stevenson et al., 1995; Gall et al., 1996).
After attachment to the fibre receptor, virus particles are rapidly internalised into 
clathrin-coated pits by receptor-mediated endocytosis (Chardonnet and Dales, 1970; 
Fitzgerald et al., 1983; Varga et al., 1991). The fibre protein dissociates from the virion 
particle early in the entry pathway (Greber et al., 1993). In Ad2, internalisation is 
mediated by the penton base protein binding to specific av integrins (Wickham et al., 
1993; Bai et al., 1993).
Viral particles penetrate into the cytoplasm from endosomes, this process requires 
a low pH environment as agents which block this environment (in endosomes) also block 
adenovirus release into the cytoplasm (Blumenthal et al, 1986; Greber et al., 1993). 
Stepwise uncoating of the viral particle continues through the cytoplasm (Greber et al., 
1993). When virions reach the nucleus, the viral core (DNA and virion proteins: V, VII, 
TP and ji) enters via nuclear pores leaving many of the other virion proteins in the 
cytoplasm (Morgan et al, 1969; Chardonnet and Dales, 1970; Greber et al., 1993).
I.I.4.2. Transcription.
The adenovirus genes are transcribed from nine initiation sites by cellular RNA 
polymerase II (Price and Penman, 1972), except for VA (virus associated) RNAs which 
are transcribed by RNA polymerase HI. Transcription occurs in a temporally regulated 
manner (Nevins et al., 1979; Glenn and Ricciardi, 1988) in the nucleus of the infected 
cell. Early genes are grouped in six transcription units ( E1A, E1B, E2A, E3, E4 and LI 
early). The first genes expressed are from the El A region and are referred to as 
'immediate early'. The larger El A gene product (289R) transactivates the other early 
transcription units and prepares the cell for efficient viral DNA replication. At 
intermediate times, close to the onset of DNA replication, intermediate genes are 
transcribed (ppIX, IVa2, VAI RNA and VAII RNA). Following DNA replication the late 
genes (L1-L5) are transcribed and these encode mainly viral structural proteins.
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Early Transcription
El A genes are expressed from the r-strand (see Figure 1.1.2) and are situated 
between 1.5-4.5 m.u. in Ad2 (Jones and Shenk, 1979b). There are five known El A 
mRNAs (Berk and Sharp 1978; Chow et al., 1979; Stephens and Harlow 1987; Ulfendahl 
et al., 1987), named: 13S, 12S, 1 IS, 10S, and 9S based on their respective sedimentation 
coefficients. They share 5' and 3' ends but are differentially spliced (see Fig 1.3.1.). The 
two larger mRNAs, 13S and 12S, are the predominant species early in infection, whilst 
the 9S mRNA is the most abundant at late stages after infection (Spector et al., 1978; 
Chow et al 1979). Proteins of 243 and 289 amino acids (243R & 289R) are transcribed 
from 12S and 13S mRNAs, respectively. These proteins differ by an internal 46 amino 
acids region, present only in the 289R protein (Perricaudet et al., 1979). The larger 
protein is primarily responsible for transactivation and induces the transcription of other 
early regions (Jones and Shenk 1979b; Ricciardi et al., 1981; Montell et al., 1982; 
reviewed in Berk 1986). The El A region is described in more detail in section 1.3.
The E1B transcription unit lies downstream of the El A region on the r-strand 
between 4.6-11 m.u. (in Ad2). A more detailed description of structure and function from 
this region can be found in section 1.4. The E1B region produces two major mRNAs 22S 
and 13S, sharing common 5' and 3' ends (Berk and Sharp 1978); both these mRNAs are 
derived from a common precursor mRNA by alternative splicing (Pettersson et al., 1983). 
The 22S mRNA codes for a 19K protein using the first AUG and a 55K protein in a 
different reading frame via the second AUG, in addition the 13S mRNA also encodes the 
19K protein (Bos et al, 1981). In Ad5, 22S mRNA is most abundant at early stages after 
infection, whereas 13S levels increase at intermediate times (Glenn and Ricciardi, 1988). 
Two minor mRNAs 14S and 14.5S have also been described, they are similar to 13S 
mRNA but have an additional third exon (Virtanen and Pettersson, 1985). These mRNAs 
encode the 19K protein and 55K related proteins (Anderson et al., 1984; Virtanen and 
Pettersson, 1985).
Along with these mRNAs, a 9S species is transcribed from its own promoter 
within the E1B region. It encodes the structural polypeptide IX which is associated with
the capsid (Furcinitti et al., 1989; Stewart et al., 1993), and is expressed at intermediate 
times after infection.
The E2 region is transcribed from the 1-strand and lies between 75.4 and 11.3 m.u. 
(Chow et al, 1979). It varies from other adenovirus transcription units by using two 
alternative promoter sites, at different times in infection. Transcripts from the E2 region 
use one of two polyadenylation sites (poly-A), generating two major classes of mRNAs: 
E2A or E2B mRNAs. Early in infection E2A transcripts are expressed from a promoter at 
75.4 m.u. and following the early to late phase transition mRNAs are transcribed from a 
promoter at 72.2 m.u. (Nevins et al., 1979; Glenn and Ricciardi, 1988). The E2A mRNAs 
terminate using the poly-A site at 62.4 m.u., whereas E2B mRNAs bypass this poly-A 
site and terminate at 11.3 m.u. (Stillman et al, 1981).
The E2A gene encodes a 72K single-stranded DNA binding protein (DBP) (Lewis 
et al., 1976). DBP is essential for viral DNA replication (Rice and Klessig, 1985; Stuvier 
and van der Vliet, 1990; Mul and van der Vliet, 1993) and is involved in the regulation of 
viral gene expression (Klessig and Grodzicker, 1979; Babich and Nevins, 1981). DBP 
also regulates its own synthesis and can enhance transcription from the El A, E2 (early) 
and major late promoters (Morin et al, 1989; Zijderveld et al., 1994).
Three mRNAs are transcribed from the E2B region (Stillman et al., 1981; Shu et 
al., 1988). The proteins pTP and adenovirus DNA polymerase (Adpol) have been 
assigned to two of these mRNAs, and they are both required for the initiation of 
adenovirus DNA replication. The 80K protein pTP acts as a primer for DNA replication 
(Smart and Stillman, 1982; Salas, 1991). This protein is cleaved by the 23K viral protease 
late in infection, resulting in the 55K terminal protein (TP) (reviewed in Challberg and 
Kelley, 1989; Hay et al, 1995). The 140K protein Adpol is required for initiation and 
elongation in DNA replication (see Hay et al, 1995; van der Vliet, 1995 and references 
therein).
The E3 region is transcribed from the r-strand between 76.8 and 85.9 m.u. This 
region is not essential for adenovirus replication in tissue culture cells, it is however 
conserved among adenovirus serotypes (reviewed in Wold et al., 1995) indicating it has 
an important role in vivo. There are approximately nine overlapping mRNAs which arise
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by alternative splicing of a common pre-mRNA precursor, and are polyadenylated at one 
of two sites E3A or E3B. (Chow et al., 1979; see Wold et al., 1995 and references 
therein). Subgroup C adenoviruses are predicted to encode nine proteins, seven of which 
have been identified, but functions have been assigned to only five proteins so far 
(reviewed in Wold et al, 1995; Tollefson et al., 1996).
E3 proteins are involved in modulating the host immune response to adenovirus 
infection, by a number of different mechanisms. One of these involves the E3 19K 
glycoprotein (gpl9K) an abundant transmembrane protein which is retained in the 
endoplasmic reticulum (ER) (PaSbo et al, 1987). In the ER gpl9K binds to Class I 
antigens of the major histocompatibility complex (MHC) and thus interferes with their 
transport to the cell surface (Sester and Burget, 1994). Class I antigens complex with viral 
peptides at the cell surface and act as a signal for virus- specific cytotoxic T lymphocytes 
(CTL) to lyse the infected cell. The result of the retention of Class I antigens in the ER is 
that cells are protected from lysis by adenovirus specific CTL (Burget et al., 1987; Cox et 
al, 1991).
The second mechanism involves E3 proteins (14.7K, 14.5K and 10.4K), which 
protect adenovirus infected cells from cytolysis by tumour necrosis factor (TNF). TNF is 
a cytokine secreted by activated macrophages, which is involved in the inflammatory and 
immune responses. Adenovirus infected cells are sensitised to TNF cytolysis by El A 
(Duerksen-Hughes et al., 1989). Two 'sets' of E3 proteins act independently to inhibit 
cytolysis induced by TNF: 14.7K which has a more dominant role (Tollefson and Wold, 
1988; Horton et al., 1991; Ranheim et al., 1993), and the 10.4K with 14.5K which 
function as a heterodimer complex protecting some cell lines (in the absence of 14.7K) 
(Tollefson etal., 1991). E1B 19K protein is another adenovirus protein that prevents TNF 
cytolysis (Gooding et al, 1991). The 10.4K/14.5K protein complex also downregulates 
the epidermal growth factor receptor (EGF-R) in adenovirus infected cells (Tollefson et 
al., 1991), resulting in the internalisation of EGF-R via endosomes and its subsequent 
degradation. The 10.4K protein alone is able to down regulate the insulin receptor and 
insulin growth factor I receptor (Kuivinen et al, 1993). In addition, reports suggest that
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the 10.4K and 14.5K proteins also downregulate El A protein levels; this is thought to 
occur via interference with the translation of El A mRNA (Zhang et al, 1994).
The 11.6K protein is a glycoprotein which is located largely at the nuclear 
membrane (Scaria et al, 1992). Recently the 11.6K protein has been shown to be 
required for efficient cell death or lysis of infected cells and as such the 11.6K protein is 
also known as the adenovirus death protein (ADP) (Tollefson et al, 1996). The functions 
of the 6.7K and 12.5K proteins are not known (see Wold et al, 1995 and references 
therein).
The E4 transcription unit lies on the 1-strand between 91.3-99.1 m.u. (see Fig
1.1.1.). Through extensive alternative splicing from a primary transcript, up to 24 
mRNAs can be produced, encoding at least ten proteins (Freyer et al, 1984; Tigges and 
Raskas, 1984; Virtanen et al, 1984). Transcripts from this region are temporally 
regulated in infection (Tigges and Raskas, 1984; Ross and Ziff, 1992; Dix and Leppard,
1993). The E4 promoter is activated by the El A proteins and inhibited by the DBP 
(Handa et al, 1983). The E4 region is predicted to encode seven different proteins; five 
are produced from ORFs colinear with the viral DNA (ORF1, 2, 3, 4, 6 and 7) and two 
are created by splicing of the primary transcript (ORF 3/4 and 6/7) (Freyer et al, 1984; 
Virtanen et al, 1984). Five of these proteins (ORF 2 3, 4, 6 and 6/7) have been detected 
in Ad5-infected cells, with the later four having functions assigned to them (Samow et 
al, 1982a; Downey et al, 1983; Cutt et al, 1987; Bridge et al, 1993; Dix and Leppard,
1995).
The ORF 3 gene product (11K) is associated with the nuclear matrix (Samow et 
al, 1982a; Downey et al, 1983). Mutations in ORF 3 affect viral DNA replication, late 
gene expression and shut-off of host cell protein synthesis (Halbert et al., 1985; Bridge 
and Ketner, 1989; Huang and Hearing, 1989; Ketner et al, 1989).
ORF 6 encodes a 34K protein which can be found physically associated with the 
E1B 55K protein or uncomplexed (Samow et al, 1984; Cutt et al, 1987). Disruption of 
the EIB 55K/E4 34K complex, resulting in the absence of either or both of these proteins, 
causes defects in late viral mRNA accumulation and transport, and delays in viral DNA 
replication (Babiss et al, 1985; Halbert et al, 1985; Pilder et al, 1986; Bridge and
Ketner, 1990). The complex is located in the nucleus of infected cells and is associated 
with viral inclusions that are thought to be sites of DNA replication and transcription 
(Omelles and Shenk, 1991). Transcripts from this region (ORF 6) differ from other E4 
mRNAs by the retention of an intron (Dix and Leppard, 1993). ORFs 3 and 6 are required 
for efficient expression of mRNA from the major late transcription unit. The proteins 
have redundant activities and expression of one is sufficient for major late mRNA 
accumulation (Bridge and Ketner, 1989; Huang and Hearing, 1989). They regulate late 
mRNA accumulation by stimulating constitutive splicing and the two proteins have been 
shown to have opposite effects on the accumulation of alternatively spliced mRNAs 
(Nordqvist et al., 1994).
Muller et al., (1992) have shown that the ORF 4 gene product (14K) regulates the 
phosphorylation of certain viral and cellular proteins. Bridge et al. (1993) found that the 
proteins expressed from E4 ORF 3, 4 and 6 interact to affect viral DNA replication, with 
ORF 4 having a negative effect on DNA synthesis.
The E4 ORF 6/7 is generated from the fusion of ORFs 6 and 7 by mRNA splicing 
(Cutt et al., 1987). This mRNA encodes a 19.5K protein, which is found in the nucleus of 
infected cells. The 19.5K protein was shown to physically interact with the transcription 
factor E2F and facilitate the formation of a stable DNA-protein complex on the E2 
promoter (reviewed in Nevins, 1995).
Intermediate and Late Transcription
The transcription unit encoding virion polypeptide DC (ppIX) lies within the E1B 
region (Wilson et al., 1979). The mRNA is transcribed from its own promoter but is 3' 
coterminal with E1B transcripts (Alestrom et al, 1980); it is the only unspliced 
adenovirus mRNA. The ppDC gene is referred to as an intermediate gene as it is expressed 
before other structural proteins are detected (Spector et al., 1978). However viral DNA 
replication was shown to be required for maximal expression (Vales and Darnell, 1989 
and references therein).
The IVa2 gene is located between 11.3 and 16 m.u. and is transcribed from the 1- 
strand; the transcripts share a polyadenylation site with E2B mRNAs. IVa2 is located in
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the nucleus (Lutz et al, 1996). The DEF-B protein complex which binds the downstream 
element (DE) of the MLP was found to comprise of a homodimer of the IVa2 gene 
product (Tribouley et al, 1994; Lutz et al, 1996 and references therein). The IVa2 
protein was also shown to be a component of the DEF-A heteromeric complex which also 
binds the MLP. The IVa2 protein is required but not sufficient for late phase specific 
activation of the MLP (Tribouley et al, 1994). Winter and D'Halluin, (1991) have shown 
that IVa2 is present in assembly intermediates. Recently the LI 52/55K protein has been
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found in complex with IVa2 (Gustin et al, 1996) and was also found in assembly 
intermediates (Hasson et al, 1992), whether the interaction of these proteins is required 
for a step in assembly has still to be determined.
The Ad2 genome encodes the virus-associated (VA)I RNA and VAJ3 RNA each 
about 160nt long (reviewed in Mathews and Shenk, 1991; Mathews, 1995). They are 
located at approximately 30 m.u., are transcribed from the r-strand by RNA polymerase 
ID and accumulate to high levels in the cytoplasm of infected cells (Weinman et al, 
1976). Most human adenoviruses have two VA genes except for those of subgenera A, F 
and some of B, which have only one (VAI RNA) (Ma and Mathews, 1993; Kidd and 
Tiemessen, 1993; Ma and Mathews, 1996). VAI RNA is required for efficient late protein 
synthesis in infected cells. VAI RNA binds to and inactivates the interferon-induced 
dsRNA-activated protein kinase (DAI) (Kitajewski et al, 1986). This kinase 
phosphorylates the protein synthesis initiation factor eIF-2a, which results in the 
inhibition of protein synthesis. Therefore the inactivation of DAI by VAI RNA 
counteracts this cellular defence mechanism and allows the synthesis of proteins to 
proceed (reviewed in Mathews, 1995). VAI RNA is the predominate VA RNA, but VAII 
RNA has also been shown to suppress DAI activation, albeit less effectively .
At late times after infection, most mRNAs are transcribed from the major late 
promoter (MLP), which is located at 16.8 m.u. on the r-strand (Shaw and Ziff, 1980). The 
major late transcription unit (MLTU) consists of a primary transcript alternatively spliced 
to give 5 families (L1-L5), with each transcript within a family having 3' coterminal ends. 
All mRNAs from the MLTU are transcribed from the MLP and have a common 201nt 5' 
leader sequence, the tripartite leader. Although the MLP is active during the early phase
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after infection, its activity is strongly increased after the onset of viral DNA replication 
(Shaw and Ziff, 1980). LI mRNA is made early in infection; after DNA replication 
mRNA is expressed from all five families (Shaw and Ziff, 1980).
DBP increases transcripton from the MLP (Zijderveld et al, 1994), by enhancing 
the binding of USF (cellular protein, upstream stimulating factor) to its recognition site 
upstream of the MLP. This is thought to occur not by direct binding of USF to DNA, but 
as a result of structural changes to the binding site induced by DBP.
Sequence elements located downstream of the MLP start site have been identified 
and shown to be involved in activation of late transcription (Mansour et al, 1986; Leong 
et al, 1990). Two main sequence elements have been identified (DEI and DE2) together 
with the transcription factors which interact with these sites. The heteromeric protein 
DEF-A binds DEI and the 3' portion of DE2 (Jansen-Durr et al, 1989; Mondesert et al,
1992), while DEF-B (a homodimer of IVa2) interacts with the 5' part of DE2 (Mondesert 
et al, 1992; Tribouley et al, 1994). Proteins which bind DE elements cooperate with 
factors bound to upstream elements in order to achieve maximal MLP activity 
(Mondesert et al, 1992).
Studies have shown that the polyadenylation (poly-A) sites LI and L3 contain cis- 
acting elements necessary to elicit a temporal switch in poly-A site use (Dezazzo et al,
1991). The LI poly-A site is weak in comparison to L3, differences in processing 
efficiencies are thought to be one of the factors involved in the early to late MLTU poly- 
A site processing switch mechanism. Prescott and Falck-Pedersen (1994) have identified 
a sequence element (A-rich) involved in the different processing efficiencies between the 
LI and L3 poly-A sites.
The LI region encodes three proteins; the 52, 55 kilodalton (52/55K) proteins and 
the IHa protein. The 52/55K proteins are produced at early and late times in infection, 
while Ilia is expressed late (Akusjarvi and Persson, 1981; Kreivi and Akusjarvi, 1994). 
Protein Ilia is a structural polypeptide (Boudin et al, 1980) associated with hexons. The 
52/55K proteins are required for assembly of virions (Hasson et al, 1992). They are 
present in empty capsids, assembly intermediates and young virions, but not in mature 
virions. LI early mRNA differs from other major late mRNAs by the presence of an
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additional leader (i) which is spliced between the second and third exons of the tripartite 
leader (Akusjarvi and Persson, 1981). This i leader inclusion is facilitated by E4 ORF3 
(Nordqvist et al, 1994).
L2 region encodes virion proteins pin, pVH, pV and protein X (precursor for the 
|i protein) (Anderson et al, 1989; Russell and Kemp, 1995).
The L3 region encodes protein pVI, hexon and the 23K protease. This protease 
specifically cleaves six virion proteins: pma, pVI, pVII, pVin, X and pTP (Weber, 
1976). The 23K protease cleaves the structural precursors and renders mature virions 
capable of initiating an infection. The protease is present at approx. 10 copies per virion 
(Anderson, 1990). Activation of the protease requires interaction with a disulphide linked 
peptide derived from the C-terminus of protein pVI (Webster et al, 1993; Mathews and 
Russell, 1995). The mature VI protein has been shown to interact with hexon (Mathews 
and Russell, 1994). The pVI protein is proteolytically cleaved to mature VI via an 
intermediate stage i VI. The interaction of VI and hexon increased during each maturation 
step indicating that each cleavage event was facilitating a stronger interaction.
The L4 region encodes three proteins, a structural protein VIE and two non- 
structural proteins of 100K and 33K. The 100K protein is involved in the assembly of 
hexon into trimers (Cepko and Sharp, 1983) and necessary for the efficient initiation of 
translation of late mRNA (Hayes et al, 1990). Riley and Flint (1993), showed that this 
process involves binding to RNA.
L5 region codes for the fibre protein. A substantial fraction (30%) of fibre 
mRNAs, in addition to the tripartite leader, have various combinations of three ancillary 
leader sequences (x, y and z) (Uhlen et al, 1982).
1.1.43. DNA Replication.
Three viral proteins are essential for adenovirus DNA replication: terminal protein 
precursor (pTP), adenovirus DNA polymerase (Adpol) and DNA-binding protein DBP, 
which are all encoded by the E2 transcriptional unit (reviewed in Hay et al, 1995; van 
der Vliet, 1995). DNA replication initiates at either end of the molecule and proceeds 
unidirectionally by a strand displacement mechanism. In this first stage, initiation and
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elongation occur with one strand as template, while the nontemplate strand is displaced as 
a single strand, this process is termed Type I replication. Subsequently the displaced 
strand is replicated (Type II replication). The ITRs base pair to form a 'panhandle' 
structure which serves as an origin for replication for the second strand (reviewed in 
Challberg and Kelley, 1989; Hay and Russell, 1989; Stillman, 1989). Initiation of 
adenovirus DNA replication differs from other eukaryotic DNA viruses, but is similar to 
Bacillus subtilis bacteriophage <J>29; both use a protein as a primer for initiation (reviewed 
in Salas, 1991). Initiation of replication at either terminus occurs via the formation of a 
phosphodiester bond between pTP serine residue 580 and the first nucleotide dCMP 
(Smart and Stillman, 1982). It is the 3' OH group of pTP-dCMP which functions as the 
protein primer for elongation by Adpol (via strand displacement). Adpol and pTP form a 
heterodimer (pTP-pol) which recognises the core origin in the ITR, this complex 
catalyses the formation of pTP-dCMP.
Two cellular transcription factors also function to enhance the efficiency of the 
initiation of DNA replication, the NFI or CAAT transcription factor and NFIH or octamer 
binding protein (reviewed in Challberg and Kelley, 1989; Hay et al., 1995; van der Vliet,
1995). These proteins bind to two adjacent sites in the ITR near the core origin, called the 
auxiliary region and their effect is dependant on the level of pTP-pol complex present 
(Temperley and Hay, 1992). NFI binds as a dimer to its recognition site (next to the core 
region) and interacts with the pTP-pol heterodimer (Dekker et al, 1996). This interaction 
acts to stabilise the initiation complex at the template and correctly positions pTP-pol at 
the site of initiation (Chen et al., 1990; Mul and van der Vliet, 1992; Armentero et al.,
1994). NFHI is a member of the POU family of transcription factors, it stimulates 
initiation of DNA replication at the octamer element (adjacent to the NFI site in the 
auxiliary region) and this is thought to occur via a direct interaction between the pTP-pol 
complex and the octamer element (Coenjaerts et al., 1994).
DBP has a stimulatory effect on initiation and that is to increase the binding of 
NFI to its recognition site (Cleat and Hay, 1989; Stuvier and van der Vliet, 1990). DBP 
also stimulates initiation by lowering the Km of the formation of the initiation complex 
(Mul and van der Vliet, 1993). This protein is absolutely required for elongation, during
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which it increases the rate of synthesis and processivity of Adpol and covers the displaced 
strands (Lindenbaum et al, 1986). It has been shown that DBP has helix destabilising 
properties (Zijderveld and van der Vliet, 1994) which could assist in strand displacement 
during replication. The crystal structure of the DNA-binding domain of DBP has been 
determined (Tucker et al, 1994), and was found to have a 17 amino acid C-terminal 
extension that hooks onto neighbouring molecules and thus forms a protein chain. Tucker 
et al, (1994), proposed that single stranded DNA is wound around a protein core of 
interacting DBP molecules.
I.I.4.4. Virion Assembly.
The first step in the assembly of adenovirus particles is the formation of 
capsomers from single polypeptides of hexon, penton base and fibre in the cytoplasm. 
The capsomers are transported to the nucleus where they assemble to form the capsid 
structure (reviewed in D'Halluin, 1995), a process that involves structural and non 
structural proteins (see Fig 1.1.3.). The assembly of the virus particle continues through 
several ordered stages, (see Fig 1.1.3.). Subsequently, DNA enters the capsid, an event 
which is mediated by a packaging sequence located at the left-hand end of the 
chromosome (reviewed in Schmid and Hearing, 1995). The encapsidation of the genome 
is polar and begins with the left end of the viral DNA. The LI 52/55K protein is present 
in assembly intermediates and is thought to act as a scaffold protein in encapsidation 
(Hasson et al, 1992). The next stage in assembly involves the entry of the core proteins 
forming a young virus particle. The final step is the action of the L3 virus coded 23K 
protease which cleaves six precursor viral proteins (Weber, 1976; Webster et al, 1993), 
resulting in the formation of an infectious mature virus particle.
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Figure 1.1.3. Adenovirus Assembly Pathway.
The four stages of virus assembly; light intermediates, heavy intermediates, young 
virions and mature virions are shown (top). The polypeptides only present in some 
structures are also shown (below). (Modified from D'Halluin, 1995).
1.2. Attachment And Internalisation.
1.2.1. Attachment
The initial contact between adenovirus and the host cell is mediated by the fibre 
protein, which binds to cell surface receptors (Philipson et al., 1968). This was shown in 
competition assays, where pretreatment of cells with purified fibre protein blocked the 
subsequent attachment of virus (Philipson et al., 1968; Wickham et al., 1993). The cell 
binding domain resides within the globular head of the fibre molecule at the C-terminus 
(Philipson et al., 1968; Henry et al., 1994; Louis et al, 1994). The number of adenovirus 
receptor sites on HeLa and KB cells has been estimated to be approximately 5,000 to 
10,000 per cell, and the number of receptor sites for fibre protein are one order of 
magnitude higher at 105 per cell (Philipson et al., 1968; Hughes and Mautner, 1973). This 
suggested that the virus undergoes multivalent binding at the cell membrane.
The identity of the cellular receptor is unknown at present, although some cellular 
proteins have been shown to bind fibre (Hennache and Boulanger, 1977; Svensson et al., 
1981; Defer et al., 1990; Belin and Boulanger, 1993; Di Guilmi et al., 1995). Hennache 
and Boulanger (1977) used affinity columns consisting of penton base and fibre such that 
the C-terminus of the fibre protein was oriented outwards. These authors identified three 
polypeptides from KB cell membranes that recognised Ad2 fibre (78K, 42K and 34K), 
furthermore these proteins could inhibit Ad2 attachment to KB cells. Svensson et al., 
(1981), showed that two glycoproteins of 40K and 42K could be purified from HeLa 
membranes using Ad2 virions immobilised on wheatgerm agglutinin columns. It is not 
known if the 42K species corresponds to that previously identified by Hennache and 
Boulanger (1977). In addition Belin and Boulanger (1993), identified three proteins of 
130K, 60K and 44K, from HeLa cell membranes, that bound with Ad2 virions in cross 
linking experiments. These proteins also bound antibodies to fibronectin and vitronectin 
receptors, and these authors suggested that extracellular matrix proteins and Ad2 may 
recognise similar adhesion sequences on the cell membrane. In an overlay protein binding 
assay Ad3 virus and Ad3 fibre bind a 130K protein from HeLa cells. (Di Guilmi et al,
1995).
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Although the cell receptor has not been identified there is evidence that 
adenoviruses from subgroups B and C use different receptors (Defer et al., 1990; 
Stevenson et al., 1995). Defer et al., (1990) showed that purified fibres from Ad2 
(subgroup C) did not efficiently block the infection of A549 or KB cells by Ad3 
(subgroup B). Also, in affinity blotting experiments with immobilised proteins from KB 
membranes, probing with either Ad2 or Ad3 virus particles revealed different patterns of 
affinity-labelled proteins from the two viruses. One major protein species of 47K was 
detected with Ad3, this protein could not be displaced by Ad2 fibre. Many proteins were 
observed that bound to Ad2 ranging from 15K to 130K. These proteins could be divided 
into two groups, based on their ability to bind Ad2 fibre. The cellular proteins described 
by these authors were also thought to be possible cellular receptor sites. Recently, 
Roelvink et al., (1996) has shown that Ad2 and Ad9 (subgroup D) can use the same 
cellular fibre receptor, but the binding strategies for attachment are different. Stevenson et 
al., (1995) found that two adenoviruses (Ad3 and Ad5) representing subgroups B and C, 
bound different cell receptors and that this interaction occurred via the fibre head domain. 
Furthermore, using chimeric fibre proteins in which the Ad3 and Ad5 head domains were 
interchanged resulted in the alteration of receptor specificity (Stevenson et al, 1995). A 
similar approach was carried out by Krasnykh et al., (1996) where an Ad5 vector was 
created with chimeric fibres consisting of Ad5 tail and shaft with an Ad3 knob domain. 
This virus also displayed an altered receptor recognition. Recently the tropism of Ad5 
has also been shown to be altered by exchanging the fibre with that of Ad7 (Gall et al,
1996). These modifications may facilitate a more efficient use of adenoviruses in areas 
such as gene therapy, where specific cell type targeting would be beneficial.
Most of the discussion so far has concentrated on subgroup B and C adenoviruses 
which have one fibre protein, however subgroup F viruses have two fibre genes encoding 
proteins of different sequence and shaft length (Kidd and Erasmus, 1989; Pieniazek et al., 
1989, 1990; Kidd et al, 1990, 1993; Davison et al, 1993; Yeh et al., 1994). In these 
viruses a mixture of fibres is present (both long and short) but only one extends from each 
vertex. In attachment studies by Yeh and Luftig (1991), Ad41 was found to bind to a 
single cell receptor on Hep-2 cells . The avian CELO adenovirus also has two fibres, but
in contrast to human subgroup F viruses both extend from the same vertex (Laver et al., 
1971; Hess etal., 1995).
Early studies showed adenovirus attachment to cells may lead to subsequent 
interactions with the cell membrane that stimulate virus internalisation. After the initial 
attachment of virus to cells, there is a clustering of adenovirus cell receptors on the cell 
surface, which is important in viral entry (Patterson and Russell, 1983; Persson et al., 
1983), as reagents that block the clustering of the receptor sites, result in the inhibition of 
virus uptake.
1.2.2. Internalisation.
I.2.2.I. Penton Base Protein.
The observation that Ad2 attaches to but does not enter some cells, suggested that 
entry into cells may require another host cell derived factor, as well as the receptor for 
Fibre protein (Silver and Anderson, 1988). Earlier studies had already suggested a 
possible interaction between the penton base protein and the cell membrane; these studies 
showed that when exposed to penton base, adherent cells round up and detach from glass 
or plastic surfaces in vitro (Pereira et al., 1958; Rowe et al, 1958).
Penton base sequences are known for a number of serotypes : Ad2 (Roberts et al.,
1986), Ad5 (Neumann et al., 1988), Ad 12 (Sprengel et al., 1994), Ad40 (Davison et al., 
1993), Ad3 (Cuzange et al., 1994), Ad4 (Mathias et al., 1994) and the fowl adenovirus 
type 10 (FAV-10) (Sheppard and Trist, 1992). Alignment of the amino acid sequences 
(Cuzange et al, 1994; Mathias et al., 1994), shows that amino and carboxy ends are 
conserved, however the central region is very variable. All the above serotypes except 
Ad40 and FAV-10, have a conserved Arg-Gly-Asp (RGD) sequence motif in the variable 
region. Ad40 differs from other human adenovirus serotypes by having an RGA sequence 
in place of RGD, however FAV-10 has no RGD sequence at all. The predicted secondary 
structure of the RGD domain suggests that it consists of a helix-tum-helix with RGD 
located at an exposed turn at the apex of the two helices (Mathias et al., 1994). The RGD 
motif is recognised by (X5P1, anbP3 and most a vp integrins (reviewed in Hynes, 1992).
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Structural studies of Ad2 virions by Stewart et al, (1993) revealed 10A protrusions on 
each polypeptide subunit of pentameric capsomer which may correspond to RGD 
domains. The RGD tripeptide motif is also found in a number of cell adhesion molecules 
including fibronectin and vitronectin. These extracellular matrix molecules adhere to cell 
membranes via their RGD sequence, which binds to cell surface receptors, termed 
integrins (reviewed in Hynes, 1992). Wickham et al, (1993), showed that internalisation 
of Ad2 is mediated by penton base binding to cell surface av integrins via the RGD 
sequence motif.
I.2.2.2. Integrins have a Role in Adenovirus Entry.
Integrins are specific cell surface receptors, they are heterodimers composed of a  
and p subunits, which are noncovalently associated with each other. There are 15 a  
subunits and 8 p subunits, which can form some 20 different heterodimers, and the 
subunit composition dictates ligand-binding properties (Hynes, 1992).
Wickham et al, (1993), showed that a number of human cell lines (A549, HeLa 
and M21) bound to penton base coated wells, and this binding was significantly reduced 
by preincubation with an RGD containing peptide. Pretreatment of cells with fibronectin 
or vitronectin reduced subsequent infection by Ad2, indicating the occupancy of cell 
surface integrins by matrix proteins. In addition, Ad2 infection was inhibited by 
preincubation of cells with soluble RGD containing peptides or with recombinant penton 
base. These results indicated that penton base interaction with cell surface integrins plays 
an important role in Ad2 infection.
In order to determine the role of specific av integrins in adenovirus infection two 
M21 melanoma cell lines were used (Felding-Habermann, 1992). M21-L4 cells express 
a vP3 and a vPs cell surface integrins and can attach and spread on immobilised Ad2
penton base protein, whereas M21-L12 cells do not express these integrins. M21-L12 
cells were significantly less susceptible to Ad2 infection than M21-L4 cells (Wickham et 
al, 1993). Also binding of penton base protein to M21-L4 cells could be inhibited by 
RGD containing peptides. In addition a combination of function-blocking monoclonal 
antibodies to a v03 and a vPs blocked Ad2 penton base attachment to cells. Inhibiting
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virus penton base RGD interaction with cells via av monoclonal antibodies or RGD 
peptides significantly reduced virus infection. The RGD sequence motif was shown to 
mediate virus binding to av integrins by Bai et al, (1993). These authors used a 
recombinant Ad2 penton base mutant containing the sequence RGE in place of RGD and 
showed that this mutant failed to support av integrin mediated cell adhesion. The mutant 
did not cause cell rounding and in an adhesion assay, cells did not adhere to wells coated 
with the penton base mutant, also these RGE mutants showed a decreased yield of virus.
Adenovirus attachment to cells is blocked by soluble fibre, but not by penton base 
protein (Philipson et al, 1968; Wickham et al, 1993). Viral attachment on both M21-L4 
(av+) cells and M21-LI2 (av-) was the same, however internalisation was significantly 
reduced in M21-LI2 cells compared to M21-L4 cells (Wickham et al, 1993). Synthetic 
RGD peptides, monoclonal antibodies to av integrins and recombinant penton base, 
could all be used to block the interaction of av integrin to virus. All of these inhibitors 
were shown to have no effect on attachment, although they did inhibit Ad2 internalisation 
(Wickham et al, 1993). These results showed Ad2 penton base interaction with cell 
surface integrins was required for efficient viral internalisation, and that virus attachment 
was an independent and separate event. There is a possibility that other integrins may also 
be involved in Ad2 internalisation, as M21-LI2 cells could be infected albeit at lower 
levels than M21-L4 cells (approx. 5 to 10 fold less).
I.2.2.3. Role of av Integrins in Other Adenovirus Serotypes.
The RGD sequence motif is conserved in several human adenovirus serotypes 
indicating that these viruses may also use av integrins for entry into host cells (Mathias et 
al, 1994). Mathias et al, (1994), looked at penton base proteins of different adenoviruses 
representing subgroups B, C and E (Ad3, Ad2 and Ad4, respectively). The cell lines 
M21-LI2 and M21-L4 were used by these authors to investigate the role of av integrins. 
They detected approx. 5 to 10 fold higher levels of infection, with all three serotypes, on 
M21-L4 cells compared to M21-LI2 cells, indicating that av integrins promote viral 
infection by different serotypes. Infection by Ad3 and Ad4 could be inhibited with a 
combination of av monoclonal antibodies or with RGD containing synthetic peptides, but
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not with RGE containing peptides. These results indicate that the RGD sequence motif in 
Ad3 and Ad4 mediate interaction with av integrins and this interaction is required for 
efficient virus infection.
Ad40 does not contain an RGD motif and it is possible that another route of viral 
entry is used by this virus, however as some non-RGD sequences can also mediate 
integrin binding (Hynes, 1992), the involvement of cell surface integrins in Ad40 cell 
entry cannot be ruled out.
1.2.2.4. av Integrins Enhance Adenovirus Mediated Gene-Delivery.
av integrins play an important part in adenovirus infection, and can be used to 
extend the host cell range to monocytes and T lymphocytes. Adenovirus has a restricted 
ability to infect PBM (peripheral blood monocytes). These cells have only low levels of 
surface av integrins and thus are resistant to Ad2 penton base binding. Huang et al., 
(1995), have shown that by exposing these cells to monocyte-specific growth factors, 
a vp3 and a vPs expression was upregulated on cell membranes. This resulted in increased
ability to bind penton base protein and increased susceptibility to adenovirus mediated 
gene-delivery. These studies could have important significance for the role of adenovirus 
in gene-delivery as a large part of the host defences involve cells of the immune system 
(i.e. monocytes and T lymphocytes).
1.2.2.5. Post-Internalisation Events.
Following internalisation adenovirus disrupts cell endosomes, a process requiring 
the low pH of the endosome and penton base protein (Seth et al., 1985; Mathias et al., 
1994; Seth, 1994; Wickham et al, 1994). In Ad2 infection, integrin a vP5 interaction with 
penton base has also been shown to be required for the release of virus from endosomes 
(Wickham et al, 1994).
Recently the L3 coded 23K protease has been shown to have a role in virus entry 
as well as assembly (Cotten and Weber, 1995; Greber et al, 1996). This was shown from 
studies using inhibitors of the protease which resulted in the inhibition of protein VI 
degradation and prevention of virus uncoating at the nuclear membrane (Greber et al.
21
1996). The protease is thought to act in entry by degrading the capsid stabilising protein 
VI and thus facilitate the dismantling of the virus particle.
The virus follows a stepwise uncoating process in which viral proteins are shed in 
an ordered fashion resulting in the release of viral DNA into the nucleus via nuclear pore 
complexes (Greber et al., 1993).
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1.3. Early Region 1A.
The El A region plays an important role in the regulation of adenovirus 
transcription and in transformation, and has thus been extensively studied. This section 
describes El A gene transcription and protein products. The roles of these proteins in 
different processes will be discussed briefly; more information can be found in the many 
reviews available (Berk, 1986; Shenk and Flint, 1991; Jones, 1992, 1995; Akusjarvi, 
1993; Nevins, 1995).
1.3.1. E1A Transcription.
The El A sequences for a number of adenovirus serotypes are now known, 
including those for human adenoviruses Ad2, 4, 5, 7, 12, 40 and 41 (see Davison et al, 
1993, and references therein). All E1A mRNAs that have been mapped, have been shown 
to be very similar, with the exception of mouse adenovirus type-1 (MAV-1) (Ball et al,
1989) which differs in having only one El A transcript (coterminal with the 3' end of 
E1B).
There are five mRNAs produced from the Ad2 El A region: 13S, 12S, 1 IS, 10S 
and 9S (see Fig 1.3.1.). All Ad2 El A mRNAs, with the exception of the 9S transcript, 
encode proteins which share amino and carboxy terminal ends and are translated in the 
same reading frame (Virtanen and Pettersson, 1983). The second exon of the 9S mRNA is 
read in a different reading frame to the 12S or 13S mRNAs. The major transcripts 
produced from the El A gene are the 13S and 12S mRNAs (Perricaudet et al, 1979), and 
the minor transcripts are 1 IS, 10S and 9S (Stephens and Harlow, 1987; Ulfendahl et al,
1987).
El A transcripts are the first mRNA expressed in a lytic infection, with 12S and 
13S first detected at 1.5-2h (Nevins et al, 1979), the level of these transcripts increase up 
to 5h p.i. and thereafter gradually decrease to 12h (Glenn and Ricciardi, 1988). The 10S 
and 1 IS mRNAs are detected at later times in infection (Stephens and Harlow, 1987) and 
the 9S mRNA accumulates in the cytoplasm at late stages after infection (Chow et al, 
1979; Wilson and Darnell; 1981).
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Figure 1.3.1. Ad2 E l A mRNAs and Protein Products .
The mRNAs are indicated by lines, introns by caret symbols and open reading 
frames by boxes. The three shaded areas represent the three regions of E l A conserved 
between different adenovirus serotypes. The size of the mRNAs and proteins are 
indicated. (Modified from Jones, 1992)
The El A promoter is active in the absence of any viral factors (Nevins, 1981), and 
consists of a TATA box, ATF binding site and many upstream promoter elements 
involved in the control of transcription. Three enhancer elements have been identified in 
the upstream region of El A. Element I is present in two copies, at least one of which is 
required to regulate and maintain a high level of El A gene transcription (Hearing and 
Shenk, 1986 and references therein). A cellular factor, EF-1A, binds to one binding site 
on both copies of element I and to three enhancer-proximal sites (Bruder and Hearing, 
1991 and references therein). Element II is situated between the two copies of element I 
and enhances transcription from all early promoters on the viral genome (Hearing and 
Shenk, 1986). Element ID is also present in two copies and contains the binding site for 
the cellular transcription factor E2F (Kovesdi et al, 1987). The E1A enhancer region is 
autoregulated by El A gene products (Tibbetts et al., 1986; Cogan et al., 1992). In the 
absence of El A proteins, transcription from the El A promoter is reduced approximately 
five fold, which suggested a role for El A proteins in the regulation of this gene (Montell 
et al., 1984a; Osbourne et al., 1984). Negative regulation also occurs and is thought to 
involve the 12S mRNA gene product (Cogan et al., 1992), thus the controlled expression 
of the gene depends on the relative amounts of El A proteins present.
1.3.2. E1A Proteins.
El A proteins are phosphoproteins located predominantly in the nucleus of 
infected cells (reviewed in Boulanger and Blair, 1991). The major El A proteins are the 
products of the 13S and 12S mRNAs, the 289R and 243R proteins respectively (see Fig
1.3.1.). The comparison of El A regions from various adenovirus serotypes, has identified 
three highly conserved regions designated CR1, CR2 and CR3 (see Fig 1.3.1) (Kimelman 
et al 1985, Moran and Mathews, 1987). Figure 1.3.2. shows different regions of the El A 
protein that have been found to have an important role in various processes and the 
binding sites of cellular proteins that are linked to some of these different functions. The 
CR1 domain present in 289R and 243R proteins is required for transcriptional repression 
and induction of DNA synthesis (reviewed in Jones, 1995). CR2 is needed for
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Figure 1.3.2. The Structural and Functional Domains of the E1A Protein.
CR1, CR2 and CR3 refer to the three conserved regions in the E l A protein of 
different adenovirus serotypes. The regions of the protein that have been shown to be 
important for the various functions indicated, are depicted by the boxes. The open boxes 
indicate regions consistently shown to be important, whereas the shaded boxes represent 
regions shown to be important in some but not all cases. (Modified from Jones, 1992)
transformation and induction of DNA synthesis, but may be dispensable for 
transcriptional repression (Stein et al, 1990). The CR3 domain is unique to the larger 
protein and is necessary and sufficient for the transactivation of adenovirus early genes. 
Protein fusion experiments show that this domain has two separable activities (Lillie and 
Green, 1989; Martin et al, 1990). The N-terminus of CR3 contains the transcriptional 
activation region and the C-terminus contains the promoter targeting region. Located 
within the N-terminus of CR3 is a C4 type zinc finger, point mutations of any of the 
cysteine residues that defined this motif eliminated transactivation function (Culp et al, 
1988; Martin et al, 1990; Webster and Ricciardi, 1991).
1.3.3. Transactivation.
E1A proteins modulate transcription from several viral (E1A, E1B, E2A, E3, E4, 
MLP and VA) and cellular promoters (including hsp70, c-fos, c-jun and PCNA) (for 
reviews see Berk, 1986; Shenk and Flint, 1991; Jones, 1992, 1995). El A proteins do not 
show sequence specific DNA binding (Ferguson et al, 1985; Chatteijee et al, 1988). It 
now appears transactivation by El A, occurs indirectly via different cellular components. 
A number of studies have identified cis-acting elements that are important in El A 
dependant transactivation through cellular trans-acting factors. The promoter elements 
and DNA binding factors important for transcription from a number of adenovirus 
promoters are shown in Fig 1.3 3. The promoters encompass a wide variety of elements 
and do not seem to share common sequences. Therefore studies concerning the 
mechanism of transactivation have concentrated on determining the cellular factors 
binding to these elements and how the activities of these factors are altered by El A 
proteins.
TFIID binds the TATA box sequence and consists of the TATA-box binding 
protein (TBP) and TBP-associated factors (TAFs) (Zhou et al, 1993). The E1A 289R 
protein can bind directly to TBP (Horikoshi et al, 1991; Lee et al, 1991), Boyer and 
Berk (1993) have shown that El A stimulates transcription by association with TFUD 
through the CR3 domain. The E1B promoter is one of the simplest found in the
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Figure 1.3.3. Diagram of Adenovirus Promoter Elements and Factor Binding Sites.
Adenovirus promoters are represented by the solid horizontal lines and the arrow 
heads designate the major sites of transcription initiation. The open boxes represent the 
main promoter elements involved in transcription. Note that the E4 transcriptional 
control region is on a different scale. (Modified from Jones, 1992)
adenovirus genome, it consists of a TATA box element and a consensus Spl binding site 
(see Fig 1.3.3.) (Wu et al, 1987). Upstream sequences that mediate the effects of E1B 
transcription in the absence of a functional Spl binding site have also been described 
(Parks et al., 1988: Spector et al, 1993). Mutations in the Spl site reduced transcription 
but El A transactivation still occurred. However, mutations in the TATA box sequence 
eliminated El A protein transactivation (Wu et al, 1987). The TATA element is also 
important in El A transactivation of some cellular genes e.g. hsp70 (Simon et al, 1988). 
Therefore it appears a subset of El A response promoters primarily require the TATA box 
for transactivation (Wu et al, 1987; Simon et al, 1988). However, other adenovirus 
promoters are not as dependent on this element for transactivation by El A (Berk, 1992). 
This was illustrated when it was shown that mutations in the TATA box sequence of the 
E3 promoter did not eliminate transactivation (Garcia et al, 1987). The E2A promoter 
contains a TATA-like sequence, but similarly mutations in this element do not much alter 
transactivation by El A. El A itself is not wholly dependant on the El A TATA box motif, 
as deletion of this element decreases but does not abolish transactivation (Hearing and 
Shenk, 1985). The 243R protein can also activate through the TATA element, although 
this activation is weaker than 289R. The 243R protein binds to Drl a cellular protein that 
interacts with TBP (Kraus et al, 1994 and references therein). El A dissociates the TBP- 
Drl complexes which inhibits transcription (Kraus etal., 1994).
Several of the adenovirus early promoters contain ATF binding sites, which bind 
the cellular transcription factor ATF (activating transcription factor). In E2A, E3 and E4 
these sites are important for both basal and El A induced transcription (reviewed in Berk, 
1986; Shenk and Flint 1991; Jones, 1995). The ATF element is identical to the CRE 
element (cAMP responsive element) and promoters containing this motif can be 
transcriptionally activated by increased cAMP levels via the CRE binding protein 
(CREB). ATF/CRE sites are recognised by a family of related proteins (see Shenk and 
Flint, 1991), many of the cDNAs encoding ATF/CREB proteins that bind to these 
elements have been cloned (Chatton et al, 1994, and references therein). Analysis of 
these proteins showed they belong to the 'bZIP' family, comprising of a basic region at 
the C-terminus which is adjacent to a leucine zipper motif, these confer sequence-specific
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DNA binding and protein dimerisation capabilities. Members of this family have been 
shown to bind as hetero or homodimers depending on the amino acid composition of the 
leucine zipper (Hai and Curran, 1991). Initially, ATF-2 was the only member of this 
family shown to mediate El A inducible transcriptional activation, whereas other 
members of the ATF family (ATF-1, ATF-4 and CREB) did not support activation in this 
system (Liu and Green, 1990). Another member of the ATF family, ATFa, has now also 
been shown to be responsive to E1A (Chatton et al., 1994). The E1A 289R protein 
interacts with ATF-2 through its DNA binding motif (bZIP), but the N-terminal 96 amino 
acids of ATF-2 are also important as deletion of this region destroys El A activation (Liu 
and Green, 1994). The ATF-2 and TBP proteins bind to different CR3 domains (Lee et 
al., 1991). A simple model is proposed in which El A functions as a coactivator or 
bridging protein by binding to ATF-2 at an upstream site and TBP, to activate 
transcription.
Proteins binding to AP-1 (activator protein 1) sites come from a group of related 
proteins, of the Jun and Fos gene families. They become active transcription factors by 
forming Jun/Jun homodimers or Jun/Fos heterodimers at target sites. The AP-1 binding 
site sequence differs from the consensus ATF/CRE site by only one nucleotide. The AP-1 
proteins share structural features to ATF/CREB proteins and can also heterodimerise with 
members of this family (Hai and Curran, 1991). Both the ATF and API sites in the E3 
promoter were shown to be crucial for transactivation by El A in vivo (Komuc et al.,
1990).
El A and E2A promoters contain E2F binding sites (see Fig 1.3.3.) (Manohar et 
al., 1990). The cellular transcription factor E2F binds two sites in the E2A promoter, and 
this has been shown to be important for its ElA-induced transcription (reviewed in 
Nevins, 1995). In addition E2F sites can confer El A inducibility to an unresponsive 
promoter (Kovesdi et al., 1987; Yee et al, 1989) and in adenovirus infected cells E2F 
DNA binding activity was shown to dramatically increase. This suggests a role for the 
ElA-dependant activation of transcription by E2F. The transcription factor E2F is now 
known to consist of a group cellular proteins, including E2F-1 and DP-1, that form 
heterodimers at E2F binding sites (Helin and Harlow, 1994). E2F binds to the two E2F
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sites on the E2A promoter, which are inverted with respect to one another. The 
cooperativity of these elements is abolished if the spacing between the E2F sites is 
increased. The DNA-protein complex is further stabilised by the cooperative binding of 
E4 19.5K (see Nevins, 1995 and references therein). E2F forms a complex with Rb (the 
retinoblastoma gene product), which blocks E2F activation of transcription (Bandara and 
La Thangue, 1991). E1A activates transcription by binding to Rb and dissociating E2F- 
Rb complexes, freeing E2F (Whyte et al, 1989; Zamanian and La Thangue, 1992). 
Interaction with Rb is dependent on sequences within the CR1 and CR2 domains of El A 
(Raychaudhuri et al, 1991). Another way the pool of free E2F can be increased is by 
phosphorylation of Rb. The phosphorylation of Rb prevents the formation of complexes 
with E2F (Kato et al, 1993), which increases the pool of uncomplexed E2F. 
Transactivation of the E2A promoter requires four elements; an ATF site, two E2F sites 
and the TATA-like sequence element; mutation of any one of these elements eliminates 
transactivation (Manohar et al, 1990). E2F sites however are the main regulators of the 
E2 promoter, whereas ATF plays a more minor role (reviewed in Akusjarvi, 1993).
The E4F cellular transcription factor binds to three regions in the E4 promoter, 
two of which overlap ATF binding sites (see Fig 1.3.3.). E4F sites have not been detected 
in other viral promoters, indicating that these proteins are distinct factors (Raychaudhuri 
et al, 1989). Mutations that eliminated E4F binding had no effect on ATF binding, 
indicating that independent pathways were used by these two factors. The E4F sites 
mediate ElA-responsiveness in the E4 promoter, this was shown when deletion of these 
upstream sequences resulted in elimination of this response. El A acts by inducing the 
phosphorylation of transcription factor E4F, leading to an increase in its DNA-binding 
activity (Raychaudhuri etal., 1989; Bondesson etal., 1992).
Other adenovirus promoters dependent on El A activation include those from the 
major late transcription unit and VA RNA genes. The MLP contains two main promoter 
elements; the TATA box sequence and an upstream sequence element (UE) (reviewed in 
Shenk and Flint, 1991), elements downstream have also been shown to have an affect on 
promoter function (Mansour et al, 1986; Mondesert et al, 1992). Leong et al, (1988) 
have shown that transcription from the MLP could be stimulated with TFIID-containing
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cell extracts. The initiation complex is further stabilised by interactions between ThilD 
and the factor USF which binds to UE (Carthew et al, 1985; Moncollin et al., 1986). For 
the MLP El A transactivation occurs through association with TF11D (Leong et al.,
1988). Activation of VA RNA gene transcription requires the transcription factors T f i i i b  
and TF111C. El A expression increases the amount of transcriptionally active TFlIlC 
(Hoeffler et al., 1988). lFlllC then binds directly to a DNA sequence within the internal 
control region of the genes, thereby allowing TFIIIB and RNA polymerase HI to bind 
(Hoeffler and Roeder, 1985).
1.3.4. Transcriptional Repression.
El A proteins can also repress the transcription of several viral (both polymerase n  
and HI) and cellular genes (reviewed in Jones, 1992). In many repression studies the N- 
terminus and CR1 domain were shown to be essential (Stein et al ., 1990 and references 
therein). However in some studies the CR2 domain and some second exon sequences are 
also thought to be involved (Lillie et al., 1986; Velcich and Ziff, 1988; Jelsma et al.,
1989). The reason for these differences is unclear but could depend on the promoter 
studied or cells used for the assay. The mechanism is unclear, however it was shown that 
the binding of a cellular protein p300 to the N-terminus and CR1 domain correlated with 
El A enhancer repression (Jelsma et al, 1989; Stein et al, 1990; reviewed in Moran,
1993). Abraham et al, (1993) found p300 interacts with TBP; a model was proposed in 
which El A sequestered p300 from TFDD complexes, resulting in transcriptional 
repression.
1.3.5. Transformation.
Adenoviruses (type 12) were first shown to be oncogenic when it was shown that 
subcutaneous injection of Ad 12 into newborn hamsters lead to the development of 
rapidly growing tumours at that site (Trentin et al, 1962). The majority of human 
adenoviruses are non-tumorigenic in hamsters, (see Table 1.1.1.). It was later shown that
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all these viruses could transform primary rodent cells (Freeman et al, 1967). The genes 
responsible for oncogenicity and cell transformation were found to be located at the left 
end of the genome and comprised the early region 1 (reviewed in Dyson and Harlow,
1992).
The El A gene products alone can immortalise primary cells in tissue culture (van 
der Eb et al, 1979; Houweling et al., 1980) but for full transformation cooperation with 
other oncogenes is required, these include the adenovirus E1B proteins, activated ras or 
polyoma middle T oncogenes (van den Elsen et al., 1983; Ruley, 1983). The E1A 
nonconserved N-terminus, CR1 and CR2 domains are necessary for cell transformation, 
whereas the CR3 region is dispensable (Lillie et al., 1986; Lee et al., 1991). The regions 
important for transformation were found to strongly correlate with areas required for 
interactions with certain cellular proteins. This suggested that these interactions were 
important for the transforming function (Egan et al., 1988; Whyte et al., 1989; Howe and 
Bayley, 1992). Many of these proteins were first identified by co-immunoprecipitation 
with El A proteins. Harlow et al., (1986) found approximately ten proteins associated 
with El A, and they ranged from 28K to 300K, Some of these have been identified and 
are described below.
p i05 (or Rb) is the retinoblastoma tumour suppressor protein (Whyte et al,
1989). This was the first of the proteins identified which was found to interact with E1A, 
it has also been found to interact with other virus proteins such as SV40 large T antigen 
and the papillomavirus E7 oncoprotein (Dyson et al, 1989; Mtinger et al., 1989). 
Activity of Rb is regulated by phosphorylation, which changes in different phases of the 
cell cycle (Ludlow et al., 1990). The unphosphorylated form is thought to be the active 
form and in this state the protein is able to complex with E2F (Kaelin et al., 1992). The 
Rb protein binds to El A via a core binding sequence termed the pocket, which is 
conserved in Rb and the Rb related protein pl07 (Corbeil and Branton, 1994 and 
references therein). The pocket consists of two regions A and B separated by a 
nonconserved spacer which is of different lengths in Rb and p i07 (Raychaudhuri et al.,
1991). Rb binding to E1A requires both CR1 and CR2, but relies largely on CR2. pl07 
was first identified by association with El A and SV40 large T antigen (reviewed in
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Dyson and Harlow, 1992). This protein shares many structural and biochemical 
properties with Rb, including binding with E2F. However unlike the Rb protein, p i07 can 
form a complex with cyclin A (p60) and is also found in complexes with cyclin E and 
cdk2 (Faha et al, 1993). Zhou et al, (1993), have isolated full length pl07 cDNA and 
found that it can inhibit cell proliferation. A function for pl07 has yet to be determined. 
However, owing to its many similarities to the Rb protein it seems likely it may be a 
tumour suppressor. Another protein that associates with El A is pi 30, which shares some 
features with Rb and pl07 proteins. One of these is that it contains the pocket region and 
has been shown to bind E1A and E2F via this area (Cobrinik et al, 1993). Analysis of 
pl30 cDNA revealed it was more closely related to pl07 than Rb, as pl30 and pl07 have 
a similar sized spacer between domains A and B in the pocket region (Li et al, 1993). 
p i30 can interact with cyclins A and E, which is reminiscent of p i07 interactions.
There are two active sites important for transformation in El A, the first consists 
of CR2 plus the N-terminal end of CR1. Proteins that bind here belong to the Rb gene 
family (Rb, p i07 and p i30), and binding occurs via the pocket region. The second active 
site consists of the N-terminus of El A and the C-terminus of CR1, the phosphoprotein 
p300 binds this region (for review see Moran, 1993 ) which has been shown to be 
responsible for repression (see section 1.3.4). Studies show that p300 is a component of 
TBP complexes, (Abraham et al, 1993). In addition the sequence of the protein has 
features associated with a transcriptional adaptor molecule (co-activator) (Eckner et al,
1994). It appears that p300 has similar functional properties to CBP which has been 
identified as a coactivator for protein kinase A (PKA) (Lundblad et al, 1995). Adding 
support to the role of p300 as a coactivator, Arany et al, (1995) has shown that CBP and 
p300 activate transcription when fused to a DNA binding domain. A model suggested for 
p300 in repression, is that El A binds to p300 thereby preventing its role as a coactivator 
and results in the repression of promoters that require this coactivator function.
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1.4. Early Region IB.
1.4.1. Genomic Organisation of the E1B Region.
The Ad2 E1B region lies immediately adjacent to the El A region, between map 
units 4.6 and 11.2 (see Fig 1.1.1.). The E1B DNA sequence has been determined for 
several serotypes including Ad2, 4, 5, 7, 12, 40, 41, CAV-2, MAV-1, SAV-16 and TAV 
(Bos et al, 1981; Kimura et al, 1981; Gingeras et al, 1982; Dijkema et al, 1982; 
Dekker et al, 1984; Fliigel et al, 1985; Tokunaga et al, 1986; van Loon et al, 1987b; 
Ishino et al, 1988; Shibata et al, 1989). There are three open reading frames present in 
this region (see Fig 1.4.1), two of which are overlapping. Comparison of sequences 
revealed there was considerable homology spread over the region at both the DNA and 
amino acid levels (van Ormondt and Hesper, 1983; Ishino et al, 1988). This was in 
contrast to El A where defined areas were found to be highly conserved (see section 1.3.).
Transcription maps for many adenovirus serotypes are also now known including 
Ad2, 5, 7, 12, 40, 41 and MAV-1 (see Steinthorsdottir and Mautner, 1991 and references 
therein; Allard and Wadell, 1992). Figure 1.4.1. shows the Ad2 E1B transcription map 
and open reading frames. Transcripts made from the Ad2 E1B region are differentially 
spliced to produce two mRNA species of 22S and 13S, plus two minor species of 14.5S 
and 14S; all of these have common 5' and 3' termini (Berk and Sharp, 1978; Virtanen and 
Pettersson, 1985). A 9S mRNA is transcribed from its own promoter and encodes the 
structuralprotein ppIX.
Other adenovirus serotypes have similar but not identical organisation to Ad2. In 
Adl2, no 13S mRNA has been detected (Virtanen et al, 1982) and the 14S transcript 
which is minor in Ad2, is major in Adl2. The MAV-1 E1B region has only two mRNAs, 
one corresponds to a 22S mRNA and the other is identical but differs with the presence of 
a splice which eliminates most of the first open reading frame. A more detailed analysis 
of the Ad40 and Ad41 E1B transcription has been carried out and will be discussed in 
detail elsewhere (see section 1.5.), however both were found to be more similar to Ad 12 
than Ad2 with 22S and 14S the predominant species and no 13S mRNA was detected.
Cotranscript counterparts of E1B mRNAs have been reported, which originate 
from the El A promoter and terminate at the 3' end of E1B. They have been detected in
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Figure 1.4.1. Transcription Map for the Ad2 E1B Region.
The sedimentation values (S) for mRNAs, and molecular weight (K) are shown, in 
addition the number of amino acids residues (R) for each protein is indicated. Solid lines 
denote RNA and introns are indicated by carets; shaded rectangles denote open reading 
frames.
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low amounts in Ad2-, Ad5- and Adl2-infected and-transformed cells (Berk and Sharp, 
1978; Kitchingman and Westphal, 1980; Sawada and Fujinaga, 1980; Saito et al, 1983; 
van den Elsen et al, 1983; Hashimoto et al, 1984). In Adl2, cotranscripts have the same 
5' ends and splice sites as the major El A mRNAs and extend to the 3’ end of E1B, with a 
splice corresponding to the splice in E1B 22S naRNA. The Ad2 cotranscript has fewer 
than 50bp of the end of El A linked to a site near the 5' end of E1B, however a detailed 
analysis of these mRNAs has not been carried out. Cotranscripts have also been detected 
in Ad40 infected cells (Hashimoto et al, 1991; Steinthorsdottir and Mautner, 1991; 
Ishida et al, 1994). A more detailed analysis of cotranscript structure with this serotype 
has been carried out and is described in section 1.5.
1.4.2. E1B Transcription.
Control of the E1B transcriptional unit is complex and occurs on many levels 
which include initiation of transcription, splicing and mRNA stability.
In Ad5, 22S mRNA is detected early in infection between 3-3.5 h p.i. and 
increases in abundance up to 9h, after which levels are constant through to 12h. The 13S 
transcript is detected at low levels until 8h p.i. and then increases in abundance; at 12h 
p.i. levels are similar to 22S. After this time 22S gradually decreases and at late times in 
infection the major transcript becomes the 13S mRNA (Glenn and Ricciardi, 1988). 
Minor E1B species were not studied by these authors, however Virtanen and Pettersson 
(1985) analysed the pattern for 14S and 14.5S mRNAs. They found that at 8h p.i. the 14S 
transcript was approx. 20 fold more abundant than 14.5S mRNA, while at late times in 
infection both species were detected in similar amounts.
Changes in the abundance of cytoplasmic E1B mRNAs is partly due to the 
relative changes in the half-life of 13S mRNA compared to 22S mRNA (Wilson and 
Darnell, 1981). Stability of E1B mRNAs is influenced by DBP (Babich and Nevins, 
1981) which causes the rapid turnover of mRNA. These authors suggested that at late 
times 13S mRNA accumulates as it is no longer destabilised by DBP and 22S is thought 
not to accumulate as it is degraded by an unknown mechanism. Another factor that may
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account for the differences in accumulation of E1B mRNA, is the change in specificity of 
the RNA splicing mechanisms. Montell et al., (1984b) found that there is an increased 
propensity to use the 13S 5' splice site at late times in infection.
1.4.3. E1B Proteins.
The E1B 22S mRNA codes for two proteins (see Fig 1.4.1) from different 
overlapping reading frames (Bos et al, 1981). The 19K protein is produced using the first 
AUG and comprises 175 amino acid residues (175R), the 55K protein (495R) is produced 
from the second AUG in a different reading frame (Perricaudet et al., 1979; Bos et al., 
1981; Gingeras et al, 1982). The 13S mRNA encodes the 19K protein, and a smaller 
species (82R) related to the 55K protein. 14S and 14.5S mRNAs encode proteins of 92R 
and 155R (15K), respectively (Green et al., 1982; Lucher et al., 1984; Lewis and 
Anderson; 1987). Both the 55K and 19K proteins will be discussed in more detail see 
sections 1.4.5. and 1.4.6.
1.4.4. E1B Promoter.
Unlike other early adenovirus genes (see Fig. 1.3.3.), E1B has a relatively simple 
promoter located within 50bp of the cap site (Wu et al., 1987). It consists of a TATA box 
(TFIED binding site) and a GC box (Spl binding site). These motifs are present in the 
E1B transcriptional control region of all the adenovirus serotypes sequenced (see Fig 
4.6.1.).
In the Ad2 E1B promoter the Spl binding site is situated -48 to -39bp and the 
TATA box -30 to -23bp with respect to the cap site (Wu et al, 1987; Schmidt et al.,
1989). The GC box is not necessary for transactivation by El A, which occurs through the 
TATA box (Wu et al., 1987), but does act to stimulate transcription and deletion of this 
element reduces E1B transcription by approx. 7 fold. The spacing between the two 
elements was shown to be critical in Ad5 (Wu and Berk, 1988a). Increasing the distance 
between the two elements by insertion of additional sequences resulted in a decrease in
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transcription (Wu and Berk 1988a; Segal and Berk, 1991). A 30bp separation decreases 
transcription levels such that the stimulatory effect of the GC box is eliminated. In 
addition to the proximal promoter elements described above upstream sequences have 
also been reported to play a role in E1B transcription (Parks et al, 1988; Spector et al,
1993). Four protein binding sites (I-IV) were identified in the region -250 to -120bp (with 
respect to the cap site) in DNase I footprint assays using KB cell nuclear extracts. These 
sites were found to stimulate transcription in cis, but only in the absence of the GC box 
(Parks et al, 1988: Spector et al, 1993). An additional site (V) which is situated adjacent 
to the E1B GC box has also been reported (Spector et al, 1993). However other studies 
have reported that this distal region (-250 to -125) makes only a modest contribution to 
E1B transcription in vivo (Wu et al, 1987; Wu and Berk, 1988b).
The transcription factor Spl activates transcription from both viral and cellular 
genes which have a GC box sequence (reviewed in Kadonaga et al, 1986; Courey and 
Tjian, 1992). A comparison of a large number of binding sites for Spl (Kadonaga et al,
1986) led to a consensus recognition sequence (5' G/T GGGCGG G/A G/A CYT 3'). Most 
Spl binding sites do not differ from the consensus by more than one or two bases, with 
the central residues highly conserved. Purified Spl appears on a SDS-PAGE gel as 2 
bands of 95K and 105K. Analysis has shown that this heterogeneity is due to 
posttranslational modifications of a single polypeptide (Kadonaga et al, 1987; Jackson et 
al, 1990). The two forms of Spl arise by differential phosphorylation. Jackson et al, 
(1990) showed that Spl is multiply phosphorylated by a kinase that requires the presence 
of DNA. The kinase was later identified as DNA-dependent protein kinase (DNA-PK) 
(Gottlieb and Jackson, 1993 and references therein). Spl has several O-linked N-acetyl 
glucosamine residues and these appear to enhance the stimulatory effect of Spl to 
activate transcription in vitro (see Courey and Tjian, 1992 and references therein). Spl 
can be purified from HeLa cells (Briggs et al, 1986), and its cDNA has been cloned and 
sequenced (Kadonaga et al, 1987). Analysis of Spl structure and function in mutagenesis 
studies revealed discrete functional domains within the protein. The carboxy terminal 168 
amino acids comprise the DNA-binding domain which consists of three zinc fingers
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(Cys-2His-2) that bind to the GC box. The amino terminus contains several regions that 
mediate transcriptional activation, two of these are glutamine-rich.
Spl activates transcription in a synergistic manner when more than one GC box is 
present, at proximal and distal sites (Courey et al 1989; Pascal and Tjian, 1991). This 
synergy involves direct contact between Spl molecules bound at two sites, with looping 
out of the intervening DNA. (Pascal and Tjian, 1991). A DNA-binding deficient form of 
Spl can interact with DNA-binding competent forms of the protein to stimulate 
transcription synergistically; this phenomenon is known as superactivation. Both these 
observations suggest that Spl binds to DNA and then activates the basic transcriptional 
apparatus through protein-protein interactions. In vitro studies show that Spl 
communicates with TFIID through a coactivator TAF protein, TAF110 (Pugh and Tjian, 
1990; Hoey et al., 1993).
1.4.5. The E1B 19K Protein.
The 19 kilodalton (19K) protein is located in the nuclear and cytoplasmic 
membranes of infected (Ad2 & Adl2) and transformed (Adl2) cells (Persson et al, 1982; 
Grand and Gallimore, 1984; White et al, 1984a; Smith et al, 1989; Mitchison et al,
1990) and has been found to associate with intermediate filaments (White and Cipriani, 
1989, 1990). Immunofluorescence studies show that 19K is present in the cytoplasm 
early in infection and accumulates in the nucleus late in infection. The 19K protein is 
post-translationally modified; it is acylated with palmitate and myristate residues 
(McGlade et al, 1987). Acylation may have a role in the membrane association of this 
protein. Another modification is that a subfraction of molecules are phosphorylated (at 
Ser-164), however this has not shown to be essential for the function of the protein 
(McGlade et al, 1989). Mutants defective in the synthesis of the 19K protein have 
various phenotypes; these include an enhanced cytopathic effect in human cells (cyt 
phenotype) (Pilder et al, 1984; Subramanian et al, 1984; Takemori et al, 1984) and the 
formation of large plaques (Ip phenotype) in KB, HeLa and A549 cells (Chinnadurai et 
al, 1983). In many cell lines, some of these mutants also elicit a DNA degradation
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phenotype (deg), with extensive degradation of cellular and viral DNA, (Ezoe et al., 
1981; Lai Fatt and Mak, 1982; Pilder et al., 1984; Subramanian et al., 1984; White et al., 
1984b) resulting in a reduced yield of virus (Subramanian et al., 1984). 19K is therefore 
thought to have an important role in the virus replication cycle and is necessary for 
stabilising viral and cellular DNAs (reviewed in Stillman, 1986; Boulanger and Blair,
1991).
In a number of studies 19K (loss of function) mutants were shown to be defective 
for complete transformation and the 19K protein required for oncogenic transformation 
(see Boulanger and Blair, 1991, and references therein; McLorie et al., 1991). DNA 
transfection studies show that either E1B 19K or 55K proteins can cooperate with El A to 
induce transformation (at reduced levels) by independent but additive pathways (White 
and Cipriani, 1990; McLorie et al., 1991). In contrast, others have found that the 19K 
protein is not required for transformation (Zhang et al., 1992a; Telling and Williams, 
1993; Telling et al., 1994). There is no clear explanation for the differences observed 
among these studies. Zhang et al (1992a) proposed these differences (for Adl2) could be 
due to an overexpression of 55K protein observed with a 19K mutant in which the 19K 
start codon is removed. Elimination of this site, which normally suppresses induction at 
the downstream 55K start codon, leads to overexpression of the 55K protein and efficient 
transformation of BRK cells. However no overexpression is detected with comparable 
Ad5 mutants and transformation efficiencies with these mutants is low (White and 
Cipriani, 1990; McLorie etal., 1991).
Adenovirus early gene expression triggers apoptosis or programmed cell death 
which is the process by which a cell can actively commit suicide under tightly controlled 
circumstances. Apoptosis has an important role in normal mammalian development and 
abnormal regulation can lead to neoplastic transformation, in addition it is a defence 
against cancer and removes virally infected cells (for reviews see White, 1994, 1995). 
The effect of apoptosis in adenovirus was first shown with E1B 19K loss of function 
mutants, which displayed cyt and deg phenotypes, also DNA fragmentation. These 
properties were also shown to be characteristics associated with apoptosis (see White, 
1995, and references therein). The DNA fragmentation characteristic of apoptosis is the
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digestion of cellular DNA into nucleosome sized pieces, indicating that DNA is cleaved 
between nucleosomes in chromatin (Wyllie et al., 1980). A pattern of nucleosomal DNA 
fragmentation more associated with apoptosis was observed with a 19K temperature 
sensitive mutant (Rao et al., 1992).
Studies with 19K defective mutants suggested that this protein acted to suppress 
apoptosis and another viral protein was the trigger for apoptosis (White and Stillman,
1987). The induction of apoptosis by adenovirus was mapped to the E1A gene by 
constructing and analysing recombinant adenoviruses with mutations in various genes in 
the background of an E1B 19K mutation. When E1A was not expressed, this led to an 
absence of the effects of apoptosis and suggested that El A was the factor that induced 
apoptosis (White and Stillman, 1987; White et al., 1991).
Apoptosis contributes to the transformation process; this was shown with studies 
using BRK cells (White et al., 1992). When E1A alone was expressed, foci formation 
was observed but not sustained. However coexpression of El A with a second cooperating 
oncogene, E1B, allowed growth of transformed foci to be sustained. This indicated that 
E1B proteins contributed to transformation by suppressing cell death (Rao et al., 1992; 
White et al., 1992). Similarly a known inhibitor of apoptosis, the Bcl-2 protein, when 
coexpressed with El A decreases cell death and increases transformation efficiencies (Rao 
et al., 1992). The 19K protein shows structural and functional homology to Bcl-2, 
indicating it might be a member of the Bcl-2 family. Both the E1B proteins 19K and 55K 
inhibit El A induced apoptosis (Rao et al., 1992). The 55K protein binds to and inhibits 
the function of p53 (tumour suppressor) in transformed cells (Yew and Berk, 1992, Yew 
et al, 1994). As 55K expression also inhibits apoptosis in transformation studies, this 
indicates that inactivation of p53 may prevent apoptosis. The E1B 19K protein is a more 
potent inhibitor of apoptosis than 55K in transformed cells (Rao et al, 1992). The 
consequence of the induction of apoptosis by El A during infection and in the absence of 
19K is the premature death of the host cell, which can substantially impair virus yield 
(Pilder et al., 1984; Subramanian et al., 1984). The suggestion that the 19K protein acts at 
a common step in the apoptosis pathway came from the ability of 19K to inhibit
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apoptosis induced by TNF-a and Fas antigen, and also with the drug cisplatin (Gooding 
e ta l, 1991; White eta l, 1992; Subramanian, 1993; Chiou et al, 1994).
There are several lines of evidence indicating that p53 has a role in ElA-induced 
apoptosis: 55K can bind to and inhibit p53 which will also suppress apoptosis (Samow et 
al, 1982b; Yew et al, 1994); E1A expression produces p53 accumulation (Lowe and 
Ruley, 1993; Chiou et al, 1994); dominant negative mutant forms of p53 suppress 
induction of apoptosis by El A (Debbas and White, 1993) while returning p53 to wild 
type results in apoptosis. This suggested that p53 was necessary for the induction of 
apoptosis by E1A with p53 perhaps acting as a molecular switch for E1A induced 
apoptosis. The 19K and Bcl-2 proteins were later shown to inhibit the induction of 
apoptosis by p53 (Debbas and White, 1993; Chiou et al, 1994). Using BRK cell lines 
transformed with El A which contained a temperature sensitive p53 mutant, introduction 
of either the 19K gene or bcl-2 gene prevented apoptotic cell death with wild type p53 
(Debbas and White, 1993). p53 can induce either apoptosis or growth arrest depending on 
the physiological conditions (reviewed in White, 1994, 1995). 19K (and Bcl-2) can 
inhibit p53-mediated apoptosis with p53-mediated growth arrest left intact (Chiou et al, 
1994). This suggests that apoptosis and growth arrest activities of p53 are separable.
p53 is a transcription factor which can repress or transactivate genes (reviewed in 
Zambetti and Levine, 1993). Sabbatini et al, (1995) have shown that 19K alleviates p53 
mediated transcriptional repression but does not affect p53 mediated transactivation. 
These authors suggest that p53 could induce apoptosis via a generalised transrepression 
mechanism and 19K inhibits this by modulating the transrepression function of p53.
The precise mechanism of how E1B inhibits apoptosis is not known yet. However 
studies have been carried out to identify cellular proteins that bind E1B 19K in an attempt 
to understand the molecular basis of this inhibition (Farrow et al, 1995; Han et al, 1996 
and references therein). A few proteins were found to bind both 19K and Bcl-2, one of 
these is Bax which is p53-inducible (Han et al, 1996). Interaction of Bax with Bcl-2 
prevents the inhibition of apoptosis and interaction with 19K similarly blocks the ability 
of 19K to inhibit apoptosis (Chen et al, 1996). Chen et al, (1996) have recently shown 
that 19K does not interact with the Bad protein, but Bcl-2 will bind it. Bad, is a cellular
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protein that regulates the Bcl-2/Bax interaction and restores susceptibility to continue 
down the apoptosis pathway. Another cellular protein that binds 19K is Bak, a member of 
the Bcl-2 family (Farrow et al., 1995).
1.4.6. The E1B 55K Protein and Related Polypeptides.
The Ad2 22S mRNA encodes the 55 kilodalton (55K or 495R) protein (see Fig 
1.4.1 and section 1.4.1). In addition there are 55K related proteins (82R, 92R and 155R or 
15K) which are encoded by the smaller mRNA species (see Fig 1.4.1) (for reviews see 
Stillman, 1986; Boulanger and Blair, 1991).
A number of studies have shown that the 55K protein is phosphorylated at both 
serine and threonine residues (Malette et al., 1983; Spindler et al., 1984; Schughurt et al., 
1985). The Ad5 15K (153R) protein was also shown to be phosphorylated, and both the 
84R and 93R proteins were found to be either unphosphorylated or phosphorylated at 
levels below detection (Takayesu et al., 1994). Experiments by Teodoro et al., (1995), in 
which phosphorylation sites were mutated, indicated that C-terminal phosphorylation 
sites may be important for transformation
The 55K protein is found both in the nucleus and cytoplasm of infected cells, 
although it is predominantly located within the nucleus (Samow et al., 1984; Omelles and 
Shenk, 1991). In the cytoplasm it is found in a diffuse pattern and in an intensely stained 
fibrous body adjacent to the nucleus (Omelles and Shenk, 1991). In the nucleus the 
protein is observed in a granular diffuse pattern and also in local concentrations both 
within and near the periphery of virus-specific inclusion bodies. Different locations may 
reflect different functional forms and different interactions of proteins.
The 55K protein is found in complex with the E4 34K protein in infected cells 
(Samow et al., 1984; Cutt et al., 1987; Leppard and Shenk, 1989); both proteins are also 
detected uncomplexed (Cutt et al., 1987; Smiley et al., 1990). The E1B 55K/ E4 34K 
complex is present in nuclei of infected cells in association with the nuclear viral 
inclusion bodies which are thought to be the sites of viral DNA synthesis and 
transcription (Moyne et al., 1978; Wolgemuth and Hsu; 1981; Chaly and Chen, 1993).
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Association of the 55K protein with nuclear pore complexes was studied by Smiley et al., 
(1990); no stable complex was detected although a portion of 55K was fractionated with 
the pore complex lamina. They suggested that 55K may affect an early step in RNA 
transport as opposed to modulating the function of nuclear pore complexes. This was in 
agreement with Omelles and Shenk, (1991) who proposed that the 55K/34K complex 
associates with and sequesters a nuclear factor to the periphery of inclusion bodies, which 
is necessary for the transport of mRNAs from their site of processing in the nucleus to the 
nuclear pores. Indeed, nuclear factors that may be involved have been identified in studies 
using in vitro transport systems (Moffet and Webb, 1983; Subramaniam et al., 1990). In 
adenovirus subgroup C transformed cells the 55K protein is present in complex with the 
cellular protein p53 (Samow et al., 1982b; Zantema et al., 1985a; Kao et al, 1990).
The 55K protein is necessary for the productive infection of most cell types and 
vims yield is severely impaired in the absence of wild type 55K protein. Several vims 
mutant studies have shown that the 55K protein is essential for the accumulation of late 
viral mRNAs in the cytoplasm, late viral protein synthesis and shutoff of host metabolism 
(Babiss and Ginsberg, 1984; Babiss et al, 1985; Halbert et al, 1985; Bernards et al, 
1986; Pilder et al 1986; Williams et al, 1986; Barker and Berk, 1987; Leppard and 
Shenk, 1989; Bridge and Ketner, 1990; McLorie et al., 1991). Mutants in the E4 ORF6 
gene which result in the absence of a functional 34K protein, also display a similar 
phenotype (Halbert et al, 1985; Weinberg and Ketner, 1986; Cutt et al., 1987; Bridge 
and Ketner, 1990). Double mutants (defective for both proteins) have no more severe 
phenotype than single mutants with either mutation (Cutt et al, 1987; Bridge and Ketner, 
1990). This indicates that the 55K/34K complex is important for the function of the 55K 
protein.
In Ad5 the absence of 55K, viral DNA replication and transcription of late genes 
is normal and this suggests that the 55K protein regulates gene expression post 
transcriptionally, either by facilitating viral mRNA transport from the nucleus or by 
stabilising the mRNA as it enters the cytoplasm (Babiss and Ginsberg, 1984; Babiss et 
al, 1985; Halbert et al, 1985; Pilder et al, 1986; Leppard and Shenk, 1989; Sandler and 
Ketner, 1989; Bridge and Ketner, 1990). Leppard and Shenk (1989) more precisely
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defined this by showing that the 55K protein acts in the nucleus on viral RNA. These 
authors monitored the movement of newly synthesised mRNA through a series of 
biochemically defined nuclear subfractions. Cells infected with a 55K defective virus 
failed to accumulate viral late transcripts in a nuclear compartment. RNA which had left 
the nuclear matrix accumulated in this compartment before interacting with the nuclear 
envelope. Furthermore the absence of either 55K or 34K or both proteins, resulted in a 
reduction of late viral mRNA in the nucleus in addition to defective nuclear mRNA 
transport (Sandler and Ketner, 1989; Bridge and Ketner, 1990). This agrees with the view 
that the 55K/34K complex facilitates viral RNA metabolism at an intranuclear step. This 
could occur by preserving the pool and stability of fully processed mRNA before 
translocation to the cytoplasm or even facilitating the translocation step itself (Omelles 
and Shenk, 1991). Leppard (1993) looked at the extent late mRNA was dependent on 
55K for accumulation in the cytoplasm, by studying the cytoplasmic levels of individual 
early and late mRNAs in a wild type infection and with a 55K mutant. All of the 
transcripts from the MLTU showed dependence on 55K, although the level of 
dependence varied among the differentially spliced products. The longer transcripts 
showed the greatest dependence on 55K. This was in agreement with the model that 55K 
facilitates the movement of mature viral mRNA from the nucleus to the cytoplasm. The 
localisation of 55K (and E4 34K) has recently been studied in the absence of other 
adenovirus proteins in yeast cells and transfection studies (Liang et al., 1995: Goodrum et 
al, 1996). In these studies 55K is predominantly cytoplasmic, as it is in adenovirus- 
transformed cells (Zantema et al, 1985a, b; van den Heuvel et al, 1993). Liang et al, 
(1995) overcame cytoplasmic restriction of the 55K protein in yeast cells by attaching a 
nuclear localisation signal to the protein. In transfection studies the E4 34K protein 
directed the 55K protein to the nucleus in primate cells, but not rodent or most mouse cell 
lines (Goodrum et al., 1996). These authors suggest that a primate factor may be involved 
in the interaction of 55K and 34K proteins.
Most of the knowledge about 55K has come from studies with group C 
adenoviruses. The Ad 12 equivalent is the 54K (482R) protein and it is also required for 
productive infection, late protein synthesis and accumulation of viral mRNA (Shiroki et
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al, 1986; Brieding et al, 1988; Mak and Mak, 1990). However in contrast to subgroup C 
viruses the 54K protein is also necessary for viral DNA replication (Zhang et al, 1992b). 
With a 54K (loss of function) mutant (Zhang et al, 1992b) both viral DNA replication 
and late viral protein synthesis was defective. Levels of El A transcripts were normal in 
this study but the accumulation of E2B and E4 mRNAs both at early and late times were 
severely reduced. This suggests that the need for 55K in Ad 12 DNA replication could be 
related to its role in the metabolism of E2B and E4 transcripts, which are required for 
viral DNA synthesis.
There were also differences observed in the host range phenotype of adenovirus 
group C (Ad5) and group A (Ad 12) viruses with 55K/54K mutations. Ad5 mutants that 
do not grow efficiently on HeLa cells, will grow to WT levels on HEK cells (Harrison et 
al, 1977), whereas Adl2 mutants do not grow efficiently on HEK cells (Brieding et al,
1988).
The role of 55K in transformation and virus replication were shown to be 
separable in mutational studies (Mak and Mak, 1990; Yew et al, 1990). Studies with 
group A and C adenoviruses have shown that the larger E1B protein is required for 
complete transformation of rodent cells in vitro (Logan et al, 1984; Bernards et al, 
1986; Barker and Berk, 1987; Byrd et al, 1988). 55K was shown to be required in both 
viral and plasmid DNA-mediated transformation, as mutations in this protein abolished 
transformation by these means (Bernards et al, 1986; Barker and Berk, 1987; White and 
Cipriani, 1990; McLorie et al, 1991; Rao et al, 1992; Zhang et al, 1992a). 55K can 
function independently of 19K, but transformation efficiency is increased when both are 
expressed (McLorie et al, 1991). The 55K protein may derive its transforming activity 
from interactions with and inactivation of the cellular p53 tumour suppressor (Samow et 
al, 1982b; Kao et al, 1990; Yew and Berk, 1992).
In Ad5 transformed cells, p53 is associated with the 55K protein and sequesters it 
into a filamentous cytoplasmic complex (Samow et al, 1982b; Zantema et al, 1985a, b). 
It was proposed this sequestration could be a possible mechanism of how 55K inactivates 
p53. In studies with Ad 12 transformed cells, initially no association between p53 and 
55K was detected although p53 was present in the nucleus and inhibition of p53 was still
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detected (Zantema et al., 1985b; Yew and Berk, 1992). Grand et al., (1994) have shown 
the Adl2 54K protein can be found in complex with p53, albeit in small amounts using a 
different experimental protocol, indicating that the mechanism for inhibition of p53 
function in Adl2 may be similar to Ad5. Indeed, both the Ad5 and Adl2 proteins 
(55K/54K) contribute equally well to transformation of primary cells in culture 
(Bernards et al., 1982). This is supported by the observation that the half life of p53 is 
strongly increased in Ad5 and Adl2 transformed cells (Zantema et al., 1985b), and that 
both proteins (55K and 54K) are able to inhibit p53-mediated transcriptional activation 
(Yew and Berk, 1992).
Another possible mechanism as to how p53 function is inhibited by the larger 
E1B protein, is that it (55K) interferes with the ability of p53 to bind its DNA recognition 
sequence. Kao et al., (1990) showed that 55K binds to the activation domain of p53 and 
thus may block it from interacting with possible targets. However a 55K mutant which 
bound p53 like wild type was defective in transformation and inhibition of p53 mediated 
transcriptional activation (Yew and Berk, 1992), suggesting 55K could play a larger part 
than simply blocking the p53 activation domain. Yew and Berk, (1994), have shown that 
55K acts as a direct transcriptional repressor. The binding of 55K to p53 does not 
interfere with the ability of p53 to bind DNA. Furthermore a fusion of 55K to the Gal4 
DNA binding domain can function as a transcriptional repressor. These results indicate 
55K contributes to adenovirus transformation by functioning as a direct transcriptional 
repressor targeted to p53 activated genes.
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1.5. Enteric Adenoviruses.
1.5.1. Identification and Classification.
Enteric adenoviruses comprise serotypes Ad40 and Ad41, belonging to subgroup 
F adenoviruses (for reviews see Albert, 1986; Wadell et al, 1994; Uhnoo et al., 1990; 
Mautner et al., 1995; Tiemessen and Kidd, 1995). These viruses were first observed in 
several studies by EM analysis of stool samples from infants with acute gastroenteritis. 
Approximately 1011 virus particles were detected per gram of sample (Gary et al., 1979; 
Retter et al., 1979; Takiff and Straus, 1982), these virus particles could not be cultivated 
on conventional cell lines used for the propagation of other adenoviruses (Flewett et al, 
1975; Madeley et al., 1977; Retter et al, 1979), but could grow in 293 cells (Graham et 
al., 1977; Takiff et al., 1981). These viruses were referred to as uncultivatable, fastidious 
or enteric adenoviruses (Jacobsson et al., 1979; Retter et al., 1979; Kidd and Madeley, 
1981). The enteric adenoviruses were shown to be distinct from the established 
adenoviruses by serology and DNA restriction analysis (Jacobsson et al, 1979; 
Johansson et al, 1980). Studies on large numbers of clinical isolates revealed the 
presence of two enteric adenovirus serotypes (Ad40 and Ad41) (de Jong et al., 1983; 
Uhnoo et al, 1983) with different restriction patterns (Uhnoo et al., 1983; Takiff et al., 
1984; Adrian et al, 1986). These two serotypes are now classified separately as subgroup 
F adenoviruses; this was based on various criteria including immunological cross 
reactivity, DNA homology and size of internal structural polypeptides (van Loon et al., 
1985b; Hierholzer et al, 1988). A number of Ad41 and Ad40 DNA variants have been 
observed through restriction enzyme analysis (Kidd et al, 1984; van der Avoort et al., 
1989). van der Avoort et al., (1989) described 11 Ad40 DNA variants and 24 Ad41 DNA 
variants, this has now been extended to 28 (cited by Tiemessen and Kidd, 1995).
Human adenoviruses had been suspected of causing gastroenteritis, this was 
difficult to prove and was hampered by the prolonged period of asymptomatic faecal 
shedding after respiratory tract infection observed with some adenoviruses (Fox et al., 
1977). Subgroup F adenoviruses were established as causal agents of gastroenteritis in 
epidemiological and clinical studies (Uhnoo et al, 1984; Kidd et al, 1986; Kotloff et al., 
1989; Tiemessen et al, 1989; Kim et al, 1990; Cruz et al, 1990; Lew et al, 1991).
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Furthermore some studies show that enteric adenoviruses are second only to rotaviruses 
as the most common cause of infantile viral gastroenteritis (Estes et al, 1983; Uhnoo et 
al, 1984; Brandt et al, 1985; Kotloff et al, 1989). Subgroup A adenoviruses (Adl2, 18 
& 31) have also been associated with diarrhoea in immunocompromised adults 
(Hierholzer, 1992).
1.5.2. Epidemiology.
In both developed and developing countries enteric adenoviruses have been 
detected in stool samples of infants and young children with acute gastroenteritis 
(reviewed in Uhnoo et al, 1990; Wadell et al, 1994; Mautner et al, 1995). In many 
studies from around the world (see Mautner et al, 1995, and references therein), enteric 
adenoviruses are reported to be associated with approximately 5 to 20 percent of 
paediatric diarrhoea. Enteric adenovirus gastroenteritis is endemic and appears to have no 
seasonality (Uhnoo et al, 1984; Brandt et al, 1985; Johansson et al, 1985; Kotloff et al,
1989). Initially both enteric adenovirus serotypes were isolated with equal frequency (de 
Jong et al, 1983; Johansson et al, 1985), however more recently the incidence of Ad40 
as a cause of gastroenteritis was found to have fallen dramatically, while Ad41 has 
increased and is now the predominant serotype (de Jong et al, 1983; Brown et al, 1990; 
Shinozaki eta l, 1991).
1.5.3. Pathogenesis.
The clinical characteristics of enteric adenovirus infection are described in detail 
elsewhere (see Uhnoo et al, 1984, 1990). The incubation period is 8 to 10 days 
(Richmond et al, 1979), considerably longer than the 1 to 3 days seen with rotavims. 
Nosocomial outbreaks occur (Rodriguez et al, 1985; Kotloff et al 1989), but spread to 
adults is not common (Chiba et al, 1983). Illness typically lasts 5 to 12 days (Uhnoo et 
al, 1984; Kotloff et al, 1989) but can occasionally last for more than two weeks. Enteric 
adenoviral diarrhoea lasts longer than other types of viral gastroenteritis. The most
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prominent feature of the disease is a watery diarrhoea which is followed by 1 to 2 days of 
vomiting (Uhnoo et al., 1984). Various other symptoms include low grade fever which 
lasts 2 to 3 days and dehydration (Yolken et al., 1982; Uhnoo et al, 1984). Respiratory 
tract symptoms have been reported, but are less common. Although the mean duration of 
diarrhoea was longer in Ad41 (12.2 days) than Ad40 (8.6 days), both viruses gave similar 
symptoms in patients. Studies show that enteric adenoviruses cause a more protracted but 
milder infection than do rotavirus, with reduced frequency of vomiting and moderate 
elevation of fever. In addition, enteric adenoviruses have been associated with fatal 
disease (Whitelaw eta l, 1977; Johansson etal., 1985); Ad41 virus particles were isolated 
from cells in the small intestine of a fatal case of gastroenteritis.
1.5.4. The Molecular Biology of the Enteric Adenoviruses.
The overall DNA homology, determined by liquid phase hybridisation, between 
Ad40 and Ad41 is 62 to 69 percent (van Loon et al., 1985b), whereas enteric adenovirus 
identity compared to Ad5 is 15 to 20 percent. Homology within subgroup F is similar to 
that within subgroup A, but lower than seen within subgroups B to E (see Table 1.1.1.). 
The complete nucleotide sequence of Ad40 strain Dugan has been reported (Davison et 
al, 1993) and is comprised of 34,214 nt. It has a similar genomic organisation to Ad2 and 
Ad5, with a few distinct differences, namely the presence of two fibre genes, one VA 
gene and variation in the E3 region. The Ad 12 genome has also recently been completed 
(Sprengel et al, 1994) and is 34,125nt long, closer in length to Ad40 than Ad2 at 
35,937nt.
Two novel protein coding regions were identified by Davison et al, (1993) in 
Ad40, one orientated rightward within the L4 33K protein coding region, the other a 
leftward 52R exon located between regions E3 and L5. These authors found this region 
highly conserved among human serotypes and propose it may be functionally significant.
Phylogenetical analysis among adenoviruses by comparison of DNA sequence 
revealed that Ad40 and Ad 12 are more closely related than was previously shown by 
DNA hybridisation studies (Bailey and Mautner, 1994). Comparison of enteric
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adenoviruses to other adenoviruses is based on DNA homology and phylogeny 
comparisons of protein-coding regions (see Mautner et al., 1995, and references therein).
I.5.4.I. Early Regions.
The ITRs of Ad40, Ad41 and Adl2 are of similar length at 163, 163 and 161bp 
respectively. The Ad40 sequence shows more sequence homology to Ad5 than to any of 
the other adenovirus serotypes, especially in the first 60-70bp (Ishino et al., 1987; 
Shinagawa et al., 1987; Allard and Wadell, 1988; Bailey and Mautner, 1994).
Extensive study of the El region of subgroup F adenoviruses has been carried out 
primarily as it is implicated in the fastidious growth of these viruses, van Loon et al, 
(1987b) first determined the El sequences of both Ad40 and Ad41. These authors found 
they were 85% identical to each other and were 52% homologous to the Ad5 El region. 
El DNA sequences have now been determined for different strains of both enteric 
adenovirus serotypes: Ad40 Dugan (van Loon et al, 1987b; Davison et al, 1993), Ad40 
Sapporo (Ishino et al, 1988;), Ad41 Tak (van Loon et al, 1987b) and Ad41 D389 
(Allard and Wadell, 1988, 1992). The overall organisation of the El region appears to be 
similar to that of other adenoviruses and ORFs have been identified which correspond to 
the E1A and E1B regions of other serotypes. E1A conserved regions (CR1 to CR3) have 
been identified in Ad40 and Ad41 (van Loon et al, 1987b; Allard and Wadell, 1988; 
Ishino et al, 1988;). The conserved regions of Ad7, Adl2 and SAV-7 share 60% 
homology to equivalent Ad5 regions while Ad40 and Ad41 have 51% and 45% 
homology to Ad5 conserved regions, respectively (van Loon et al, 1987b). CR1 is the 
least well conserved, although CR2 and CR3 also have low homology with Ad5 
compared to other serotypes. In comparisons of E1B protein -coding sequences, both 
Ad40 E1B ORFs (19K & 55K) are more similar to Adl2 than to Ad2 (Ishino et al,
1988). Although no conserved regions have been identified in E1B, an alanine rich region 
near the N-terminal of the 55K protein present in Ad2 and Ad 12 is not found in Ad40, 
but a central domain in 55K that binds p53 and is important for the transformation
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activity of Ad2 is moderately conserved in both Adl2 and Ad40 (Yew and Berk, 1992; 
Yew etal., 1990,1994).
El transcription maps for Ad40 and Ad41 have been determined in cells 
transformed with Ad40 and Ad41 El plasmids (van Loon et al, 1985a, 1987b). For Ad40 
the three E1A mRNA species corresponding to Ad2 9S, 12S and 13S mRNAs were 
detected. However no Ad40 E1B mRNA was detected in these cells (van Loon et al, 
1985a). For Ad41 transformed cells only the E1A 13S transcript and E1B 22S mRNA 
were detected. Both the Ad40 and Ad41 E1B transcription maps have been determined in 
a lytic infection (Steinthorsdottir and Mautner, 1991; Allard and Wadell, 1992) (see 
Figure 1.5.1). Both viruses have transcripts equivalent to the Ad2 14S and 22S mRNA 
but lack 13S mRNA which is the major species in the Ad2 E1B region. The Adl2 E1B 
transcription map also has the E1B 14S mRNA as a major transcript with no 13S detected 
(Virtanen et al., 1982; Virtanen and Pettersson, 1985). In addition E1A-E1B cotranscript 
counterparts of the 14S and 22S mRNAs were detected in Ad40, which contained the first 
40 codons of the E1A region spliced to a site 4-5nt downstream of the E1B cap site. The 
splice junction is unusual in that it does not conform to splice consensus sequences 
(Steinthorsdottir and Mautner, 1991; Ishida et al., 1994). In Ad41 an additional small 
exon is detected in the 14S mRNA that is not observed in Ad40 (Allard and Wadell, 
1992).
The E2A gene (encoding the DBP) has been identified in Ad40 and Ad41 (Vos et 
al, 1988). The enteric adenoviruses have smaller DBPs (Ad40 is 473R and Ad41 is 
474R) compared to Ad5 (529R). The Ad40 pTP compared to the Ad2 pTP and the Ad40 
Adpol protein compared to Ad2 Adpol, share good DNA homology. In contrast less DNA 
homology was detected between the Ad40 DBP and the Ad2 DBP (Davison et al, 1993).
The Ad40 (Davison et al., 1993) and Ad41 (Yeh et al, 1996) E3 sequences are 
almost identical. The E3 ORFs from Ad40, 12 and 2 were compared by Mautner et al., 
(1995), these authors found the E3B region moderately conserved. The Ad40 E3B 
proteins 90R, 107R and 122R had respectively 41%, 33% and 53% amino acid identity, 
with their Ad2 counterparts. However there were significant differences in the E3A 
region between these serotypes. Furthermore, in Ad40 no E3A 19K glycoprotein
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Figure 1.5.1. Transcription Maps for Ad40 (Dugan) and Ad41 (Tak) E1B Regions.
Solid lines denote RNA and introns are indicated by carets; filled rectangles are 
open reading frames; rectangles with rounded comers are proteins that have not yet been 
confirmed experimentally. (Modified from Mautner et al., 1995)
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equivalent to the one seen in Ad2 was present. In addition, Ad40 can encode two proteins 
of 173R and 276R that share no homology to the other adenovirus proteins; these were 
also present in the Ad41 E3 region (Yeh et al, 1996).
The Ad40 E4 region contains ORFs equivalent to those in Ad2 and Ad 12, except 
for ORF1 which it lacks (Davison et al, 1993). However Ad40 can complement the Ad2 
E4 mutant dl808 which lacks ORF1 and this indicates that the Ad40 E4 region is 
functional (Mautner and Mackay, 1991).
I.5.4.2. Late Regions.
The enteric adenoviruses contain two fibre genes, which encode proteins of 
different shaft length and have distinct sequences (Kidd and Erasmus, 1989; Pieniazek et 
al, 1989, 1990a; Kidd et al, 1990, 1993; Davison et al, 1993; Yeh et al, 1994). 
Phylogeny studies revealed that the subgroup F two fibre genes (IV-1 and IV-2) are more 
closely related to each other (i.e. Ad40 IV-1 to Ad41 IV-1 and Ad40 IV-2 to Ad41 IV-2) 
than to other adenovirus fibre genes (Bailey and Mautner, 1994). These authors propose 
this could have arisen through gene duplication shortly after subgroups A and F diverged, 
but before the separation of serotypes Ad40 and Ad41. EM analysis show only one type 
of fibre is incorporated at each vertex of the capsid (Kidd et al, 1993). This is in contrast 
to avian adenoviruses, where two fibres (of different length) are attached to each vertex 
(Laver eta l, 1971).
The 100K L4 protein is the best conserved of the L4 proteins among the serotypes 
Ad40, 12 and 2. The 33K protein is well conserved; also present is a putative 22K 
polypeptide that could be generated if the 33K splice is not used (Davison et al, 1993).
The hexon proteins of Ad40 and Ad41 have 88% identity (Toogood and Hay, 
1988; Toogood et al, 1989). This level of sequence homology was in agreement with that 
detected between subgroup C adenoviruses (Kinloch et al, 1984; PringAkerblom and 
Adrian , 1993). However there are differences detected in the variable loop regions which 
are on the surface of the virion. It has been shown that these regions contain type-specific 
determinants (Toogood et al, 1989; Toogood et al, 1992; Crompton et al, 1994).
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The Ad40 penton base protein is 81% homologous to Adl2 (Sprengel et al,
1994), but unlike other adenovirus penton bases (Ad2, 3, 5 and 12) which have an RGD 
motif, Ad40 has an RGA motif (Davison et al 1993).
The human adenoviruses of subgroups A, F and some of B, together with simian 
adenovirus type 7 (SAV-7) have only one VA gene (Kidd and Tiemessen, 1993; Kidd et 
al, 1995). In a study of 12 monkey adenovirus genomes Kidd et al, (1995) found they 
also possess only one VA RNA gene which had good DNA homology with the VA RNA 
gene from adenovirus subgroups A and F. Ad40 and Ad41 are susceptible to 
lymphoblastoid interferon in Chang conjunctival cells (Tiemessen and Kidd, 1993), 
unlike Ad2 which is resistant. It is unclear if the function or expression of the VA RNA 
gene correlates with this susceptibility. This could occur through defective expression of 
the El A gene which transactivates the VA gene through the cellular transcription factor 
TFmc.
1.5.5. Growth Properties of Enteric Adenoviruses in Culture.
The enteric adenoviruses cannot be grown in most cell lines that are used for the 
routine isolation of adenoviruses. However they can be propagated to a limited extent in: 
Chang conjunctival cells (Kidd and Madeley, 1981); Hep-2 and tertiary cynomolgus 
monkey kidney cells (tCMK) (de Jong et al, 1983); 293 cells (Takiff et al, 1981; de 
Jong et al, 1983); HT-29 cells (Uhnoo et al, 1983) and HRT-18 cells (Gomes et al,
1992). 293 cells are HEK cells that have been immortalised by integration of DNA from 
the Ad5 early region 1 (Graham et al, 1977). Although some studies have shown Ad40 
can be propagated in these cells (Takiff et al, 1981; de Jong et al, 1983), others have not 
(Chiba et al, 1983; Uhnoo et al, 1983). de Jong et al, (1983) carried out a detailed study 
of some 200 isolates from subgroup F adenoviruses in various cell lines. These authors 
reported there were differences in virus growth due to the virus strain used, host cell type 
used, different batches of the same cell line and differences in the growth of the same 
virus strain between laboratories. This may explain the contrasting results obtained in 
different laboratories regarding the growth of enteric adenoviruses in various cell lines.
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For instance, Witt and Bousquet (1988), successfully grew Ad40 and Ad41 in Chang 
conjunctival, 293 and KB cells, but only Ad41 could grow in HeLa cells. In contrast, 
Pieniazek et al, (1990a, b), could not propagate Ad41 in 293 cells but were successful 
with HeLa, Hep-2 and INT407 cells. In addition, Perron-Henry et al, (1988) report that 
not all strains of Ad41 can grow in Hep-2 cells. Hashimoto et al, (1991) have reported 
that the Sapporo strain of Ad40 can produce plaques in A549 cells (derived from lung 
cell carcinoma). Ad40 and Ad41 can also grow efficiently in the human hepatocellular 
carcinoma cell line PLC/PRF/5 and reportedly Ad41 can produce plaques in this cell line 
(Grabow et al, 1992).
Witt and Bousquet (1988) detected lower infectious titres with Ad40 compared to 
Ad41 in KB and HeLa cells. When high moi of virus were used, no viral replication was 
detected, however Ad40 did grow at lower moi. A possible explanation for this may be 
the presence of defective virus particles and their consequent interference with infectious 
nondefective virions. In addition, Brown (1985) has reported that the production of Ad40 
virions is 3 to 10 fold lower in 293 cells than that observed for other adenoviruses, 
whereas the yield of infectious virus is 100 to 1000 fold lower. Brown et al, (1992) have 
conducted studies on the propagation of Ad40 and Ad41 in 293 and HeLa cells. These 
authors demonstrated that most 293 cells in a culture could be productively infected, 
while only 10 to 20 percent of the HeLa cell culture were infected. However the 
uninfected HeLa cells were capable of being infected. The intracellular viral yield was 
comparable for the two cell lines, however progeny virus was released from 293 but not 
HeLa cells. Although the yield of viral particles was similar for the enteric adenoviruses 
compared to Ad5, the particle to infectivity ratios were 100 to 1000 fold greater for Ad40. 
It was proposed that the high particle to infectivity ratio and the block in release of virus 
from HeLa cells could be a major factor in the fastidious growth of these viruses in tissue 
culture. Indeed Tiemessen and Kidd (1994) showed that different strains of Ad40 and 
Ad41 display differing growth characteristics at several stages in the viral replication 
cycle and in various cell lines. This suggests that the poor growth of enteric adenoviruses 
in cell culture is multifactorial.
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Another factor influencing Ad41 propagation is serum concentration. Ad41 
growth restriction on a number of primary cell lines can be alleviated by reduced serum 
concentrations (0.2-1% ) in the infecting medium (Pieniazek et al., 1990b), these authors 
suggest that a factor(s) present in the serum is responsible for the effect. This serum 
inhibition was not observed in continuous cell lines (Hep-2 or 293 cells).
It appears that the Ad41 growth defect is less severe than Ad40 in cell culture, as 
demonstrated by the number of cell lines that support Ad41 growth but not Ad40 (de 
Jong et al 1983; Uhnoo et al, 1983, 1984; van Loon et al 1985b). Studies by Tiemessen 
and Kidd (1988, 1990) were focused on the growth restriction of Ad41 in tissue culture. 
These authors have shown that Ad41 can be complemented by Ad2 in semi-permissive 
Chang conjunctival cells and non-permissive HEF cells. In addition, interference by 
Ad41 on Ad2 replication in HEF cells was observed, with the extent of interference 
depending on the time of infection of each virus (Tiemessen and Kidd, 1988). This is also 
detected with other adenovirus serotypes and is attributed to the trans-repression function 
of El A proteins (Leite et al 1986; Tibbetts et al 1986; Larson and Tibbetts, 1987).
The pattern of Ad41 growth kinetics was analysed by Tiemessen and Kidd (1990). 
A pattern of one-hit kinetics was observed with Ad41 on 293 cells, where one infectious 
virus particle was capable of infecting a cell. In a double infection of Ad2 and Ad41 on 
Chang conjunctival or HEF cells, a pattern of 2-hit kinetics was observed. However with 
a single Ad41 infection on Chang conjunctival cells 4 to 5 infectious virus particles were 
required to productively infect a cell. A possible explanation for this pattern of 
replication, is that there is a requirement for a certain product(s) which is produced in 
limiting amounts, thus infection by a number of genomes may be needed to attain a 
critical level, in order for the progression of viral replication in semi-permissive cells.
The El region was implicated in the growth restriction of enteric adenovirus from 
studies by Takiff et al, (1981), in which these viruses were successfully propagated on 
293 cells. Both Ad40 and Ad41 El A proteins are able to induce expression from the Ad2 
E4 promoter in transient transfection assays, but the level of transactivation is a great deal 
lower than that detected with the Ad5 El A protein (van Loon et al., 1987a). Ishino et al., 
(1988) also demonstrated that the Ad40 El A protein is a weaker transactivator than either
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Ad5 or Adl2 E1A. In addition these authors found that Ad40 E1A has a weaker ex­
acting activity than Ad 12. More studies implicate the E1B gene as a major factor in the 
poor growth of subgroup F adenoviruses. Both Ad40 and Ad41 only partially transform 
BRK cells, but in Ad40 transformed cells no E1B mRNA is detected (van Loon et al, 
1987b). The importance of the E1B region in the growth restriction of Ad40 was clearly 
demonstrated by Mautner et al, (1989). These authors used stably transformed KB cell 
lines constitutively expressing El A only (KB8), E1B only (KB 18), both El A and E1B 
(KB 16) and neither El A or E1B (KB7) (Babiss et al, 1983). Ad40 could not grow in 
cells expressing El A alone, but could grow in cells containing E1B (Mautner et al, 1989; 
Gomes eta l, 1992).
In HeLa cells infected with Ad40, no E1B mRNA is detected early in infection 
and only low amounts of 22S and 14S mRNA are observed after the onset of DNA 
replication (Mautner et al, 1990; Bailey et al, 1994; this thesis). However in 293, KB 16 
and INT407 cells, 22S mRNA is detected before the onset of DNA replication and 14S is 
first observed at the same time as DNA synthesis (Bailey et al, 1994; this thesis). 
Hashimoto et al, (1991) have reported Ad40 E1A and E1B mRNAs before the onset of 
DNA synthesis in A549 cells. Initially the 55K protein was not observed in permissive 
Ad40 infected cells (Mautner et al, 1990). Subsequent studies have shown that the 55K 
protein can be detected in Ad40 infected KB 16 and 293 cells both at early and late times, 
using antiserum to the 15K protein expressed in bacteria (Bailey et al, 1993). The 19K 
protein is also produced in Ad40 infected cells; in HeLa cells at late times and, both at 
early and late times in 293 and KB 16 cells.
Expression of the Ad40 E1B region has been studied in more detail using 
Ad5/Ad40 recombinants which have the Ad40 E1B region in place of the Ad5 E1B 
region in dl309, either under the control of the Ad5 E1B promoter (sub5P) or Ad40 
promoter (sub40P) (Bailey et al, 1994). Both recombinants could plaque on 293 cells but 
not on HeLa cells, also the yield and growth rate of recombinants was reduced in HeLa 
cells compared to 293 and KB 16 cells. The expression from the Ad40 E1B region was 
impaired even under the control of the Ad5 promoter. Both recombinants showed a 
comparable pattern of E1B mRNA splicing and temporal regulation, but this was cell
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type specific. The results show that the E1B promoter is important for determining the 
growth characteristics of Ad40, but the host cell type is also important. In further studies 
on the Ad40 E1B promoter (see Mautner et al., 1995 for review), it was shown to be 
poorly transactivated in transient transfection assays by Ad40 El A, Ad5 El A and VZV 
pl40. Compared to the Ad5 E1B promoter, very low activity was detected and was 
shown to be host cell type specific with higher levels detected in 293 and intermediate in 
INT407 cells.
1.5.6. Aims of Project
The fastidious enteric adenovirus type 40 grows poorly in conventional cell lines 
used to grow other human adenoviruses, but can be propagated in cells which express El 
proteins. This growth restriction has been attributed to defects in E1B gene expression. 
The aim of the work presented in this thesis was to investigate the host range phenotype 
of Ad40 in tissue culture, primarily using INT407 cells which were not known to express 
El proteins in comparisons with other permissive and semi-permissive cell lines. Two 
main areas investigated were the growth properties of the virus and early region El gene 
expression. A timecourse of Ad40 DNA replication on the different cell lines was 
compared. Viral infectivity was examined by fluorescent focus assay with the different 
cell types in order to determine if there were differences in the number of productively 
infected cells. Infection of permissive and semi-permissive cells was further characterised 
in attachment and internalisation assays. The E1B transcription map had previously been 
determined using RNA obtained from cells with endogenous El proteins. Therefore the 
pattern of E1B transcription was analysed on INT407 cells in order to determine if there 
were any differences in E1B splicing patterns with this cell line. In addition, the Ad40 
E1B promoter was examined by looking at protein binding at the putative Spl binding 
site.
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2. MATERIALS
2.1. Tissue Culture.
2.1.1. Tissue Cells.
KB16 are human nasopharyngeal derived cells, expressing the Ad2 El region 
(Babiss et al., 1983). These cells were routinely used for the growth of Ad40 seed stocks. 
They will herein be referred to as KBa+b cells.
HeLa are human cervical carcinoma cells. The current laboratory stock, originally 
obtained from Flow laboratories, was used for virus infection and nuclear extract 
preparation.
293 are human embryonic kidney cells derived by transformation with the Ad5 
El region (Graham et al., 1977). They were used for virus infection and for the 
propagation of adenovirus mutants.
INT407 were described as human embryonic intestinal cells (Henele and 
Deinhardt, 1957) and obtained from the European Collection of Animal Cell Culture 
(ECACC). Subsequently these cells were found to be HeLa cell derivatives (Gilbert et 
al, 1990). These cells were used for virus infection and nuclear extract preparation.
A549 are human lung carcinoma cells (Giard et al., 1973) originally obtained 
from the ECACC, and were used for virus infections.
CV-1 are African green monkey kidney cells (Jensen et al., 1964, Kit et al., 1965) 
and were kindly donated by Dr A. Davison. They were used to prepare Spl protein.
Sf21 are Spodoptera frugiperda cells (Brown and Faulkner, 1977) and were used 
for the growth of AcNPVfibFL582.
2.1.2. Tissue Culture Media.
HeLa, INT407, A549 and CV-1 cells were propagated in Dulbeccos modified 
Eagles medium (DMEM), without sodium pyruvate, with 4500mg/L glucose (Gibco).
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The medium was supplemented with 5% FCS, 4mM L-glutamine, lOOunits/ml penicillin 
and lOOpg/ml streptomycin.
KBa+b and 293 cells were propagated in Glasgow modified medium (GMEM) 
supplemented with 5% FCS.
Sf21 cells were grown in TC100 mediun\ (Gibco) which was supplemented with 
5% FCS, lOOunits/ml penicillin and lOOpg/ml streptomycin.
2.2. Viruses.
The adenovirus type 40 (Ad40) strain Dugan was used in this study; it was 
originally obtained from Dr J. de Jong (de Jong et al., 1983). KBa+b cells were used to 
propagate the virus (see 2.1.1.). Most experiments were carried out using passage 9 
stocks of the virus, but for the Immunofluorescence experiments passage 10 was used.
dl309 (Jones and Shenk, 1979a) is derived from Ad5 but lacks Xba I sites at 29, 
79 and 85 mu, also the region from 83 to 85mu is deleted. dl309 does not produce E3 
14.7K, 14.5K, and 10.4K proteins.
dl312 (Jones and Shenk., 1979a; Ross et al., 1980) is derived from dl309 and 
contains an additional deletion between nt 448-1349. This results in an absence of El A 
proteins.
pml722 (Barker and Berk, 1987) is derived from dl309 and the El region of Ad2; 
it contains a G to A mutation at nt 1722 introducing a stop codon. pml722 does not make 
the E1B 19K protein.
dll520 (Barker and Berk., 1987) is also derived from dl309 and Ad2 El 
sequences. It has a C to T mutation at nt 2022, changing an arginine to a stop codon and 
the region from 2496 to 3323 nt is deleted. The E1B 55K and 15K proteins are not made 
in this virus.
AcNPVflbFL582 (Novelli and Boulanger, 1991); this recombinant baculovirus 
was a kind gift from Dr P. A. Boulanger. The virus AcNPVfibFL582 contains the gene for 
full length Ad2 fibre.
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v-Spl is a recombinant vaccinia virus which overexpresses wild-type Spl protein 
(Jackson et al, 1990). This virus was a kind gift from Dr S. P. Jackson.
2.3. Bacteria.
2.3.1. Bacterial Strain.
Plasmids were propagated in the E.coli strain K12 NM522 [supE, thi, 6(lac- 
proAB), hsd5, (F \ proAB, lacl, lacZ6M15)], (Gough and Murray, 1983).
2.3.2. Bacterial Culture Media.
Bacterial cultures were routinely grown in suspension at 37°C in L-broth [177mM 
NaCl, lOg/L Difco bactopeptone, 5g/L yeast extract (pH7.5 prior to sterilisation)].The 
medium was supplemented with ampicillin (50pg/ml) and chloramphenicol (200pg/ml) 
where appropriate. Plates were made with L-broth agar containing 1.5% (w/v) agar and 
the appropriate antibiotic.
2.4. Plasmids.
Clones were grown from seed stocks supplied by Dr V. Mautner unless otherwise
stated.
The following plasmids were derived from pAA12 (van Loon et al., 1985a, 
1987b) which contain the Cla I-B fragment of Ad40 (nt 1-3933). Regions described 
below were subcloned into pTZ18 vectors (Mautner et al., 1989, 1990).
pNM82 has the whole of the Cla I-B fragment, comprising the El region. 
pNM83 contains the Ad40 El A region from nt 1-1211.
The following plasmids were derived from the Bgl II fragment of Ad2 and 
subcloned into pTZ18 vectors (Mautner et al., 1990).
pNM90 contains the Ad2 El region from nt 1-1569. 
pNM92 contains the Ad2 El region from nt 1569-3322.
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The plasmid pAB106 was kindly donated by Dr A. Bailey. It was constructed 
from a PCR product cloned into the pET3a vector (Bailey et al.., 1993) and contains the 
Ad40 E1B region from nt 1719-3149.
2.5. Oligonucleotides.
The oligonucleotides used in this study were synthesised on a PS-250 Cruachem 
DNA synthesiser. Oligonucleotides are listed below :
RTR3 Ad40 El region, nt 1345-1373.
5, g TGTTTATTTCTTGGGCGTGTTTGTGGG 3’
RTR4 Complementary strand to RTR3.
5’ CCCACAAACACGCCCAAGAAATAAACAC 3’
RTR5 Ad2 E1B nt -59 to -31 with respect to the Ad2 E1B cap site.
5’ CGTGTTAAATGGGGCGGGGCTTAAAGGG 3’
RTR6 Complementary strand to RTR5.
5’ CCCTTTAAGCCCCGCCCCATTTAACACG 3’
RTR11 Derived from RTR3, underlined nt are T to G or C mutations.
5, g t g TTTATTTCT£GGGCG£G££TGTGGG 3’
RTR12 Derived from RTR4, underlined nt are A to G or C mutations. It is
complementary to RTR11.
5’ CCCACAGCCCCGCCCCAGAAATAAACAC 3’
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OCT27 HSV-1 IE gene 2 promoter octamer/TAATGARAT motif, nt -158 to
-139 with respect to the IE2 cap site (Bailey and Thompson, 1992). 
5’ CGATATGCTAATTAAATACAT 3’
OCT28 Complementary strand to OCT27.
5’ ATGTATTTAATTAGCATATCG 3’
AB42 Ad40 E1B region, nt 3110-3049, lower case nt are non Ad40
El sequences.
5’ CGACATCATCTGGTGGTCCGTAACGCAGCTGCTCGGTCA 
CGTTCAGAGTTGCTGGATATAACCgctacg 3’
2.6. Enzymes.
Restriction enzymes were obtained from Boehringer Mannheim or Bethesda 
Research Laboratories (BRL).
Boehringer Mannheim also supplied S1 nuclease.
New England Biolabs supplied T4 Polynucleotide Kinase.
The following were obtained from Sigma: Lysozyme, Proteinase K, RNase A 
and subtilisin.
RQ1 RNase free DNase I was obtained from Promega.
DNA polymerase I / DNase I mix was obtained from Pharmacia.
2.7. Antibodies.
10/5.1 is an Ad5 anti-Hexon mAb, it was a kind gift from Dr I. R. Sharp 
(Laboratory of Microbiological Reagents, Central Public Health Laboratory, 61 Colindale 
Avenue, London.).
The Goat anti-mouse antibody used in the immunofluorescence experiments was 
an anti-mouse IgG obtained from Nordic Immunochemicals.
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2.8. Chemical Reagents.
All chemicals were of analytical grade or higher and were supplied by BDH 
Chemicals and Sigma Chemical Company, except for the following:
Ammonium persulphate (APS) and N, N, N', N'-Tetra methylenediamine
(TEMED) - BioRad Laboratories, California
Caesium chloride - Melford Laboratories Ltd, Suffolk
Ecoscint - Nuclear Medical Electronic Systems and Services Ltd, Livingstone
Ethanol - Hayman Ltd, Essex
Ficoll 400 and Deoxynucleotide triphosphates (dNTPs) - Pharmacia 
LKB Biotechnology, Milton Keynes.
Formamide and Formldehyde - Fluka Chemicals Ltd, Dorset.
Acetic acid, Acetone, Chloroform, Hydrochloric acid (HC1), Isopropanol 
and Methanol - Prolabo, Manchester.
Glycerol - May and Baker Ltd, Essex.
Trichloro-trifluro-ethane (Arcton) - ICI, Cheshire.
2.9. Radiochemicals.
All radiochemicals used in this study were supplied by Amersham International 
PLC. The specific activities were 3,000 Ci/mmol for [a -32P]-dNTPs, 60 Ci/mmol for 
[3H] - thymidine and 5000 Ci/mmol [y -32P]-ATP.
2.10. Solutions.
3 x aqueous hybridisation mix: 3M NaCl, 0.5M HEPES pH7.5, ImM EDTA pH8.0. 
Bradford reagent: 0.1% (w/v) Coomassie brilliant blue G, 4.75% (v/v) ethanol, 8.5% 
(v/v) phosphoric acid.
Buffer A: lOmM HEPES pH7.9, 1.5mm MgCl2, lOmM KC1, 0.5mM
phenylmethylsulfonyl fluoride (PMSF), 0.5mM DTT.
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Buffer C: 20mM HEPES pH7.9, 25% (v/v) glycerol, 0.42M NaCl, 1.5mM MgCl2, 
0.2mM EDTA, 0.5mM DTT, 0.5mM PMSF.
Cell adhesion buffer: DMEM supplemented with 2mM MgCl2, 1% (w/v) BSA, 20mM 
HEPES pH7.9.
50 x Denhardts solution: 1% (w/v) ficoll, 1% (w/v) BSA fraction V, 1% (w/v) 
polyvinylpyrollidone.
5 x DNase I buffer: 200mM Tris-HCl pH7.5, 30mM MgCl2, 50mM NaCl.
EB buffer: 0.5% (w/v) SDS, lOOmM NaCl, 50mM Tris-HCl pH7.5.
Formamide dye mix: 98% (v/v) formamide, 10mm EDTA pH8.0, 0.1% (w/v) xylene 
cyanol, 0.1% (w/v) bromophenol blue.
2 x HBS: 280mM NaCl, 50mM HEPES, 1.5mM Na2HP04, [pH the whole solution to 
7.12].
1 x HBSE: lxHBS, 20mM EDTA.
High salt buffer (HS): 50mM Tris-HCl pH7.5, 0.42M KC1, 20% (v/v) glycerol, 10% 
(w/v) sucrose, 5mM MgCl2, 0.1mm EDTA, ImM PMSF, ImM sodium metabisulphite, 
2mM DTT.
Hirt buffer: 10mm Tris-HCl pH7.9, lOmM EDTA, 0.6% (w/v) SDS.
10 x Kinase buffer: 50mM Tris-HCl pH7.6, lOmM MgCl2, O.lmM EDTA, O.lmM 
spermidine, 0.5mM DTT.
Loading dye mix: 50% glycerol, ImM EDTA pH8, 0.25% (w/v) xylene cyanol, 0.25% 
(w/v) bromophenol blue.
10 x MOPS: 180mM MOPS [3-(n-Morpholino)-propanesulphonic acid] pH7.0, 50mM 
sodium acetate, lOmM EDTA.
Phosphate buffered saline (PBS):
PBSA: 170mM NaCl, 3.4mM KC1, ImM N^HPO* 2mM KH2P04 and buffered to pH 
7.2.
PBSB: 6.8mM CaCl2.
PBSC: 4.8mM MgCl2.
PBS: 8 parts PBSA : 1 part PBSB : 1 part PBSC.
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Phenol/Chloroform: phenol equilibrated with TE was mixed in equal volumes with 
chloroform.
4 x RM: 0.4mg/ml (w/v) BSA, 25mM HEPES pH7.4,2mM DTT, 8mM MgCl2.
RNA lysis buffer: 150mM NaCl, lOmM Tris-HCl pH7.9,0.65% NP40.
2 x SI buffer: 0.56M NaCl, lOOmM sodium acetate pH4.5,9mM ZnS04.
Sample buffer: 50% (w/v) sucrose, lOOmM EDTA, 0.2% (w/v) bromophenol blue. 
Solution I: 50mM glucose, 10mm EDTA, 25mM Tris-HCl pH8.
Solution II: 0.2M NaOH, 1% (w/v) SDS.
Solution III: 3M potassium acetate, 11.5% (v/v) glacial acetic acid.
20 x SSC: 3M NaCl, 0.3M tri-sodium citrate pH7.0.
20 x SSPE: 3M NaCl, 0.2M NaH2P04, 0.02M EDTA pH7.4.
Sucrose solution: 250mm sucrose, 2mm MgCl2, 50mM Tris-HCl pH8.0.
TBE: 90mM Tris, 90mM boric acid, ImM EDTA pH8.3.
TE: lOmM Tris-HCl pH8.0, ImM EDTA.
Tris-saline (TS): 140mM NaCl, 30mM KC1, 280mM Na2HP04, lmg/ml glucose, 25mM 
Tris-HCl pH7.4, 0.001% (w/v) phenol red, 100 units/ml penicillin, 100 pg/ml 
streptomycin.
Triton solution: 0.5% (v/v) Triton X-100, 62.5mM EDTA pH8.0, 50mM Tris-HCl 
pH8.0.
Trypsin: 0.25% (w/v) trypsin (Difco) dissolved in Tris-saline.
Urea buffer: 7M urea, 0.35M NaCl, 0.01M Tris-HCl pH7.4, 0.01M EDTA, 1% (w/v) 
SDS.
Versene: 0.6mM EDTA in PBSA containing 0.0015% (w/v) phenol red.
Z' buffer: 25mM HEPES pH7.6, 12.5mM MgCl2, 20% (v/v) glycerol, 0.1% NP40, 
lOmM ZnS04, ImM DTT, 0.1M KC1.
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3. METHODS.
3.1. Tissue Culture.
Most cell types were grown as monolayers at 37°C in an atmosphere of 95% air 
and 5% C02. They were grown to 80-90% confluency in 80cm2 or 175cm2 flasks 
(Nunclon) and routinely passaged every 3-4 days. Cells were harvested by washing twice 
in 12ml of a 5:1 versenertrypsin mix and resuspended in fresh medium. This suspension 
was used to seed subsequent monolayers.
Sf21 cells were passaged every 3-4 days in 175cm2 flasks at 28°C in air. 
Confluent monolayers were dislodged by vigorous shaking into 10ml of medium and this 
suspension was used to seed subsequent monolayers.
For storage, cells were resuspended at approximately 2.5 x 106 cells/ml in either 
40% medium, 40% FCS and 20% glycerol or 10% DMSO, 70% medium and 20% FCS. 
Aliquots were frozen slowly to -140°C. For recovery, cells were thawed rapidly and 
resuspended in growth medium.
3.2. Virus Preparation.
3.2.1. Virus Stocks.
Ad40 seed stocks were prepared by infecting subconfluent monolayers of KBa+b 
cells grown on 50mm plates. Plates were inoculated with lOOpl of a 1/10 dilution of 
virus in TS. Virus adsorption was carried out at 37°C for lh, after which medium 
(GMEM + 0.5% FCS) was added. Incubation was continued at 37°C, until a good cpe 
was apparent (3-5 days). Cells were harvested by scraping into the overlaying medium 
and transferred to a 15ml falcon tube. Samples were centrifuged at 2,000rpm for lOmin 
in a refrigerated centrifuge. The supernatant was discarded and the cell pellet resuspended 
in TS, at 0.25ml/plate. Samples were subjected to three freeze thaw cycles (-70°C to
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37°C). The cell debris was pelleted as above and the supernatant containing the virus 
stock was transferred to a fresh vial; virus stocks were stored at -20°C and -70°C. Ad40 
virus yield was estimated by restriction digest analysis of viral DNA.
Ad40 does not plaque on any of the permissive cell lines used in this laboratory, 
although the virus has been reported to plaque on A549 cells (Hashimoto et al., 1991). 
This cell line was also tried, but no plaques were observed even after attempts to enhance 
plaque formation. Differences in virus strain and different laboratory cell stocks may 
have accounted for this. In the absence of a suitable quantitation method for Ad40, virus 
yield was estimated by restriction digest analysis of viral DNA.
Adenovirus mutant seed stocks were prepared in a similar fashion to Ad40. 
Virus was inoculated onto 293 cells at O.lpfu/cell. Cells were harvested 3-5 days 
postinfection as above and titrated by plaque assay on 293 cells (Williams, 1970).
v-Spl (see 3.18.).
AcNPV flbFL582 (see 3.15.).
3.2.2. Density-Gradient Purified Virus.
Crude virus stocks were grown as described (see 3.2.1.). w-butanol was added to 
virus preparations to give a final concentration of 1% (v/v) and incubated on ice for lh 
with frequent mixing. The suspension was spun at 500g for 20min at 4°C. The 
supernatant containing virus was removed and purified on a glycerol/caesium chloride 
gradient. The gradient was made up of 2ml 40% glycerol in lOmM Tris-HCl pH7.9 at the 
top followed by 3ml of 0.32g/ml caesium chloride in lOmM Tris-HCl pH7.9 and then 
2ml of 0.418g/ml caesium chloride in lOmM Tris-HCl pH7.9, finally the vims 
supernatant was carefully layered on top. Tubes were spun at 25,000rpm for 1.5h. The 
opalescent vims band was collected and dialysed against TE at 4°C overnight. The vims 
was aliquoted and stored at -70°C.
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3.2.3. Labelled Virus.
dl309 - 293 cells were grown on a 140mm plate (lxlO7 cells) and infected at 50 
pfu/cell. Adsorption was carried out at 37°C for lh and cells overlaid with infecting 
medium (GMEM + 2% FCS). 2.5 mCi of tritiated thymidine was added to the overlaying 
medium at 12h postinfection and incubation continued at 37°C. The virus was harvested 3 
days post infection and purified as described (see 3.2.2.). The specific activity of the 
virus was 2.8 x 10-5 cpm/particle.
Ad40 - KBa+b cells were grown on a 140mm plate (lxlO7 cells) and infected 
with a 1/5 dilution of Ad40. Virus was adsorbed for lh at 37°C and then overlaid with 
infecting medium (GMEM + 0.5% FCS). 2.5 mCi of tritiated thymidine was added to the 
overlaying medium at 24h postinfection. The virus was harvested at 5 days postinfection 
and purified as described (see 3.2.2.). The specific activity of the virus was 4.3 x lO-6 
cpm/particle.
Virus particle concentration (above) was estimated by the Bradford assay 
(Bradford, 1976), using a molecular wt of 1.75xl08 daltons for adenovirus (Green et al., 
1967).
3.3. Extraction of Nucleic Acids.
3.3.1. Extraction of Viral DNA.
Viral DNA was prepared by incubating virus suspensions with lOOpg/ml of 
Proteinase K and 0.1% (w/v) of SDS at 37°C for 2-3h. An equal volume of 
phenol/chloroform was added, mixed, then centrifuged at 12,000rpm for 2min in a 
microfuge. This was followed by a chloroform extraction. The DNA-containing upper 
aqueous phase was concentrated by the addition of 2.5 volumes of ethanol, 0.1 volumes 
of 3M sodium acetate pH5.2, with lpg of tRNA added as a carrier. Samples were 
incubated at -70°C for 30 min or -20°C overnight. DNA was pelleted by centrifugation at 
12,000rpm for lOmin in a microfuge and resuspended in DW.
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3.3.2. Extraction of Intranuclear Viral DNA.
Nuclei were isolated as described (see 3.3.3.) and intranuclear DNA was extracted 
by a modified Hirt procedure (Hirt et al., 1967; Hay et a l ., 1984).The nuclear pellet was 
resuspended in lOOpl TE, after which 600pl of Hirt buffer was added and incubated at RT 
for 10 min. This was followed by the addition of 150jil of 5M NaCl, with vials inverted 
to mix and incubated at 4°C overnight. Samples were spun free of cell debris at 20,000g 
for 30 min in a refrigerated microfuge. The DNA supernatant was incubated with 
O.lmg/ml RNase A for lh at 37°C, followed by the addition of O.lmg/ml Proteinase K for 
3h at 37°C. A phenol/chloroform followed by a chloroform extraction was then carried 
out. The DNA was precipitated at -20°C overnight with an equal volume of isopropanol 
and 0.1 volumes of 3M sodium acetate pH5.2. The DNA was pelleted and resuspended in 
either TE or DW and stored at -20°C.
3.3.3. Preparation of Cytoplasmic RNA.
Cytoplasmic RNA was extracted (Sharp et al., 1974) from cells grown on 50mm 
plates. Monolayers were washed twice with cold PBS, the cells from two plates were 
pooled by scraping into 1ml PBS and centrifuged at 5,000rpm in a benchtop microfuge 
for 30 sec. The cell pellet was resuspended in 200pl ice-cold RNA lysis buffer and 
centrifuged at 5,000rpm for 40 secs. The nuclear pellet was frozen at -70°C and stored for 
subsequent extraction of intranuclear DNA (see 3.3.2.). The supernatant containing 
cytoplasmic RNA was transferred to a fresh vial containing 200pi urea buffer at RT, and 
two successive phenol/chloroform and chloroform extractions were carried out to remove 
proteins. The RNA was precipitated by the addition of 0.1 volumes of 10M ammonium 
acetate and 2 volumes of ethanol. Tubes were incubated at -20°C overnight. The RNA 
was pelleted by centrifugation at 12,000rpm for lOmin and washed with 70% ethanol. 
The RNA was either DNase I treated (see 3.4.) or resuspended in lOOpl DEPC treated 
water, then 200pl ethanol was added and the RNA stored in this mix at -20°C. Before use 
an aliquot of the RNA mix was removed and precipitated by the addition of 0.1 volumes
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of 10M ammonium acetate and incubated for 30min at -70°C. RNA was pelleted at 
15,000g for lOmin at 4°C and redissolved in DEPC treated water.
3.4. DNase I Treatment of RNA.
Cytoplasmic RNA pellets (see 3.3.3.) were resuspended in lxDNase I buffer and 
2 units of RQ1 RNase free DNase I was added. Samples were incubated at 37°C for 
30min after which they were phenol/chloroform followed by chloroform extracted. The 
RNA was precipitated at -20°C overnight with 2 volumes of ethanol and 0.1 volumes of 
10M ammonium acetate. The RNA was pelleted at 15,000g for lOmin at 4°C and 
redissolved in lOOpl DEPC treated water, 200pl of ethanol was then added. The RNA 
was stored in this mix until use (see 3.3.3.).
3.5. Quantitation of Nucleic Acids.
Quantitation of nucleic acids was carried out by measuring optical density (OD) 
at 260nm and 280nm on a Beckman DU-62 spectrophotometer. Readings at 260nm 
allowed concentrations to be calculated using conversion factors for 1 OD unit at 260nm. 
For single stranded DNA this was 20|ig/ml, for RNA 40pg/ml and for double stranded 
DNA this corresponds to 50pg/ml.
The ratio between 260 and 280nm gave an estimate of the purity of the nucleic 
acid. Pure preparations of DNA have a ratio of 1.8 and pure preparations of RNA have a 
ratio of 2.
The molarity of oligonucleotides was determined using the following formula, 
when Em (molar extinction coefficient) is the optical density of a 1M solution of the 
oligomer at 260nm (Tullis et al., 1989).
OD/Em
[where Em =A(16,000) + G(12,000) + C(7,000) + T(9,600)]
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3.6. Electrophoretic Separation of Nucleic Acids.
3.6.1. Agarose 'Midi' Gels.
DNA was analysed by preparing 100ml horizontal 0.8-2% agarose gels (140mm x 
110mm x 7mm) containing 0.5|ig/ml ethidium bromide in lxTBE. Electrophoresis was 
carried out with gels submerged and run at 150V for 2h in lxTBE. DNA samples had 0.2 
volumes of sample buffer added prior to loading.
3.6.2. Formaldehyde Agarose Gels.
RNA was prepared for Northern blotting (see 3.12.) by electrophoresis on 
denaturing formaldehyde agarose gels (140mm x 110mm x 7mm). The gel was prepared 
by boiling 1.2g of agarose in 87ml DEPC treated water. The agarose was cooled to 55°C, 
then 10ml of lOxMOPS and 3ml of 37% formaldehyde was added, thoroughly mixed and 
the gel poured immediately. RNA samples were prepared by dissolving RNA pellets in 
6pi DEPC treated water followed by the addition of 2.5pl lOxMOPS, 12.5pl formamide 
and 4.5pl 37% formaldehyde. Samples were mixed gently and incubated at 55°C for 
15min, 5pi of loading dye mix was added prior to loading. Gels were run submerged in 
lxMOPS and electrophoresis carried out at 70 volts for 2.5h in a fumehood.
3.6.3. Non-denaturing Polyacrylamide Gels.
Gel retardation assays (see 3.19.) and the purification of double stranded 
radiolabelled oligonucleotides (see 3.10.2.) were carried out using vertical gels (260mm x 
160mm x 2mm) with the appropriate concentration of acrylamide in 0.5xTBE. 
Acrylamide gels were prepared from a stock solution of 30% acrylamide (29% 
acrylamide and 1% N-N' methylene bisacrylamide), with 0.5xTBE. Gels were 
polymerised by the addition of 0.2ml of 25% APS and 30pl TEMED. Samples for gel 
retardation assays were run without loading dye mix but double stranded DNA samples
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had 0.2 volumes of loading dye mix added prior to loading. Electrophoresis was carried 
out at 200V for 2-2.5h.
3.6.4. Denaturing Urea/Polyacrylamide Gels.
Gels for SI analysis (see 3.13.) were carried out using vertical gels (450mm x 
230mm x 0.35mm) with the appropriate concentration of acrylamide in lxTBE. Gels for 
purification of oligonucleotides (see 3.10.1) were carried out in vertical gels (260mm x 
160mm x 2mm) with 15 or 20% acrylamide in lxTBE. Gels were made from a stock 
solution of 20% acrylamide and 1% N-N' methylene bisacrylamide with 7M urea in 
lxTBE. Polymerisation was carried out by the addition of 0.25ml of 25% APS and 40pl 
TEMED. Electrophoresis was carried out with a prerun (40W for S1 gels and 200V for 
purification of oligonucleotides on gels) for lh prior to samples being loaded. The 
samples were denatured by adding 0.2-1 volumes of formamide dye mix, boiling for 
5min and rapid cooling on ice. Samples were run for l-2h in lxTBE. The gels for SI 
analysis were dried under vacuum, then exposed to film at -70°C for autoradiography.
3.7. Electroelution of DNA from Polyacrylamide Gels.
Polyacrylamide gels used for purification of radiolabelled single or double 
stranded oligonucleotides were exposed to autoradiography film for 2 min. Bands of 
interest were cut out and electroelution performed in a Schleicher and Schuell BIOTRAP 
apparatus. Electroelution was carried out in 0.25xTBE at 200V for 2h into a 200pl 
volume trap in the biotrap. Electroeluted DNA was stored in this 200pl volume at -20°C.
3.8. Preparation of Plasmid DNA.
3.8.1. Small Scale Preparation of Plasmid DNA.
A single colony was picked using a sterile toothpick into 5ml L-broth with 
50jig/ml ampicillin and incubated overnight in an 37°C orbital shaker. 1.5ml was
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removed and pelleted at 12,000rpm for 20secs in a benchtop microfuge. The pellet was 
resuspended in lOOpl of Solution I containing lmg/ml fresh lysozyme and incubated at 
RT for 5 min. This was followed by the addition of 150pl of fresh Solution II and after 
mixing a further 5 min incubation at RT. 150pl of Solution HI was added, tubes were 
inverted to mix and incubated for 5min at RT. Samples were pelleted at 12,000rpm for 
5min in a benchtop microcentrifuge. The DNA-containing supernatant was transferred to 
a fresh vial and phenol/chloroform extracted. DNA was precipitated by adding 2 volumes 
of ethanol and centrifuged at 12,000rpm for 5min. Pellets were washed in 70% ethanol 
and resuspended in 40pl DW. DNA was analysed by restriction enzyme digestion, in the 
presence of 20pg/ml of RNase A.
3.8.2. Large Scale Preparation of Plasmid DNA.
A 10ml L-broth culture containing 50pg/ml ampicillin was grown up overnight in 
a 37°C orbital incubator. The overnight culture was added to 350ml L-broth containing 
ampicillin and shaken at 37°C until OD630 was between 0.6-0.8. Chloramphenicol was 
added to a final concentration of 200pg/ml and incubation continued overnight. The 
culture was pelleted by centrifugation at 7,000rpm for lOmin and resuspended in 2ml 
sucrose solution with fresh lysozyme added to a final concentration of 4mg/ml. After 
incubating at RT for 30min, 3.2ml Triton solution and 800|il 0.25M EDTA pH8.0 were 
added, mixed, and left for a further 15min at RT. The cell debris was removed by 
centrifugation at 17,000rpm for 40min at 4°C in a Sorvall SS34 rotor. Plasmid DNA was 
purified by equilibrium centrifugation in a caesium chloride gradient. For each 6ml 
sample, the gradient consisted of 3.5ml of DNA sample, 250pl of lOmg/ml ethidium 
bromide and 4.5g caesium chloride, the final solution was made up to 9.3g with TE. The 
gradients were centrifuged at 40,000rpm for 18h at 18°C in a Dupont ultracentrifuge 
using a TV865 rotor. The lower band of the gradient consisting of closed circular plasmid 
DNA was collected. Ethidium bromide was removed by adding an equal volume of 
isopropanol, mixing, allowing the two layers to separate and discarding the top 
isopropanol layer. This was repeated twice or until the bottom DNA containing layer was
71
no longer pink. Caesium chloride was removed from the DNA solution by dialysing 
against TE for 18h at 4°C. DNA was incubated with RNase A to a final concentration of 
lOOpg/ml for lh at 37°C followed by Proteinase K at lOOpg/ml and 1% SDS for 2h at 
37°C. Finally the DNA was extracted once with phenol/chloroform and twice with 
chloroform, before being ethanol precipitated at -20°C overnight (with 2 volumes of 
ethanol and 0.1 volumes of 3M sodium acetate pH5.2). DNA was pelleted at 12,000rpm 
for lOmin and resuspended in DW.
3.9. Radioactive Labelling of DNA.
3.9.1. Internal Labelling of DNA by Nick Translation.
0.5-lpg of plasmid DNA was radiolabelled by the addition of 25pCi of two 
a[32P]-dNTPs, 20|iM of the other two dNTPs and 2 units of DNA polymerase I /DNase I 
enzyme mix. After a lh incubation at 16°C, unincorporated nucleotides were removed by 
fractionation on a 5ml G-50 Sephadex column. Sephadex beads (Pharmacia) were 
swollen overnight in DW. Columns were prepared in plastic 5ml pipettes with glass wool 
plugs and equilibrated with 10ml TE. To determine percentage incorporation of 
radiolabel, lpl from labelled DNA, (loaded onto a Sephadex G-50 column) was spotted 
onto glass fibre filter paper discs (Whatman GF/C, 2.1cm diameter) and dried. After 
elution through the column, the first four 250pl peak fractions were pooled and lOpl 
dotted onto a filter and dried. To remove unincorporated nucleotides from this filter only, 
it was washed twice in 10% (w/v) TCA for 5min and twice in 5% (w/v) TCA for 5min, 
followed by a 5min ethanol wash. The filter was then dried. Both filters were counted in 
a scintillation counter. Comparison between the two determined percentage 
incorporation. Probes generally had a specific activity of Ixl07-lx l08cpm/|ig.
3.9.2.5’ End Labelling of Oligonucleotides.
To 100-200ng of oligonucleotide was added 50 fiCi of [y -32P]-ATP and 20 units 
of T4 polynucleotide kinase in lxKinase buffer. Incubation was carried out at 37°C for
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2h. The DNA was phenol/chloroform and chloroform extracted followed by ethanol 
precipitation with 2 volumes of ethanol, 0.1 volumes of 3M sodium acetate pH5.2 and 
3pl of lpg/pl tRNA at -20°C overnight. After pelleting for lOmin at 12,000rpm in a 
benchtop microfuge, the DNA was resuspended in DW.
3.10. Manipulation of Oligonucleotides.
3.10.1. Purification of Oligonucleotides.
Synthetic oligonucleotides were synthesised, on a Cruachem PS-250 DNA 
synthesiser, on columns. The DNA was eluted from the column by incubating in 2.5ml of 
concentrated ammonia solution for 2-2.5h at RT. The oligonucleotides were deprotected 
by incubating the oligonucleotide containing ammonia solution at 55°C for 5h, after 
which the solution was split into three aliquots and lyophilised. Pellets were resuspended 
in 90% formamide, heated at 95°C for 3min before being applied to a 15 or 20% 
denaturing polyacrylamide gel containing 7M urea and run in lxTBE (see 3.6.4.). 3pl of 
formamide dye mix was loaded in a separate well to act as a migration marker. The gels 
were electrophoresed at 200V until the bromophenol blue had migrated two thirds of the 
way down the gel. The DNA was visualised by placing a TLC plate underneath the gel 
and viewed with an angled shortwave UV lamp. The oligonucleotide appeared as a dark 
band against a uniform green fluorescent background. The band containing the full length 
oligonucleotide was excised and eluted overnight at RT into lml of TE. The DNA 
supernatant was filtered into a fresh vial and ethanol precipitated, with two volumes of 
ethanol and 0.1 volumes of 3M sodium acetate pH5.2. The DNA was pelleted at 
12,000rpm for lOmin in a benchtop microfuge and resuspended in DW.
3.10.2. Annealing Complementary Oligonucleotides.
Equivalent amounts of each oligonucleotide were added together in 50pl of DW. 
Oligonucleotides were thoroughly denatured by the addition of 2pi of 5M NaOH, 
samples were mixed and incubated at 37°C for 30min. The NaOH was neutralised and
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DNA precipitated by the sequential addition of 5pl of 3M sodium acetate pH5.2, lOOpl of 
ethanol and 2pl of lpg/pl tRNA. Samples were precipitated at -70°C for 15min before 
centrifugation at 12,000rpm for lOmin. DNA pellets were air dried, resuspended in 20pl 
DW and annealed at 37°C for 30min. Double stranded oligonucleotides were stored at - 
20°C.
Where one strand was radiolabelled, as for gel retardation probes, annealed 
oligonucleotides were run on non-denaturing polyacrylamide gels (see 3.6.3.) to check 
for annealing efficiency. Probes were purified by electroeluting (see 3.7.) into 200|il 
0.25xTBE and subsequently stored at -20°C.
3.11. DNA Slot Blot Analysis.
Samples of DNA were boiled for 5min in a 200pl volume of 6xSSC and rapidly 
cooled on ice to denature. Nylon membranes (Hybond-N from Amersham) were 
presoaked for 5min in DW before soaking in 6xSSC for 5min. Membranes were placed in 
the slot blot apparatus (Schleicher and Scheull). A vacuum was applied, and the DNA 
samples were loaded into the slots. The wells were washed once with 6xSSC. Membranes 
were then air dried for 10-15min and the DNA irreversibly bound by exposing to 
shortwave UV for 3.5min. DNA hybridisation was carried out by prehybridising and 
hybridising membranes in 50% formamide, 5xSSC, lxDenhardts and lOOpg/ml salmon 
sperm DNA at 42°C in a shaking water bath. The membranes were prehybridised for 4h 
after which the prehybridisation mix was replaced by the hybridisation mix which also 
contained denatured radiolabelled probe. Hybridisation was carried out at 42°C overnight. 
Membranes were washed at RT twice in 2xSSC, 0.1% SDS for 30min and twice in 
O.lxSSC, 0.1%SDS for 30min. Finally membranes were washed briefly in DW before 
autoradiography on flashed film with an intensifying screen at -70°C.
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3.12. Northern Blot Analysis.
RNA samples were run on formaldehyde gels (see 3.6.2.) until the bromophenol 
blue dye was approximately two thirds of the way down the gel. The gel was washed four 
times in DW, for 5min each wash, at RT to remove formaldehyde. The gel was 
equilibrated in lOxSSC for lh at RT. The RNA was blotted onto nylon membrane 
(Hybond-N) by capillary blot with 20xSSC. Nylon membrane was cut to the size of the 
gel, as were two pieces of filter paper; a wick was also made of filter paper. This was 
soaked in 20xSSC and placed over a glass plate bridging the transfer dish such that the 
ends of the wick touched the bottom of the dish. Air bubbles were removed and the gel 
placed on top of the wick, the nylon membrane equilibrated in lOxSSC was carefully 
placed over the gel. Finally the two pieces of filter paper and a two inch thick pile of 
paper towels were added and a weight applied on top. The capillary transfer was left 
overnight at RT. The membrane was carefully removed and the RNA crosslinked by 
exposing to UV for 30 seconds in a Stratagene stratalinker. Membranes were 
prehybridised and hybridised in 50% formamide, 5xSSPE, 1% SDS, 5xDenhardts 
solution and 0.5|ig/ml salmon sperm DNA. Prehybridisation was carried out at 42°C for 
2h, after which the solution was replaced with hybridisation mix containing denatured 
probe and hybridised overnight at 42°C. Membranes were washed at 42°C once with 
2xSSPE, 0.1%SDS for 15min, followed by 0.5xSSPE, 0.1% SDS for lOmin and finally 
once in O.lxSSPE, 0.1%SDS for lOmin. Membranes were briefly washed in DW and 
exposed to flashed film with an intensifying screen at -70°C.
Membranes were stripped of probe by either boiling a solution of 0.1% (w/v) 
SDS, which was poured onto the membrane and allowed to cool to RT. The second 
method was to incubate membranes at 65°C for 2h in 5mm Tris-HCl pH8, 2mm EDTA 
and O.lxDenhardts solution. Membranes were autoradiographed to check probe had been 
removed. The filter was then prehybridised and hybridised with new probe.
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3.13. SI Nuclease Digestion.
SI nuclease digestion was carried out essentially as described (Ausubel et al., 
1992). RNA pellets (15pg) to be digested were air dried and resuspended in 30pl of 
lxaqueous hybridisation mix containing approximately 2ng of a 5* labelled 
oligonucleotide probe. Samples were denatured at 75°C for lOmin and rapidly transferred 
to 55°C for hybridisation overnight. Tubes were spun briefly and 300pl of SI digestion 
mix was added, containing 4pg of salmon sperm DNA and 400units of SI nuclease in 
lxSl buffer; digestion was carried out at 37°C for 1.5h. The reaction was stopped by the 
addition of 6pl of 0.25M EDTA (pH8), and 2pl lmg/ml tRNA with 700pl of ethanol was 
added. Protected fragments were precipitated at -70°C for 30min then pelleted at 
12,000rpm for lOmin and washed with 70% ethanol. They were resuspended in 3pi of 
0.1M NaOH and 3pi of formamide dye mix was added. The samples were denatured by 
boiling before being loaded on a denaturing polyacrylamide gel (see 3.6.4.). Gels were 
electrophoresed for l-1.5h at 40W and dried under vacuum before autoradiography at - 
70°C.
3.14. Indirect Immunofluorescence.
Coverslips were prepared for cells by boiling in 500ml DW with a few drops of 
Decon. They were then washed for 30min with DW and stored overnight in ethanol; 
before being dried between two pieces of filter paper and sterilised (by autoclaving) in 
glass petri dishes.
Cells were grown on circular coverslips (16mm in diameter) in 50mm plates at 
37°C. The cells were infected when just confluent, with various dilutions of Ad40 in TS, 
each coverslip was infected with 20pl of virus dilution. Coverslips were incubated at 
37°C for lh before medium was added and further incubated at 37°C. Cells were fixed at 
48h postinfection. Cells were washed twice with cold PBS and fixed by adding a 3:1 mix
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of ice-cold methanol:acetone, followed by incubation at RT for lOmin. The methanol mix 
was removed and cells were washed twice with PBS. Coverslips were either stored under 
PBS at 4°C for a few days or stained immediately.
The primary antibody used was an Ad5 anti-hexon mAb (10/5.1) which was 
diluted 1/100 in PBS and spun at 12,000rpm for 2min. Coverslips were incubated with 
20|il of the antibody dilution for 30min at RT. The coverslips were washed in PBS four 
times. The second antibody was goat antimouse IgG fluorescein isothiocyanate conjugate 
(Nordic Immunochemicals) diluted 1/100 in PBS, filtered through an 0.45pm filter and 
spun at 12,000rpm for 2min. 20pl was layered onto the coverslips and cells were 
incubated at RT for 30min. The cells were washed 7 times in PBS and once in DW. 
Coverslips were mounted on microscope slides in a 1:1 mix of glycerol:PBSA. The 
coverslips were sealed with nail varnish and the cells examined on a Nikon Microphot- 
SA fluorescence microscope using the blue filter at wavelength 480nm for fluorescein.
3.15. Preparation of Crude Ad2 Fibre.
5xl07 Sf21 cells were infected with lpfu/cell of AcNPVfibFL582 (Novelli and 
Boulanger, 1991). Virus was adsorbed for lh at 28°C before the addition of medium and 
incubation continued at 28°C. Cells were harvested 72h postinfection. Virus was 
extracted by five freeze thaw cycles (-70°C to 37°C) and pelleted free of debris at 
2,000rpm for lOmin. An equal volume of arcton was added to the virus containing 
supernatant and vortexed for lmin, after which the mix was spun at 2,000rpm for lOmin. 
The top layer of crude Ad2 fibre was stored in aliquots at -70°C.
Maintenance of AcNPVfibFL582 and preparation of crude Ad2 fibre were kindly 
carried out by G. Brown.
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3.16. Attachment and Internalisation Assay.
Cells were grown to confluency in linbro wells (2cm2 surface area) at 37°C. The 
amount of attached virus particles was determined by incubating cells at 4°C with tritium 
labelled virus particles (see 3.2.3.). Cells were precooled at 4°C fbr 30min; before 
infection cells were counted (on extra wells plated) and virus dilutions were adjusted 
accordingly. 40pl of labelled virus (diluted in TS) was then added and incubation 
continued for 2h at 4°C, with wells shaken every 15min. Cells were washed with cold 
lxHBS three times followed by the addition of 200pl of cell adhesion buffer (warmed to 
37°C). Cells were warmed to 37°C and incubated for various times at this temperature. To 
distinguish attached from internalised virus half the wells were treated with the protease 
subtilisin. Cells were washed twice in cold lxHBSE, after which 200pl of either lxHBSE 
or lxHBSE containing 2mg/ml subtilisin was added (both sets of buffers were warmed to 
37°C); incubation was continued at 37°C for 30min. Finally the cells were scraped into a 
1.5ml vial and washed twice with 400pl cold cell adhesion buffer. lOOpl EB buffer was 
added to cell pellets, samples were vortexed and incubated at RT for lOmin. 10ml of 
ecoscint was added to each sample and thoroughly mixed, and the tritium counts per 
minute were counted in a scintillation counter.
For competition experiments cells were preincubated with either ten fold excess 
unlabelled banded Ad40 virus particles or 8jig of crude Ad2 fibre (see 3.15.); both 
competitors were diluted in TS and pretreated at 56°C for 30min. Cells in linbro wells 
were cooled to 4°C for 30min, and competitors added (in 40pl volumes) to half the wells 
and 40pl of TS added to the remainder; incubation was continued for lh with frequent 
shaking. Cells were washed twice with cold lxHBS and labelled particles added at 4°C. 
After a 2h incubation at 4°C the cells were washed three times with cold lxHBS and 
pelleted. The pellets were dissolved in lOOpl of EB buffer and processed as above.
For attachment experiments, cells were precooled to 4°C for 30min, various 
dilutions of labelled virus particles (40pl in TS) were added and incubation continued for
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2h at 4°C (with frequent shaking). Cells were washed three times with cold lxHBS and 
pelleted. The pellets were dissolved in lOOpl of elution buffer and processed as above.
3.17. Preparation of Nuclear Extracts.
Nuclear cell extracts were prepared using the modified Dignam procedure 
(Dignam et al., 1983). Cells were grown on 140mm plates to confluency. Plates were 
washed with 10ml ice cold PBS and cells scraped into 5ml ice cold PBS. Cells were 
pooled and pelleted by centrifugation in a Dupont table top centrifuge at 4°C for 5min at 
2,000rpm. Cell pellets were resuspended in two pellet volumes of buffer A and incubated 
on ice for 20min. Samples were mixed by pipetting up and down, and incubation on ice 
continued for a further lOmin. Cells were then lysed by 15 strokes in a dounce 
homogeniser. Nuclei were pelleted by centrifugation at 6,000rpm in a benchtop 
microcentrifuge for 2min at 4°C. The cytoplasmic fraction was removed and the nuclei 
packed down again by centrifugation at 15,000g in a microcentrifuge for 15min at 4°C. 
Any remaining supernatant was removed and the nuclei were resuspended in two cell 
volumes of buffer C. Samples were incubated on ice for 20min, and mixed every 5min by 
pipetting up and down. Suspensions were pelleted free of nuclear debris by centrifugation 
at 15,000g for 15min. The supernatant was aliquoted and stored at -70°C.
Protein concentrations were determined by the Bradford protein assay (Bradford, 
1976) using known amounts of BSA for a standard curve. 1ml of Bradford reagent was 
added to samples, mixed and incubated for 20min at RT. The absorbance was then 
measured at 595nm.
3.18. WGA Affinity Chromatography of Spl.
3.18.1. Preparation of Spl Extracts.
CV-l cells (5xl07 cells) were infected with the vaccinia virus recombinant vSpl 
at lOpfu/cell. Virus was adsorbed at 37°C for 1.5h and then medium was added. At 26h
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postinfection cells were harvested by washing twice with cold PBS and scraping into 
PBS. The cells were pelleted at 2,000rpm for lOmin at 4°C. The pellet was resuspended 
in 2ml of HS buffer and spun free of cell debris at 42,000rpm for lh at 4°C. The 
supernatant was subjected to wheat-germ agglutinin (WGA) affinity chromatography 
(see 3.18.2.).
Maintenance of vSpl and preparation of Spl extracts were kindly carried out by 
A. Rinaldi.
3.18.2. WGA Affinity Chromatography.
Spl was purified by WGA affinity chromatography (Jackson and Tjian, 1989). 
The column was made from WGA-agarose resin (Vector laboratories). The packed 
column volume was 0.4ml, and was equilibrated with 2ml of HS. Cell extracts were 
loaded onto the column in 2ml of HS buffer (see 3.18.1.) and the column washed with 
2ml of HS buffer followed by 4ml of Z' buffer. Glycosylated proteins were eluted in five 
0.4ml fractions with 2ml of 0.3M N-acetylglucosamine (NAcGlc) in Z' buffer. The 
fractions were pooled, made up to 50% glycerol with respect to Z' buffer and stored in 
aliquots at -70°C.
3.19. Gel Retardation Assay.
Probes for gel retardation assays were prepared by 5’ labelling oligonucleotides 
(see 3.9.2.) which were subsequently annealed with their unlabelled complementary 
strands (see 3.10.2.), and purified (see 3.7.) on non-denaturing polyacrylamide gels.
Binding reactions were performed in a 20pl mix containing lxRM, l-2pg poly 
(dl-dC).poly (dl-dC), approximately lng of probe, 5pg of nuclear extract or 0.5pg Spl 
protein purified by WGA affinity chromatography (see 3.18.) and a total of 4pl buffer C. 
Samples were incubated at 25°C for 30min then loaded directly onto a 3.5% non­
denaturing polyacrylamide gel (see 3.6.3.). 4pl loading dye mix was run in an adjacent
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well as a marker. Electrophoresis was carried out in 0.5xTBE at 180V for 2.5h. Gels were 
dried under vacuum, and exposed to film at -70°C.
In competition experiments, annealed unlabelled oligonucleotides were added to 
extracts (with all buffers present) and incubated for 15min at 25°C, after which probe was 
then added to the samples, followed by a 30min incubation at 25°C. The samples were 
then processed as above.
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4. RESULTS.
Introduction.
The overall aim of this thesis was to characterise Ad40 growth in the permissive 
cell line INT407.
Ad40 grows poorly on conventional human cell lines, such as HeLa and KB, 
which are used to grow non-fastidious adenovirus serotypes (Takiff and Straus, 1982; 
Mautner., et al 1989). Takiff and Straus (1982) found it was an early replicative block 
that was responsible for the poor growth of Ad40 (and Ad41). This block was overcome 
by growing in cells which constitutively express the Ad5 or Ad2 El regions; these are 
293 and KBa+b cells lines respectively (Takiff et al., 1981, de Jong et al., 1983; Mautner 
et al., 1989). In contrast, some workers have had variable success growing Ad40 on 293 
cells (Chiba et al, 1983; Uhnoo et al., 1983). This may have arisen due to differences in 
virus isolates used. Alternatively, Ad40 can grow in KBb cells which express only the 
Ad2 E1B region (Mautner et al., 1989). This suggested that the Ad40 E1B region was 
defective. Complementation assays conducted in trans with helper viruses, supplying the 
Ad2 or Adl2 E1B 19K or 55K functions (Mautner et al., 1989; Gomes et al, 1992), 
indicated that expression or function of the Ad40 E1B 55K protein was defective, a
As it is uncertain how Ad40 gene expression and DNA replication may be 
affected by the endogenous El proteins present in KBa+b and 293 cells, a better cell line 
to use would be of intestinal origin, which supports virus growth but does not express 
adenovirus viral gene proteins. Some continuous cell lines, which are permissive for 
enteric adenoviruses but do not express adenovirus proteins have been reported (Kidd and 
Madeley, 1981; Pieniazek et al, 1990a; Hashimoto et al., 1991; Steinthorsdottir 1991; 
Gomes et al., 1992). Steinthorsdottir (1991) found that the INT407 cell line (described in 
the ATCC as an embryonic intestinal cell line) could support Ad40 growth. The virion 
DNA yields on INT407 cells were 70% of that in KBa+b cells, while for HeLa the level 
was only 17%. This experiment indicated that Ad40 could grow in tissue culture without
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complementing viral gene products and there was an increase of permissiveness from 
HeLa through INT407 to KBa+b cells.
INT407 cells were permissive for Ad40 growth and were not known to express 
adenovirus proteins. INT407 cells have subsequently been shown to be a HeLa cell 
derivative (Gilbert et al., 1990). However there is a clear difference in the permissivity 
for Ad40 between INT407 and HeLa cells. Therefore this study was undertaken to 
characterise the growth of Ad40 in INT407 cells in comparison to other permissive 
(KBa+b, 293) and semi-permissive cell lines (HeLa, A549).
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4.1. Timecourse of Viral DNA Replication in Ad40 Infected 
Permissive and Semi-Permissive Cells.
A detailed comparison of Ad40 DNA replication in INT407, KBa+b and HeLa 
cells was conducted. The following experiment was carried out in order to elucidate the 
time of onset of DNA replication and the overall yield of Ad40 virion DNA on KBa+b 
cells (which complement the Ad40 E1B 55K defect) in comparison with INT407 cells 
(which are not known to express adenovirus proteins).
KBa+b, HeLa and INT407 cells were grown on 50mm plates and infected with 
lOOpl of a 1/10 dilution of Ad40 p9 (in TS). After incubation at 37°C, two plates were 
pooled and harvested at various times for each cell type. Viral DNA was extracted as 
described (see 3.3.1.) and dilutions of DNA were applied to nylon membranes using a 
slot blot apparatus (see 3.11.). Membranes were probed with nick translated plasmid 
containing the Ad40 El region (pNM82). The membranes were exposed to 
autoradiography film (Figure 4.1.1.) and quantitated using phosphorimager technology 
(Figure 4.1.2.).
The pattern of virion DNA is shown in Figure 4.1.1. and is first detected in small 
quantities at 24h for both KBa+b and INT407 cells, after which there is a steady increase 
in DNA replication up to 72h post infection. A greater level of DNA replication is 
detected on INT407 compared to KBa+b cells at 30h. At subsequent times the level 
observed on KBa+b cells is greater than on INT407 cells and this difference is more 
marked as time goes on, as shown in Fig 4.1.2. For HeLa cells, Ad40 replication was just 
detectable at 30 and 36h p.i., an increase in DNA is detected later between 36 to 42h post 
infection. At 72h the amount of Ad40 replication on HeLa cells was approximately 4-fold 
lower than that seen on KBa+b cells. In Fig 4.1.2., the pattern of virion DNA replication 
on both INT407 and KBa+b cells is shown to be very similar up to 36h, after which there 
is a dramatic increase in KBa+b infected cells. Levels of virion DNA on INT407 cells are 
intermediate between KBa+b and HeLa, but the pattern is the same as KBa+b, with no 
plateau observed. In HeLa infected cells very small amounts of replication are detected
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Figure 4.1.1. Timecourse of Virion DNA Replication on Ad40 Infected KBa+b, 
HeLa and INT407 Cells.
KBa+b, HeLa and INT407 cells were infected with lOOjil of a 1/10 dilution of 
Ad40 p9 stock (in TS). Virus was harvested at the times indicated p.i., and viral DNA 
extracted. Dilutions (A is 1/10, B is 1/25 and C is 1/100) were applied to nylon 
membranes using a slot blot and probed with a nick translated plasmid containing the 
Ad40 El region (pNM82). The experiment was conducted three times with a similar 
outcome, a typical result is shown. The top three panels show a timecourse of Ad40 DNA 
replication on infected KBa+b, HeLa and INT407 cells. The bottom left hand panel 
shows the plasmid control.
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Figure 4.1.2. Quantitative Analysis of Ad40 DNA in Various Cell Lines.
M embranes were scanned on a Phosphorimager and quantitated with a 
Imagequant software package (Molecular Dynamics). The amount of DNA in ng was 
calculated by comparing the 5ng value of Ad40 E l plasmid standard (see Fig 4.1.1.) to 
Ad40 DNA from the timecourse. The values above correspond to the 1/10 dilution (see 
Fig 4.1.1.).
until 36h, after which there is a sharp increase to 48h, thereafter there is an apparent 
plateau.
4.1.1. Summary.
A similar pattern of virus replication is observed on KBa+b and INT407 cells. 
This experiment indicates that Ad40 can grow in cells not known to express El proteins. 
The growth of Ad40 on INT407 cells is reduced compared to KBa+b cells at 72h post 
infection. However these cells are clearly more permissive than HeLa cells in terms of the 
onset of replication and the overall yield of virus replication.
85
4.2. Replication of Ad5 and Adenovirus Early Region El 
Mutants on Permissive and Semi-Permissive Cells.
The following experiments were undertaken in order to investigate the growth of 
other adenovirus serotypes on the INT407 cell line. If INT407 cells could support the 
growth of Ad40 which had an E1B 55K defect, the question was asked if adenovirus 
mutants defective in E1B 55K function could also be complemented by INT407 cells.
The A549 cell line which was reported to be permissive for Ad40 (Hashimoto et 
al, 1991), but not known to express El proteins, was also included. A549 cells were 
shown to be permissive for Ad40 by Steinthorsdottir (1991). However this author found 
the level of virus replication was intermediate between INT407 and HeLa cells.
The first experiment was carried out with Ad5/2 El mutants. The Ad5 mutant 
dl309 was isolated by Jones and Shenk (1979a). This virus lacks three of the four Xba I 
sites present in wt Ad5, and in addition a large portion of the E3 region is deleted (83 to 
85 mu). However dl309 grows as well as wt in tissue culture and was used as a model for 
wt virus in these studies. The two E1B mutants used (Barker and Berk, 1987) were 
constructed from dl309 and Ad2 El sequences. The E1B mutant pml722 contains the 
Ad2 E1B region in a dl309 background. The E1B sequences have a G to A point 
mutation at nt 1722, introducing a stop codon, which prevents expression of the EIB 19K 
protein. This mutant replicates as well as wt in HeLa cells, but displays cyt and deg 
phenotypes characterised by extreme cytopathic effect and degradation of cellular DNA, 
respectively. The E1B 55K mutant, dll520, consists of Ad2 El A and E1B in a dl309 
background. The E1B sequences are altered with a C to T point mutation at nt 2022, 
which generates a stop codon. In addition, the region from 2496 to 3323nt is deleted, thus 
the E1B 55K and related proteins are not made, but the 19K open reading frame is 
unaffected. Virus replication is defective in HeLa cells with this mutant, but can be 
partially overcome at high moi.
Ad40 was used at a 1/10 dilution, and the Ad5/2 viruses were used at a moi of 
3pfu/cell. The four cell lines used in this experiment were: KBa+b, HeLa, INT407 and 
A549. Cells were grown on 50mm plates, infected with lOOpl of virus dilutions (in TS)
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and harvested at 72h post infection. Virus was released by three rounds of freeze thawing 
and the virion DNA extracted as described (see 3.3.1.). Dilutions of the DNA were 
applied to nylon membranes. The membranes were probed with a mix of Ad2 El A- and 
ElB-containing plasmids (for the Ad5/2 mutant viruses) or with a plasmid which 
contained the whole of the Ad40 El region. The resulting autoradiographs were 
quantitated by Hoeffer scanning densitometry. Probes had previously been tested for lack 
of cross-reaction between Ad5 and Ad40 sequences by Steinthorsdottir (1991).
The autoradiographs are shown in Figure 4.2.1. The wt virus dl309 grows on all 
cell types, with similar overall levels observed on INT407 and A549 cells. Virus 
replication in KBa+b cells is 25% less than the level detected on A549 and INT407 cells. 
In HeLa cells, a lower DNA yield is observed, approximately 50% less than the level 
detected in INT407 and A549 cells. The 19K mutant pm1722 replication is similar to wt 
(dl309) on A549, but lower in HeLa cells. However, very low yields are obtained in 
KBa+b and INT407 cells; from previous reports higher DNA levels of pml722 were 
expected on KBa+b cells (Steinthorsdottir, 1991). Extreme cytopathic effects had been 
observed on both these cell types at 72h post infection. This may account for the lower 
levels seen on these cell lines, particularly if cells had lysed, releasing virus into the 
surrounding medium. This virus would not have been harvested, as virion packaged DNA 
was prepared from cell-associated virus.
Wild type virus grew equally well on INT407 and A549 cells, but the 55K mutant 
dll520 grew better on INT407 than on A549, however even on INT407 the yield is lower 
relative to wt. The amount of d ll520 virion DNA from KBa+b cells is reduced compared 
to that described previously (Mautner et al, 1989). The highest level observed is on 
INT407 cells (with 40% of wt levels). On A549, dll520 replication is 70% of the level 
seen on INT407 cells. In contrast very little complementation is observed for d ll520 on 
HeLa cells, as expected (Barker and Berk, 1987; Mautner. et al., 1989).
For Ad40 infected cells, the amount of DNA detected is 5-fold and 3-fold lower 
on HeLa and A549 cells (respectively), compared to KBa+b cells. These results were 
comparable to those found previously (see 4.1.) and reported elsewhere (Steinthorsdottir, 
1991).
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Figure 4.2.1. Infection of Ad5/2 Mutants on KBa+b, HeLa, INT407 and A549 Cells.
Cells were infected with 3pfu/cell of the Ad5/2 mutants and 100|il of a 1/10 
dilution of p9 Ad40 (in TS). Virus was harvested at 72h p.i. and virion DNA
extracted. The following dilutions were applied to nylon membranes; 1/40, 3/400 and 
1/400. Membranes were probed with nick translated plasmids containing either a mix of 
Ad2 E l A and E1B (pNM90 and pNM92) for the Ad5/2 mutants or the Ad40 E l region 
(pNM82) for Ad40 sequences. The top eight panels show the yield of virus on the four cell 
types and the two lower bottom right hand panels show plasmid controls used.
The experiment was repeated with a lower moi; in order to see if the low level of 
virus DNA detected on KBa+b and INT407 cells with the pml722 mutant was a result of 
the extreme cytopathic effect observed. In addition, it would be possible to investigate if 
the complementation obtained with dll520 on INT407 and A549 cells was due to the 
virus being used at a high moi, as has been previously reported for this mutant (Barker 
and Berk, 1987).
The Ad5 El A mutant dl312 was also included in this experiment. dl312 was 
constructed by Jones and Shenk (1979a) and it contains a large deletion in the El A region 
of dl309. It is defective for growth on HeLa cells, but the defect can be complemented by 
growing on 293 cells. This virus was included in order to determine if adenovirus El A 
mutants could be complemented on INT407 and A549 cells.
The resulting autoradiographs are shown in Figure 4.2.2. and the quantitation by 
densitometric analysis in Figure 4.2.3. At lpfii/cell, the level of virus replication detected 
for dl309 on INT407 is lower than the level observed on KBa+b cells. The level of viral 
DNA replication detected on HeLa and A549 cells is similar, but is reduced (approx. 3 
fold) compared to KBa+b. Near wild type (dl309) levels of pml722 are observed on most 
cell lines. The amount of pm1722 viral DNA is similar on INT407 and KBa+b cells, but 
in comparison virus replication was reduced on HeLa and A549 cells. Thus the lower 
levels of pm1722 DNA replication (compared to wt) detected for INT407 and KBa+b 
cells in Figure 4.2.1. was probably due to the higher moi used and extreme cytopathic 
effect observed, d ll520 was complemented most on KBa+b and INT407 cells, and 
moderately on A549 cells (see Figure 4.2.3.). In addition, d ll520 replication is reduced 
compared to wt, on these cell lines. This mutant is defective for replication on HeLa cells, 
as described previously.
The pattern of Ad40 DNA replication seen in Figure 4.2.2. was similar to that 
described previously, with highest levels of Ad40 DNA replication detected on KBa+b 
and lowest on HeLa cells with intermediate levels on INT407 and A549 cells i.e. KBa+b 
> INT407 > A549 > HeLa.
In KBa+b cells, the E1B 55K defect in dll520 is complemented by endogenous 
E1B proteins. However this mutant also grew in INT407 and A549 cells, which are not
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Figure 4.2.2. Infection of Ad5/2 Mutants on KBa+b , HeLa, INT407 and A549 Cells at 
a Low moi.
Cells were infected with lpfu/cell of the Ad5/2 mutants and lOOfil of a 1/10 dilution of p9 
Ad40 (in TS). Cells were harvested at 72h p.i. and virion DNA extracted. The following
dilutions were applied to nylon membranes; 1/40, 3/400 and 1/400. The membranes were probed 
with nick translated plasmids, either a mix of pNM90 and pNM92 (containing the Ad2 El A and 
E1B region) or pNM82 (containing the Ad40 El region). The top eight panels show virus 
replication on the four cell types and the bottom right hand panel shows plasmid controls used.
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Figure 4.2.3. Quantitation of Ad5/2 and Ad40 Virion DNA from Various Cell Lines.
Autoradiographs (Fig 4.2.2.) were quantitated by densitometric analysis (Hoeffer). 
The amount of DNA in ng was calculated by comparing the 5ng values of the adenovirus 
El plasmid standards (see Fig 4.2.3.) to virion DNA at 72h post infection. The values 
above correspond to the 1/40 dilution (see Fig 4.2.3.).
4.3. Growth Kinetics of Ad40 on Permissive and Semi' 
Permissive Cells.
Tiemessen and Kidd (1988) employed an immunofluorescent assay to investigate 
the complementation and interference effects of Ad2 and Ad41 separately and in mixed 
infections. In non-permissive human embryo fibroblasts (HEF) cells, Ad41 late antigen 
synthesis was only detected in coinfections, with Ad2 providing a helper function. Ad41 
replication in semi-permissive Chang conjunctival cells was enhanced by Ad2, and this 
complementation was dependent on the input concentration of the virus. In addition there 
was interference by Ad41 on Ad2 replication in HEF cells. The extent of interference 
depended on the relative time of infection by each serotype. The complementation of 
Ad41 by Ad2, in HEF cells, suggested that Ad41 was completely dependant on Ad2 
helper function in these cells. These workers used this assay to monitor the number of 
Ad41 infected cells at various dilutions (Tiemessen and Kidd, 1990). Ad41 infection of 
Chang conjunctival cells followed multiple-hit kinetics (i.e. many virions were required 
to infect a cell), while in Ad41/Ad2 coinfections in HEF cells, Ad41 showed two-hit 
kinetics (i.e. two virus particles were needed to infect a cell). On the permissive 293 cell 
line, fluorescent cell counts for Ad41 were directly proportional to input concentration, 
which showed infectivity of one-hit kinetics. A possible explanation for the multiple hit 
pattern seen in Chang conjunctival cells , may have been due to the limiting concentration 
of an essential product. Many infecting genomes may overcome this limitation and lead 
to increased numbers of cells being productively infected, as the concentration of input 
virus increased. The requirement for this product is probably cell type dependent as single 
infections on HEF and Chang conjunctival cells are non-permissive and semi-permissive 
respectively.
The work in this section described the growth kinetics of Ad40 in cells showing 
different degrees of permissiveness. These experiments were conducted in order to see if 
differences in infectivity could explain the pattern of DNA replication previously 
observed between cell types (see 4.1.).
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4.3.1. Investigation of the Growth Kinetics of Ad40 on Permissive and 
Semi-Permissive Ceil Lines Using Indirect Immunofluorescence.
A similar approach was used as described by Kidd and Tiemessen (1988, 1990). 
Ad41 late antigen synthesis was monitored by indirect immunofluorescence using an 
Ad41 mAb. The four cell types studied were KBa+b, HeLa, INT407 and A549 cells. The 
method is described in detail elsewhere (see 3.14.) and briefly outlined here. Cells were 
grown on coverslips; when subconfluent they were infected with various dilutions of 
Ad40 in TS. The virus stock had a titre of 5.6X106 FFU/ml, on KBa+b cells. Cells were 
fixed at 48h p.i. and incubated with Ad5 anti-hexon mAb at a 1/100 dilution (in PBS). 
The second antibody (Goat anti-mouse FTTC) was added at a 1/100 dilution (in PBS). 
Coverslips were mounted and examined using either the x20 or xlO objective on a Nikon 
Microphot-SA fluorescence microscope.
The raw data is shown in Table 4.3.1., and is expressed as focus forming units 
(FFU) per field, where one FFU represents a single infected fluorescent cell. A graticule 
with a grid (10mm x 10mm) was fitted into the right hand eye piece of the microscope; 
one field counted corresponded to the area of the graticule. Ten fields were counted for 
each coverslip and four replicate coverslips were counted per dilution for each cell type. 
Coverslips with KBa+b and INT407 infected cells were counted using the x20 objective, 
as there were a higher number of fluorescent cells, whereas the x 10 was employed for 
A549 and HeLa cells, which had fewer fluorescent cells.
Table 4.3.1. shows the mean FFU/field and the standard error of the mean (SEM) 
for different moi of Ad40 infected cells. On KBa+b cells the number of FFU/field 
observed decreases proportionally compared to Ad40 input concentration i.e. the count 
for the 1/20 dilution was 40.2 FFU/field, for the 1/40 and 1/80 dilutions the values were 
22.52 and 11.60 respectively; showing an approximately two fold decrease at each two 
fold reduction in dilution. Thus the FFU/field appears to be directly proportional to the 
virus input concentration. The greatest number of FFU/field are observed on KBa+b cells 
at each input concentration, compared to the other cell lines. Ad40 FFU/field on INT407 
cells have the second highest counts and also appear to decrease proportionally to Ad40 
input, although the correlation is not as close as observed on KBa+b cells. For both HeLa
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Table 4.3.1. Ad40 Late Antigen Synthesis at 48h p.i. on KBa+b, INT407, HeLa and 
A549 Cell Lines.
Ad40 input
concentration
(Dilution)
Ad40 Fluorescence 
mean FFU/Field " ±  SEM
x 20 >> X 10 b
KBa+b INT407 HeLa A549
1/20 40.20 ±- 3.13 32.02 + 2.97 31.60 ± 4.97 10.87 + 2.82
1/40 22.52 ± 2.10 17.45 ± 2.85 13.05 ± 2.52 5.62 ±- 2.48
1/60 17.40 ±- 1.94 13.50 ± 2.36 5.60 ±- 1.26 1.87 ± 0.85
1/80 11.60 ± 1.37 6.65 ± - 1.59 4.85 ±- 1.29 1.50 ± 0.78
1/100 6.20 ± 1.28 5.02 + 1.53 1.95 ± 1.22 0.87 ±- 0.72
a this value is the mean of 40 fields counted over 4 replicate coverslips 
(10 fields counted/coverslip).
b Cells were counted using the x20 or xlO objectives.
and A549 cells much lower numbers of FFU/field are detected, the numbers decrease as 
input concentration is reduced and the relationship does not appear to be directly 
proportional.
Fluorescent counts were expressed as FFU/106 cells (see Table 4.3.2.) which took 
into account the magnification and the differences in the total number of cells, between 
cell types. The results expressed as FFU/106 cells are shown in Table 4.3.2. with the 
Ad40 input concentration, expressed as FFU/ml. To determine the total number of cells 
per coverslip, 20 fields were counted over four replicate coverslips (5 fields/coverslip), 
with the x40 objective, using the bright field path of the microscope.
The greatest levels of Ad40 late antigen synthesis are detected at every Ad40 
input concentration on KBa+b cells. The number of cells productively infected on 
INT407 are comparable to those seen on KBa+b cells. Ad40 fluorescent cell counts are 
approx. reduced by 7 and 16 fold on HeLa and A549 cells, respectively compared to 
KBa+b cells, at the 1/20 dilution.
In order to examine if Ad40, infected cells with one or two hit kinetics, the log 
values of Ad40 fluorescence and log Ad40 input concentration were calculated and 
plotted in Figure 4.3.1., the lines of best fit are shown and were generated from these data 
points using Linear Regression analysis (see below).
The question was asked how the data from this experiment differed from one and 
two hit kinetics. One hit kinetics is when a single virus particle is sufficient to infect a 
cell productively (Dulbecco and Vogt, 1953) and for two hit kinetics two virus particles 
are required. Theoretical data points were calculated for one and two hit kinetics. These 
data points were calculated assuming that each particle has an equal chance of infecting a 
cell following one or two hit kinetics and that infection of individual cells occurs 
independently. An arbitrary value was used for the 1/20 dilution (5xl05 FFU/106 cells for 
both lines) and subsequent dilutions were calculated based on one or two hit kinetics. The 
results are expressed as log FFU/106 cells and are shown in graphical form in Figure 
4.3.2 , with best fit lines.
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Table 4.3.2. Ad40 FFU on Permissive and Semi-Permissive Cells at 48h p.i., 
Expressed as FFU/106 Cells.
Ad40 input 
concentration
Ad40 Fluorescen
( x l
ice FFU/106 cells
LO5)
Dilution FFU/ml
(xl05)
KBa+b INT407 HeLa A549
1/20 2.850 2.525 1.827 0.349 0.140
1/40 1.425 1.410 0.999 0.144 0.073
1/60 0.950 1.100 0.768 0.062 0.024
1/80 0.712 0.730 0.379 0.054 0.020
1/100 0.570 0.390 0.285 0.022 0.014
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Figure 4.3.1. Ad40 Fluorescent Cell Counts for Permissive and Semi-Permissive 
Cell Lines, at Different Input Concentrations.
Ad40 fluorescent cell counts from Table 4.3.2. were expressed as log FFU/106 
cells, these values were plotted against Ad40 input concentration log FFU/ml for each 
of the four cell types: KBa+b, INT407, HeLa and A549. The lines of best fit are also 
shown (solid black lines).
The lines of best fit (see Figures 4.3.1. & 4.3.2.) were generated using the 
following Linear Regression equation (Minitab statistical package) and the data points 
shown in Fig 4.3.1.:
y =Po+Px+e
p0 = y intercept of the line.
P = slope of the line of best fit.
e = is the residual or the distance between the y value of the data point and the 
corresponding value of y that lies on the line of best fit at the same x value for the 
data point i.e. the predicted y value.
The p0, P, se(P) and R-sq values from this analysis are shown in Table 4.3.3. In
order to determine if the experimental data followed one or two hit kinetics, the slopes of
the best fit lines for this data (Fig 4.3.1.) were compared in turn to the slopes for one or 
two hit kinetics (Fig 4.3.2.) using a t confidence interval test (Tytell et a l 1962; Altman, 
1991; Personal communication Dr B. Tarsney). This statistical test estimates if the slopes 
of two lines differ from each other, by assessing what the 95% confidence interval of the
slope is when one slope is subtracted from the other. If the resulting interval contains zero
the conclusion is that the slopes are not significantly different from each other, as in 
theory the two lines could have the same slope. However if the interval does not contain 
zero the conclusion is that the slopes are significantly different from each other. The 
equation to calculate the 95% confidence interval for the slopes of two lines is:
Pl —P2±f«.0S- [^se(Pl)] + [^(PlIJ2
pi = slope of best fit line 1.
p2 = slope of best fit line 2.
se(pi) = standard error of the slope Pi.
se(P2) = standard error of the slope P2.
t 0.05 = is a constant and corresponds to the 95% confidence limits for the t 
distribution.
For this analysis the degrees of freedom (def) are 6 and represent the 5 data points 
for each line minus the two regression coefficients (which are the y intercept and the
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Figure 4.3.2. Theoretical Lines for One and Two Hit Kinetics.
Theoretical one and two hit lines were determined using an arbitrary value for 
the 1/20 dilution (5 x 105 FFU/106 cells), subsequent dilutions were calculated based on 
one and two hit kinetics. The log values for FFU/106 cells and Ad40 input 
concentration log FFU/ml are shown. The lines of best fit are also shown (solid black 
lines).
Table 4.3.3. Linear Regression Analysis of Lines of Best Fit
Line of Best 
Fit for:
Slope of 
line (P)
se(P) y-intercept
(Po)
R-Sq (%)
One Hit 
Kinetics
1.0044 0.2255 0.0032 100.0
Two Hit 
Kinetics
2.0027 0.0180 0.0180 100.0
KBa+b cells 1.1401 0.1662 -0.7260 94.0
INT407 cells 1.1573 0.1547 -0.9988 94.9
HeLa cells 1.6115 0.2013 -4.5630 95.5
A549 cells 1.6385 0.2053 -4.3450 95.5
se (p) = is the standard error of the slope p.
R-Sq = is the coefficient of determination and indicates the percentage of the 
variation in the data explained by the straight line relationship.
slope of the line) for each line, thus def =[(n-2) + (n-2)] (Personal communication Dr B. 
Tarsney). The to.05 value corresponds to 2.477 for 6 def (see t distribution tables in 
Altman, 1991). The 95% confidence intervals were calculated using the data from Table 
4.3.3. and are shown in Table 4.3.4.
The analysis revealed that the slopes of the best fit lines for KBa+b and INT407 
cells are not significantly different from the one hit slope, but are significantly different 
from the two hit line. In contrast the slopes for HeLa and A549 cells are not significantly 
different from the two hit slope, but are significantly different from the one hit slope.
4.3.2. Particle to Infectivity Ratio.
In addition the data from this experiment was used to derive Ad40 titres on each 
of the cell lines and thus compare particle to infectivity ratios for cell types. These are 
tabulated in Table 4.3.5. Titres of Ad40 on KBa+b and INT407 cells are similar but a 
lower titer is detected on HeLa cells, with the lowest titer detected on A549 cells. The 
Ad40 titer on A549 cells was approximately 15 fold less than that obtained with KBa+b 
cells.
The particle count of the Ad40 stocks used were kindly carried out by Mr J. 
Aitken and for this experiment was 2xl010 particles/ml. The number of particles present 
was divided by the titer to give particle to FFU ratios. Greater particle to infectivity ratios 
were detected for the semi-permissive cell lines than the permissive cells, with the lowest 
ratio observed on KBa+b cells. The ratios were comparable to particle to FFU ratios 
previously reported by Mautner et al., (1990), these authors reported a ratio of xlO3 on 
KBa+b cells.
4.3.3. Summary.
These results show a marked difference in the number of productively infected 
cells between different cell types. The number of cells infected with Ad40 at each 
dilution from KBa+b and INT407 cells was much greater than from A549 and HeLa
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Table 4.3.4. The 95% Confidence Intervals of Lines of Best Fit.
Lines of Best Fit
1 2 95 % Confidence Interval P Significance
One Hit KBa+b 0.2710, -0.5424 P > 0.05 NS
One Hit INT407 0.2254, -0.5312 P > 0.05 NS
One Hit HeLa -0.1321, -1.1369 P < 0.05 S
One Hit A549 -0.1147, -1.1033 P < 0.05 s
Two Hit KBa+b 1.2720, 0.4534 P < 0.05 s
Two Hit INT407 1.2271, 0.4637 P < 0.05 s
Two Hit HeLa 0.8685, -0.1401 P > 0.05 NS
Two Hit A549 0.8857, -0.1033 P > 0.05 NS
P = Probability
NS = Not Significant; the interval does contain zero therefore conclude slopes 
are not significantly different.
S = Significant; the interval does not include zero therefore conclude that slopes 
are significantly different.
Table 4.3.5. Titres and Particle-to-FFU Ratios for Ad40 on KBa+b, INT407, HeLa 
and A549 Cell Lines.
Cells Titre (FFU/ml) Particle: FFU
KBa+b 5.345 x 106 3.7 x 103:1
INT407 4.208x106 4.7x103:1
HeLa 9.050x105 2.2x104:1
A549 3.465 x 105 5.8 x 104;1
cells. Regression analysis of the slopes of the best fit lines when virus yield was plotted 
against virus input show that the KBa+b and INT407 slopes are not significantly different 
from a theoretical slope for one hit kinetics. Moreover the HeLa and A549 slopes are not 
significantly different from a theoretical slope for two hit kinetics.
Fewer cells were infected on HeLa and A549 cells, showing they may be 
defective in their ability to support the growth of Ad40. One possibility for this difference 
could be that lower numbers of particles attach and possibly enter HeLa and A549 cells 
compared to KBa+b and INT407 cells (see next section).
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4.4. Attachment and Internalisation of Ad40 and dl309 on 
INT407 and HeLa Cells.
Viral attachment to and internalisation in cells has been extensively studied for 
adenovirus subgroups B and C (see section 1.2.) ( Philipson et al., 1968; Chardonnet and 
Dales, 1970; Defer et al., 1990; Wickham et al., 1993). The fibre protein, which extends 
from the penton base, mediates the initial attachment of adenovirus to cells. Following 
attachment to cells the virus is internalised by receptor-mediated endocytosis (Varga et 
al., 1991). In Ad2 the virus binds to cell surface ay integrins via an RGD sequence (Arg-
Gly-Asp) which is present in the penton base protein. Wickham et al, (1993) found that 
the interaction of ayP3 and a vp5 integrins with penton base promoted efficient uptake of
virus into cell endosomes. These authors used antibody blocking assays and two 
melanoma cell lines, one possessing av integrins and another deficient in these receptors. 
Their studies demonstrated that in Ad2, binding of penton base to integrins is needed for 
efficient internalisation, but not for attachment where interaction of the virion with a cell 
receptor is required. Mathias et al., (1994) found other adenovirus serotypes (Ad3 and 
Ad4) also use av integrins for infection. Ad40 does not have an RGD motif, instead an 
RGA motif is present. It is therefore possible that Ad40 may not use the pathway 
described for Ad2.
A possible explanation for the difference in the number of cells productively 
infected with Ad40, between permissive and semi-permissive cells, (see section 4.3.) may 
be due to differences in cell attachment and/or internalisation of the virus. Therefore the 
following assays were conducted in order to look at the possible differences in attachment 
and internalisation of Ad40 on INT407 and HeLa cells. In addition these assays were also 
carried out with dl309, to compare attachment and internalisation with Ad40 on these cell 
lines.
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4.4.1. Attachment of Ad40 and dl309 to INT407 and HeLa Cells.
The method is described in detail elsewhere (see 3.16.). Briefly, cells were grown 
in linbro wells and various dilutions (40pl in TS) of tritium labelled virus (see 3.2.3.) 
were added to cells that had been cooled for 30min at 4°C. Studies have shown that at this 
temperature virus does not internalise but can bind cells efficiently (Fitzgerald et al., 
1983; Varga et al., 1991; Wickham et al., 1993), therefore this experiment was conducted 
at 4°C to ensure that none of the virus was internalised. Assays were carried out in 
duplicate for each dilution. The multiplicity of infection in this section corresponds to the 
number of labelled virus particles added to cells. Different multiplicities were used for 
Ad40 and dl309 which reflected their relative specific activities (see 3.2.3.). The intention 
had been to label and use virus of the same specific activities, however when the viruses 
were labelled the specific activity of Ad40 was found to be lower than dl309 (see 3.2.3.). 
Preliminary experiments were conducted using the same moi for both Ad40 and dl309. 
For Ad40, the level of cpm (counts per minute) detected bound to cells was only a few 
fold greater than background levels, whereas for dl309 counts were dramatically higher. 
Therefore a higher range was used for Ad40 in order to increase cpm detected. 
Attachment was carried out for 2h at 4°C, after which the cells were washed and pelleted. 
The pellets were dissolved in EB buffer and scintillation fluid was added, samples were 
finally counted in a scintillation counter.
The tritium counts per minute for each duplicate were tabulated along with the 
error (8i 82) (e.g. see columns 2 and 3 in Table 4.4.1.). The error was calculated by the
scintillation counter as a percentage of the counts for each sample which were then 
converted into cpm, these represented the standard deviations for each of the duplicates 
(81 and 82 for each duplicate). The background values were not subtracted, but are shown
in notes attached to each table.
This cpm data was expressed as particles/cell (e.g. see columns 4 and 5 in Table
4.4.1.) in order to compare experiments carried out on each cell line. Samples containing 
known numbers of labelled virus particles were also counted in each assay, and were used 
as a standard with which the number of particles was calculated for each sample in the 
assay. In addition extra linbro wells were seeded with cells which were counted for each
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experiment, this data along with the number of particles per sample was then used to 
calculate particles/cell. The experiments in this section do not however take into account 
any loss of cells due to washing and assumes that the number of cells remain the same 
throughout the assay (i.e. compared to the number that was counted at the start of the 
assay).
The mean number of particles bound (particles/cell) and standard deviation (5) of 
the two duplicates was calculated and tabulated (e.g. see columns 6 and 7 in Table 4.4.1.). 
The 5 value was calculated using the following formula (Personal communication from 
Dr J. Love and Dr G. Murray).
The cell lines used for these experiments were INT407 and HeLa cells. In 
preliminary experiments KBa+b cells had also been included, but these monolayers were 
not as robust as INT407 and HeLa cells; even with gentle washing, KBa+b cell, 
monolayers detached after two washes, therefore further experiments were carried out 
with INT407 and HeLa cells only.
4.4.I.I. Attachment of Ad40 to INT407 and HeLa Cells.
The first experiment was carried out with labelled Ad40, at moi of 1000, 3000, 
5000 and 7000 particles per cell, with both INT407 and HeLa cells. The cpm data, 
particles/cell, mean and 8 values are tabulated in Tables 4.4.1. and 4.4.2. The mean 
number of particles bound and 8 values were also represented in graphical form and are 
shown in Figure 4.4.1.
Where:
81 = is the error from duplicate one.
82 = is the error from duplicate two.
5 = is the combined standard deviation from duplicates one and two.
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Table 4.4.1. Tritium Labelled Ad40 Attachment on 1NT407 Cells.
Input
moi
cpm 
Bound a
Error
51,52
(cpm)
Particles 
Bound &
(part/cell)
Error
51,52
(part/cell)
Mean
Particles
Bound
(part/cell)
5 « 
(part/cell)
1000 53, 68 15, 16 61, 78 17,18 69 17
3000 184, 214 27, 29 196, 228 29,31 212 30
5000 367, 321 38, 36 479,419 50,47 449 48
7000 446, 399 42,40 609, 545 57,54 577 55
Table 4.4.2. Tritium Labelled Ad40 Attachment on HeLa Cells.
Input
moi
cpm
Bound0
Error
51,52
(cpm)
Particles 
Bound ft 
(part/cell)
Error
51,52
(part/cell)
Mean
Particles
Bound
(part/cell)
5 * 
(part/cell)
1000 89, 82 19, 18 102, 94 22,21 98 21
3000 323, 343 36, 37 345, 368 38, 39 356 38
5000 398, 504 40,45 520, 659 52, 59 589 56
7000 444, 662 42,51 606, 904 57, 69 755 63
a The background value was 13 cpm. 
b part/cell denotes particles/cell.
c  The 8 value was calculated from 8i and 82 using the formula described in
section 4.4.1.
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Figure 4.4.1. Analysis of Ad40 Attachment to INT407 and HeLa Cells.
Cells grown in linbro wells were cooled for 30min at 4°C, after which 40(0.1 of 
labelled virus was added (in TS), the input moi used are shown above. Incubation was 
carried out at 4°C for 2h. Cells were then washed three times with cold lxHBS and 
dissolved in 100jil of EB buffer. Ecoscint was added to each sample and counted in a 
scintillation counter. The mean and 8 (capped lines) values of Ad40 particles that bound to 
INT407 and HeLa cells are shown.
The results show that approximately 7 to 9 % of input Ad40 particles attached to 
INT407 cells and, 10 to 12% bound to HeLa cells. At each moi a greater number of 
particles bound to HeLa cells than INT407 cells. In addition, Ad40 cell receptor sites 
were not saturated, as no plateau of attached virus is observed over the range of input 
multiplicities, with both HeLa and INT407 cells. Higher moi were not used in this study, 
as there would have been insufficient vims to complete the experiments. A moi of 7000 
particles/cell was used for Ad40 in subsequent experiments.
4.4.I.2. Attachment of dl309 Virus to INT407 and HeLa Cells.
Attachment of dl309 on INT407 and HeLa cells was looked at, to examine if there 
were any differences in attachment of another adenovirus serotype on these cells. The 
method was as stated previously, but the input moi used for labelled dl309 were 500, 
1000, 2000 and 3000 particles/cell. The results are shown in Tables 4.4.3. and 4.4.4. with 
the cpm data, particles/cell, mean and 8 values. The number of mean particles bound were 
plotted on a graph and are shown with 8 values in Figure 4.4.2.
Over the range of input multiplicities approximately 7 to 10% of labelled dl309 
attached to INT407 cells and 5.5 to 7% bound to HeLa cells. In three of the input 
concentrations used, more dl309 particles attached to INT407 cells than to HeLa cells, 
this was the opposite of the pattern detected with Ad40 in the previous section. Again no 
plateau is observed over the various moi, indicating that the receptor sites for the vims 
were not saturated. Previous studies with Ad2 (Philipson et al., 1968) found the number 
of receptor sites on HeLa cells to be approximately 104 sites. Higher moi were not looked 
at in this study and the moi used for labelled dl309 in subsequent experiments was 3000 
particles/cell.
Initially it was also hoped to compare these results to the Ad40 results. However 
the vimses were found to have different specific activities (see 3.2.3.). Therefore different 
input multiplicities were used and direct comparison could only be made with the 1000 
and 3000 moi which were included in both experiments and this is shown in Fig 4.4.3. 
More dl309 vims attached to INT407 cells than Ad40 vims at both input moi, whereas on 
HeLa cells more Ad40 bound to cells than dl309.
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Table 4.4.31 Tritium Labelled dl309 Attachment on INT407 Cells.
Input
moi
cpm 
Bound a
Error
81,82
(cpm)
Particles 
Bound b 
(part/cell)
Error
81,82
(part/cell)
Mean
Particles
Bound
(part/cell)
8 « 
(part/cell)
500 156, 137 25,23 46, 41 7, 7 43 7
1000 220, 224 30, 30 78, 80 11, 11 79 11
2000 483, 518 44,45 139, 149 13, 13 144 13
3000 1644, 1186 81,69 343, 247 17,14 295 16
Table 4.4.4. Tritium Labelled dl309 Attachment on HeLa Cells.
Input
moi
cpm
Bound0
Error
81,82
(cpm)
Particles 
Bound b 
(part/cell)
Error
81,82
(part/cell)
Mean
Particles
Bound
(part/cell)
8 c 
(part/cell)
500 109, 77 21, 17 32, 33 6, 5 27 5
1000 178, 201 27, 28 63, 72 10, 10 67 10
2000 540,449 46,42 155, 129 13, 12 142 12
3000 1034,937 64,61 216, 195 13, 13 205 13
a The background value was 13 cpm. 
b part/cell denotes particles/cell.
c The 8 value was calculated from 8i and 82 using the formula described in
section 4.4.1.
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Figure 4.4.2. Analysis of d!309 Attachment to INT407 and HeLa Cells.
Cells grown in linbro wells were cooled for 30min at 4°C, after which 40p,l of 
labelled virus was added (in TS), the input moi used are shown above. Incubation was 
carried out at 4°C for 2h. Cells were then washed three times with cold lxHBS and 
dissolved in IOOjllI of EB buffer. Ecoscint was added to each sample and counted in a 
scintillation counter. The mean and 5 (capped lines) values of dl309 particles that bound to 
INT407 and HeLa cells are shown.
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Figure 4.4.3. Comparison of Ad40 and d!309 Virus Attachment.
2] Ad40 
■  dl309
1000 3000 1000 3000
_______________ I I_________________ I
INT407 Cells HeLa Cells
Input Particles 
(particles/cell)
The mean number of virus particles bound to INT407 and HeLa cells at input 
multiplicities of 1000 and 3000 particles/cell for Ad40 and dl309 viruses are shown above.
4.4.I.3. Competition of Attached Virus with Ad40 Virus or Ad2 Fibre.
Competition experiments were carried out in order to look at the specificity of 
attachment (see 3.16.). Cells grown in linbro wells (cooled to 4°C for 30min) were 
preincubated with competitor (40pl in TS) to block receptor sites. Half the wells received 
competitor while the other half received 40pl of TS. After lh at 4°C, cells were washed 
and labelled virus was added to all cells, the incubation was then continued for 2h at 4°C. 
The cells were washed, pelleted and processed as described (see 3.16.). The tritium 
counts per minute data was used to calculate particles/cell, mean and 5 values as 
described previously.
The competitor used for tritium labelled Ad40 was a ten fold excess of unlabelled 
banded Ad40 virus. Labelled virus was used at a moi of 7000 particles/cell. The results 
for competition experiments with INT407 and HeLa cells are shown in Table 4.4.5., in 
addition mean and 5 values are represented in graphical form in Fig 4.4.4. Assays were 
carried out twice for each cell line and within each assay each sample was done in 
duplicate. The first set of experiments denoted by INT/1 for INT407 cells and HeLa/1 for 
HeLa cells were carried out concurrently with attachment assays (see 4.4.1.1.). The 
second set of experiments are denoted by INT/2 and HeLa/2.
The results show that attached Ad40 virus is inhibited by approximately 80 
percent on both cell lines, using a ten fold excess of unlabelled virus as a competitor.
The competitor used for dl309 was 8jig of Ad2 fibre (in 40jal of TS), which was a 
crude preparation of baculovirus expressed recombinant protein. The assay was carried 
out as previously described (see 3.16.) with labelled virus used at a moi of 3000 
particles/cell. Experiment 1 on both cell lines was carried out concurrently with 
attachment assays (see section 4.4.1.). The cpm data, particles/cell, mean and 8 values are 
shown in Table 4.4.6., also the mean and 5 values are shown on a graph shown in Figure 
4.4.5.
With Ad2 fibre as a competitor, the amount of dl309 that bound to both cell lines 
was inhibited by some 95 to 97%, indicating that dl309 binding is specifically inhibited.
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Table 4.4.5. Competition of Labelled Ad40 with a 10-fold Excess of Unlabelled Virus.
Cells® 
/Expt No
Comp b cpm 
Boundc
Error
51,82
(cpm)
Particles
Bound
(part/cell)
Error
51,52
(part/cell)
Mean
Particles
Bound
(part/cell)
5
(part/cell)
INT/1 - 446, 399 42,40 609,545 57, 54 577 55
INT/1 + 89, 78 19, 18 121,106 26,24 113 25
INT/2 - 244,315 31,35 479, 617 61,67 548 64
INT/2 + 47, 56 14,15 92, 110 27,29 101 28
HeLa/1 - 444, 662 42,51 606,904 57, 69 755 63
HeLa/1 + 91,101 19,20 124, 138 26, 27 131 26
HeLa/2 - 364, 384 38, 39 713,753 75, 77 733 76
HeLa/2 + 82, 86 18, 18 161,169 35, 35 165 35
a INT represents INT407 cells.
b Denotes the presence or absence of a ten fold excess of unlabelled virus as 
competitor.
c The background value for experiment 1 was 13cpm and 21 cpm for experiment 2. 
d part/cell denotes particles/cell
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Figure 4.4.4. Attachment of Labelled Ad40 Virus is Inhibited by a Ten Fold Excess of 
Unlabelled Virus.
Cells were grown in linbro wells, half the wells were preincubated with a ten fold 
excess of unlabelled Ad40 (40pl in TS) and the other half with 40pl of TS. After lh at 4°C 
the cells were washed twice with lxHBS. All cells were infected with labelled virus (40pl 
in TS) at 7000 particles/cell and incubated for 2h at 4°C, after which they were washed 
three times with cold lxHBS and pelleted. The pellet was dissolved in lOOpl of EB buffer 
and 10ml of ecoscint was added, samples were counted in a scintillation counter. The 
mean number of particles bound (particles/cell) with 8 values (capped lines) are shown.
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Figure 4.4.5. Competition of dl309 Virus with Ad2 Fibre.
Cells were grown in linbro wells, half the wells were preincubated with 8pg of 
Ad2 fibre (40pl in TS) and the other half with 40pl of TS. After lh at 4°C the cells were 
washed twice with lxHBS. All cells were infected with labelled virus (40pl in TS) at 3000 
particles/cell and incubated for 2h at 4°C, after which they were washed three times with 
cold lxHBS and pelleted. The pellet was dissolved in lOOpl of EB buffer and 10ml of 
ecoscint was added, samples were counted in a scintillation counter. The mean number of 
particles bound (particles/cell) with 5 values (capped lines) are shown.
4.4.1.4. Summary*
The percentage of Ad40 and dl309 particles binding to INT407 and HeLa cells 
was similar, with approximately 7 to 12 percent of Ad40 input particles attaching to cells 
compared to 6 to 10 percent of dl309 particles. Overall on both cell types viral attachment 
was inhibited with unlabelled competitor, indicating that attachment was specific. 
However these results do not explain the differences observed between permissive and 
semi-permissive cells in section 4.3. (i.e. the number of cells going on to productive 
infection). Indeed slightly more Ad40 particles attached to HeLa cells than to INT407 
cells, therefore the amount of virus internalised was investigated (see next section).
4.4.2. Analysis of Adenovirus Internalisation.
The amount of virus that was internalised in cells was examined, in order to see if 
there were differences between cell types. The internalisation assay is described in detail 
elsewhere (see 3.16.), but briefly cells (in linbro wells) were precooled to 4°C for 30min 
before infection. Tritium labelled virus (40|il in TS) was added and cells incubated for 2h 
at 4°C. Cells were washed to remove unbound virus and after cell adhesion buffer was 
added, internalisation was initiated by warming to 37°C for various times. Half the wells 
were treated with the protease subtilisin (Sigma), in order to distinguish attached from 
internalised virus. Attached virus is removed by treatment with subtilisin, whereas 
internalised virus is protease resistant and is not affected (Philipson et al., 1968). Samples 
not protease treated represent both attached and internalised virus, except for the Omin 
timepoint which is not incubated at 37°C and therefore represents attached virus only. At 
various times cells were washed and either lxHBSE or IX HBSE containing subtilisin 
was added. Incubation was continued for 30min at 37°C, after which cells were washed 
with cell adhesion buffer and pelleted. Samples were processed as described previously 
(see 3.16.). Each sample was carried out in duplicate for the timepoints 0, 15, 30 and 
45min and every assay was carried out twice for each virus on the two cell types.
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Experiments marked experiment 1 in each set were conducted by G. Brown, all other 
experiments (experiment 2) were the authors own efforts.
4.4.2.I. Internalisation of Ad40 in INT407 and HeLa cells.
The input moi used for Ad40 was 7000 particles/cell. The results (represented as 
particles/cell) are shown in Tables 4.4.7. and 4.4.8., for both experiments 1 and 2. The 
mean values were also plotted on graphs with 5 values in Figures 4.4.6. and 4.4.7.
The mean total number of virus particles (attached and internalised) show some 
variability between experiments 1 and 2 with both cell types. This may be due to the fact 
that they were carried out by different people and reflect different washing intensities. 
The number of particles binding to INT407 and HeLa cells and not internalised is 
represented by the Omin timepoint. Higher numbers of Ad40 particles are observed 
binding to INT407 cells than had previously been detected in section 4.4.1. However the 
results from subtilisin treated samples are more consistent than untreated samples and 
there appears to be a gradual increase in the number of particles/cell in subtilisin treated 
samples from 0 to 45min (see Fig 4.4.6. and Fig 4.4.7.). This indicates that virus is being 
internalised.
Originally the intention had been to pool experiments 1 and 2, however as results 
from experiment 1 showed more variability on HeLa cells, only the experiment 2 data 
was used to look at the percentage of internalisation between cell types. The percentage 
of virus that was internalised was calculated, by subtracting the mean particles/cell for the 
Omin timepoint of subtilisin treated samples from the subsequent timepoints (15, 30, 
45min) of subtilisin treated and untreated samples. The treated samples were then 
represented as a percentage of the total number of virus particles (untreated samples) at 
each timepoint (15, 30,45min). These values are shown in Table 4.4.9a.
For Ad40, the percentage of particles internalised is similar up to 30min on both 
cell types, after which on INT407 cells the percentage of virus only increases slightly to 
21%. On HeLa cells there is a larger increase up to 45min with 31% of virus internalised.
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Table 4.4.7. Internalisation of Ad40 in INT407 Cells.
Subtilisin
Treatment
Time
(min)
Particles 
Bound 
(part/cell) a
Error
81,82
(part/cell)
Mean
Particles
Bound
(part/cell)
8
(part/cell) b
Experiment 1
- 0 433,449 50,51 441 50
- 15 356, 508 47, 54 432 51
- 30 447, 522 51,55 484 53
- 45 710,515 64, 54 612 59
+ 0 138, 100 28, 23 119 26
+ 15 155, 124 31,26 139 29
+ 30 158,167 31,31 162 31
+ 45 204, 284 35,41 244 38
Experiment 2
- 0 727,799 72, 75 763 73
- 15 685,788 70, 75 736 72
- 30 766, 690 73,73 728 73
- 45 788,752 75, 73 770 74
+ 0 148,148 32, 32 148 32
+ 15 196, 228 38, 39 212 38
+ 30 255,261 43,43 258 43
+ 45 219,343 39, 50 281 45
a part/cell denotes particles/cell
b The 8 value was calculated using the formula in section 4.4.1.
Table 4.4.8. Internalisation of Ad40 in HeLa Cells.
Subtilisin
Treatment
Time
(min)
Particles 
Bound 
(part/cell) a
Error
81,82
(part/cell)
Mean
Particles
Bound
(part/cell)
8
(part/cell) b
Experiment 1
- 0 513,552 55,57 532 5 6
- 15 567,474 58, 52 520 5 5
- 30 534, 624 57,61 579 5 9
- 45 943,922 75,75 932 7 5
+ 0 108, 113 25, 25 110 2 5
+ 15 183,227 33, 37 205 35
+ 30 200,188 34, 33 194 33
+ 45 281,204 40, 34 242 37
Experiment 2
- 0 708,700 74,74 704 74
- 15 687, 680 74,74 683 74
•- 30 770,713 78,76 741 77
- 45 869,767 84,78 818 81
+ 0 127,135 32, 32 131 32
+ 15 135,233 32,42 184 37
+ 30 287,265 48,46 276 47
+ 45 295, 390 48, 56 342 52
a part/cell denotes particles/cell
b The 5 value was calculated using the formula in section 4.4.1.
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Figure 4.4.6. Ad40 Internalisation in INT407 Cells.
Cells grown in linbro wells were cooled for 30min at 4°C, then infected with 7000 
particles/cell of labelled Ad40 virus (40|il in TS) and incubated for 2h at 4°C. Cells were 
washed three times with lxHBS and cell adhesion buffer added to all wells, after which 
cells were warmed to 37°C and incubated for various times. At each timepoint four wells 
were washed twice with lxHBS. To two wells 200p,l of lxHBSE was added while the 
other two received 200|il of lxHBSE containing 2mg/ml of subtilisin. These four wells 
were incubated for 30min at 37°C. Cells were then scraped into 1.5ml vials and washed 
twice with cell adhesion buffer before being pelleted. The pellet was dissolved in lOOpl of 
elution buffer and 10ml ecoscint was added, samples were counted in a scintillation 
counter. The mean number of particles (particles/cell) are shown with 8 values (capped 
lines). The unfilled symbols represent results from experiment 1 and filled symbols 
represent results from experiment 2.
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Figure 4.4.7. Ad40 Internalisation in HeLa Cells.
Cells grown in linbro wells were cooled for 30min at 4°C, then infected with 7000 
particles/cell of labelled Ad40 virus (40joi in TS) and incubated for 2h at 4°C. Cells were 
washed three times with lxHBS and cell adhesion buffer added to all wells, after which 
cells were warmed to 37°C and incubated for various times. At each timepoint four wells 
were washed twice with lxHBS. To two wells 200(il of lxHBSE was added while the 
other two received 200[il of lxHBSE containing 2mg/ml of subtilisin. These four wells 
were incubated for 30min at 37°C. Cells were then scraped into 1.5ml vials and washed 
twice with cell adhesion buffer before being pelleted. The pellet was dissolved in 100|il of 
elution buffer and 10ml ecoscint was added, samples were counted in a scintillation 
counter. The mean number of particles (particles/cell) are shown with 8 values (capped 
lines). The unfilled symbols represent results from experiment 1 and filled symbols 
represent results from experiment 2.
Table 4.4.9a. Internalisation of Ad40 in INT407 and HeLa Cells.
Cells
% Internalisation at various Times (min)
15 30 45
INT407 11 19 21
HeLa 10 24 31
Table 4.4.9b. Internalisation of dl309 in INT407 and HeLa Cells
Cells
% Internalisation at various Times (min)
15 30 45
INT407 9 21 33
HeLa 9 19 41
4.4.2.2. Internalisation of dl309 in INT407 and HeLa Cells.
The next experiment was carried out to examine the amount of dl309 that was 
internalised in INT407 and HeLa cells. The input moi used was 3000 particles/cell. The 
counts per minute were converted to particles/cell and are shown in Tables 4.4.10. and 
4.4.11., together with the mean and 8 values, which are also represented in graphical form 
in Figure 4.4.8. and 4.4.9.
Results from both experiment 1 and 2 on HeLa cells and experiment 2 on INT407 
cells show a similar pattern and only differ in the number of particles that were bound. In 
these experiments the pattern of viral internalisation is the same with a gentle increase of 
virus particles observed up to 45min. Thus the overall pattern for dl309 is similar to that 
observed with Ad40.
The data from experiment 1 on INT407 cells was variable, therefore only the data 
from experiment 2 was used to look at the percentage of virus that had been internalised 
on HeLa and INT407 cells. This was calculated in the same way as described for Ad40 in 
the previous section, and results are shown in Table 4.4.9b.
More dl309 is internalised in HeLa cells compared to INT407, however the 
overall pattern of internalisation detected over time is the same. At 45min the amount 
internalised was some 33 to 41% in INT407 and HeLa cells, respectively and this 
compared to the 31% level in Ad40 infected HeLa cells at 45min cells in Table 4.4.9a.
4.4.2.3. Summary.
A similar pattern of internalisation was observed for dl309 particles in INT407 
and HeLa cells and this was comparable to the amount of Ad40 virus internalised in 
HeLa cells. A larger number of Ad40 virus particles were internalised in HeLa cells than 
INT407 cells, this was surprising given the previous results from sections 4.1. and 4.3., 
thus differences between these cell types is probably not due to the number of particles 
that attach or are internalised in these cell lines. The pattern of El transcription was 
therefore investigated in order to see if this could account for the increased permissivity 
of INT407 cells over HeLa cells (see next section).
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Table 4.4.10. Internalisation of d!309 in INT407 Cells.
Subtilisin
Treatment
Time
(min)
Particles 
Bound 
(part/cell) a
Error
81,82
(part/cell)
Mean
Particles
Bound
(part/cell)
8
(part/cell) b
Experiment 1
- 0 323, 343 12, 12 333 12
- 15 256,236 10,10 246 10
- 30 190,210 9, 9 200 9
- 45 207, 256 9,10 231 9
+ 0 73,110 5, 7 91 6
+ 15 167, 198 8, 9 182 8
+ 30 99,126 6, 7 112 6
+ 45 117,112 7, 7 114 7
Experiment 2
- 0 270,278 15,15 274 15
- 15 251,242 14,14 246 14
- 30 256, 263 14, 15 259 14
- 45 244, 338 14, 16 291 15
+ 0 52, 61 6, 7 56 6
+ 15 66, 81 7, 8 73 7
+ 30 94, 103 9, 9 98 9
+ 45 120, 146 10,11 133 10
a part/cell denotes particles/cell
b The 8 value was calculated using the formula in section 4.4.1.
Table 4.4.11. Internalisation of dl309 in HeLa Cells.
Subtilisin
Treatment
Time
(min)
Particles 
Bound 
(part/cell) a
Error
81,82
(part/cell)
Mean
Particles
Bound
(part/cell)
8
(part/cell) b
Experiment 1
- 0 299, 307 20,21 303 20
- 15 289, 283 20, 20 286 20
- 30 324, 288 21,20 306 20
- 45 277,295 19,20 286 19
+ 0 77,77 10, 10 77 10
+ 15 86, 87 11, 11 86 11
+ 30 102,110 12, 12 106 12
+ 45 142,159 14, 15 150 14
Experiment 2
- 0 291, 372 13, 15 331 14
- 15 385, 304 15, 14 344 14
- 30 350, 330 15, 14 340 14
- 45 319,316 14, 14 317 14
+ 0 139,134 9,9 136 9
+ 15 163,148 10, 10 155 10
+ 30 175, 175 10, 10 175 10
+ 45 211,212 11, 11 211 11
a part/cell denotes particles/cell
b The 8 value was calculated using the formula in section 4.4.1.
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Figure 4.4.8. dl309 Internalisation in INT407 Cells.
Cells grown in linbro wells were cooled for 30min at 4°C, then infected with 3000 
particles/cell of labelled dl309 virus (40pl in TS) and incubated for 2h at 4°C. Cells were 
washed three times with lxHBS and cell adhesion buffer added to all wells, after which 
cells were warmed to 37°C and incubated for various times. At each timepoint four wells 
were washed twice with lxHBS. To two wells 200pl of lxHBSE was added while the 
other two received 200pl of lxHBSE containing 2mg/ml of subtilisin. These four wells 
were incubated for 30min at 37°C. Cells were then scraped into 1.5ml vials and washed 
twice with cell adhesion buffer before being pelleted. The pellet was dissolved in lOOpl of 
elution buffer and 10ml ecoscint was added, samples were counted in a scintillation 
counter. The mean number of particles (particles/cell) are shown with 8 values (capped 
lines). The unfilled symbols represent results from experiment 1 and filled symbols 
represent results from experiment 2.
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Figure 4.4.9. dI309 Internalisation in HeLa Cells.
Cells grown in linbro wells were cooled for 30min at 4°C, then infected with 3000 
particles/cell of labelled dl309 virus (40pl in TS) and incubated for 2h at 4°C. Cells were 
washed three times with lxHBS and cell adhesion buffer added to all wells, after which 
cells were warmed to 37°C and incubated for various times. At each timepoint four wells 
were washed twice with lxHBS. To two wells 200jil of lxHBSE was added while the 
other two received 200(ll1 of lxHBSE containing 2mg/ml of subtilisin. These four wells 
were incubated for 30min at 37°C. Cells were then scraped into 1.5ml vials and washed 
twice with cell adhesion buffer before being pelleted. The pellet was dissolved in 100|xl of 
elution buffer and 10ml ecoscint was added, samples were counted in a scintillation 
counter. The mean number of particles (particles/cell) are shown with 8 values (capped 
lines). The unfilled symbols represent results from experiment 1 and filled symbols 
represent results from experiment 2.
4.5. Analysis of E l Transcription in Ad40 Infected Cells
Study of the Ad40 DNA sequence shows that the El region has a similar 
organisation of transcriptional units and ORFs to that of other human serotypes (van 
Loon et al, 1987b; Ishino et al., 1988; Davison et al., 1993). Transcripts for the Ad40 
and Ad41 El regions were mapped by van Loon et al., (1987b), using RNA obtained 
from BRK cells transformed with an Ad40 El containing plasmid. In Ad40 infected cells, 
these authors identified E1A transcripts corresponding in size to the Ad2 9S, 12S and 13S 
mRNAs, but no E1B mRNA was detected. For Ad41 infected cells, only 13S E1A and 
22S E1B transcripts were present. Steinthorsdottir and Mautner (1991) determined the 
Ad40 E1B transcription map by SI mapping and primer extension analysis of RNA 
obtained at late times from infected KBa+b cells. E1B transcripts equivalent to the Ad2 
14S (encoding 19K and 15K), 22S (encoding 19K and 55K) and 9S (encoding ppIX) 
mRNAs were identified, but there was no transcript equivalent to E1B 13S mRNA. A 
similar pattern is seen in Ad 12 (Virtanen et al., 1982; Saito et al., 1983), where no 13S 
message is detected and the predominant E1B species at late times is 14S mRNA. 
Steinthorsdottir and Mautner (1991) also identified novel cotranscript counterparts of the 
Ad40 E1B 14S and 22S mRNAs. These consisted of the first 40 codons of the E1A 
region spliced to a site 4-5nt downstream of the E1B capsite. This splice junction did not 
contain consensus splice sequences and thus may not be generated by conventional 
splicing mechanisms. Allard and Wadell (1992) have determined the Ad41 E1B 
transcription map from a lytic infection. They found a similar pattern to Ad40 with 22S, 
14S and 9S mRNA detected, but no 13S transcript. However no E1A-E1B cotranscript 
counterparts were found in Ad41, but an extra exon in the 14S mRNA was detected 
which is not present in Ad40. Mautner et al., (1990) found that in KBa+b cells, Ad40 
E1B transcripts could be detected, but only after the onset of DNA replication. In HeLa 
cells, Ad40 E1B mRNA was detected at low levels, after the onset of DNA replication. 
Subsequently Bailey et al., (1993) have shown that the E1B 55K protein (&19K) is 
indeed expressed in KBa+b cells.
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The following experiments were conducted to see if there were any differences in 
the pattern of El transcription in infected INT407 cells compared to KBa+b and HeLa 
cells. In order to look at the transcripts produced over time in infected cells, a timecourse 
of mRNA was analysed by Northern blotting. In addition E1B mRNA was examined by 
SI nuclease analysis in the presence and absence of DNA replication.
4.5.1. A Timecourse of Ad40 E l Transcription and DNA Replication in 
Infected Cells.
The pattern of El transcription was investigated by Northern blot analysis (see 
3.12.) of cytoplasmic RNA from infected KBa+b, HeLa and INT407 cells, harvested at 
various times post infection. Cells grown on 50mm plates were infected with lOOpl of a 
1/10 dilution of Ad40 p9 (in TS). After incubation at 37°C, two plates were pooled and 
harvested for each cell type. Cytoplasmic RNA was extracted (see 3.3.3.) and separated 
on 1.2% agarose/ formaldehyde gels (one third harvest of a 50mm plate/lane). The RNA 
was then blotted onto nylon membranes (Hybond-N) and probed with a nick translated 
plasmid containing the Ad40 E1B 55K region (pAB106). Following exposure to 
autoradiography film, the blots were stripped of probe (see 3.12.) and reprobed with a 
nick translated plasmid containing Ad40 El A sequences (pNM83). To examine the 
efficiency of RNA transfer, stripped membranes were also probed with a nick translated 
plasmid containing the mouse y actin pseudogene (Leader et al., 1987), similar levels of 
actin mRNA were observed for the three cell lines (not shown). An RNA marker (BRL) 
was run in conjunction with samples to determine sizes of mRNA. In parallel, to the 
Northern blot analysis, DNA was recovered from mock infected and infected cell nuclei 
(see 3.3.2.) and applied to nylon membranes on a slot blot (one twentieth harvest of a 
50mm plate/slot). Membranes were then probed with a nick translated plasmid 
containing the Ad40 El region (pNM82).
The pattern of E1B transcription and DNA replication is shown in Figure 4.5.1. In 
infected KBa+b cells low levels of 22S E1B mRNA are first detected at 18h p.i. 
preceding the onset of DNA replication which was observed at 24-30h. 14S mRNA was
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Figure 4.5.1. A Timecourse of E1B Transcription and DNA Replication in KBa+b, 
HeLa and INT407 Cells.
Cells grown on 50mm plates were infected with lOOpl of a 1/10 dilution of 
Ad40. Cytoplasmic RNA was then harvested from cells at the times indicated. The RNA 
was run on 1.2% agarose/formaldehyde gels (1/3 harvest of a 50mm plate/lane) and 
blotted onto nylon membranes. An RNA marker (BRL) was also run on gels (not 
shown). Membranes were probed with nick translated plasmid containing the Ad40 E1B 
55K region (pAB106). The Northern blots, shown in the upper part of the figure, were 
exposed to autoradiography film for 5 days.
In parallel, DNA was extracted from cell nuclei and applied to nylon membranes 
using a slot blot (1/20 harvest of a 50mm plates/slot). Membranes were probed with a 
nick translated plasmid containing the Ad40 El region (pNM82). These blots are shown 
in the lower part of the figure and were exposed to autoradiography film for 18h.

not detected until 24h p.i., coinciding with the onset of DNA replication. This pattern is 
similar to Ad5 (Glenn and Ricciardi, 1988) with 22S mRNA predominant at early times 
in infection. However in Ad5 13S mRNA accumulates after the onset of DNA replication 
whereas here 14S mRNA is the main E1B transcript at late times in infection. No E1B 
mRNA is detected at early times in Ad40 infected HeLa cells, confirming previous 
reports (Mautner et al., 1990; Steinthorsdottir, 1991). The appearance of mRNA i:s 
concurrent with the onset of DNA replication (30-36h p.i.) with small amounts of 22S 
and 14S mRNAs first detected at 36h and a dramatic increase in 14S at 72h p.i. For Ad40 
infected INT407 cells, the pattern of E1B mRNA is similar to that seen in KBa+b cells, 
but delayed by approximately 6h. A small amount of 22S is first detected at 24h p.i. 
before the onset of DNA replication between 24-30h, thereafter it increases up to 36h, but 
from 42h to 72h much reduced amounts are observed. The 14S mRNA is first detected at 
30h and becomes the predominant mRNA late in infection in INT407 cells. The level of 
DNA replication increases up to 36h, but lower levels are detected at later timepoints 
compared to KBa+b cells.
Figure 4.5.2. shows the results when the Northern blots were probed with E1A 
sequences. The 12S and 13S transcripts are indistinguishable in KBa+b infected cells but 
are clearly visible, especially, at lower exposures in INT407 infected cells (not shown). In 
INT407 and KBa+b infected cells, E1A mRNA is detected in low amounts at the same 
times that E1B transcripts were first detected (see above). For both these cell types there 
is a steady increase in El A mRNA up to 72h. In HeLa cells, Ad40 El A mRNA is first 
detected at 36h, coincident with the onset of DNA replication, and lower levels are 
detected than for the other two cell types. In this experiment both El A and E1B mRNA 
appear at the same time for each cell type. However from this study the possibility that 
E1A mRNA is made in very low amounts before E1B cannot be ruled out at present, as 
times between 12-18h were not investigated.
4.5.1.1. Summary.
These experiments showed for the first time that Ad40 El mRNAs were made at 
early times in infection, in both KBa+b and INT407 cells. Both E1B 22S mRNA and
106
Figure 4.5.2. A Timecourse of E1A Transcription and DNA Replication in KBa+b, 
HeLa and INT407 Cells.
Northern blots from Figure 4.5.1. were stripped of probe and reprobed with a 
nick translated plasmid containing the El A region (pNM83). RNA blots were exposed 
for 5 days to autoradiography film.
DNA blots are as in Figure 4.5.1., and show the onset of DNA replication 
compared to E l A transcription.

El A transcripts were detected before the onset of DNA replication. The pattern and level 
of mRNA produced in INT407 infected cells was more comparable to that seen in 
KBa+b, than to HeLa cells. In HeLa cells mRNA was detected coincident with the onset 
of DNA replication and at much lower levels compared to the other two cell types. This 
pattern was consistent with previous reports of Ad40 infected HeLa cells (Mautner et al., 
1990; Steinthorsdottir, 1991).
The probe (nick translated plasmid pAB106) used for the detection of E1B 
mRNA (in Figure 4.5.1.), contained the whole of the E1B 55K region and was uniformly 
labelled. This made the probe more sensitive to 22S than to 14S mRNA, as more 
radioactive signal hybridised to the longer transcript. Thus comparison between these 
mRNAs could not be made easily. To circumvent this, E1B transcription was further 
investigated by SI nuclease protection (see next section).
4.5.2. Analysis of E1B mRNA Produced in the Presence and Absence of 
DNA Replication.
From Northern blot analysis it appeared that low amounts of E1B mRNA were 
produced before the onset of DNA replication in KBa+b and INT407 cells. Therefore the 
following experiment was conducted to confirm that E1B transcripts were indeed made 
before the onset of DNA replication. The experiment involved investigating E1B 
transcription by SI analysis in the presence and absence of DNA replication. SI analysis 
was used for this experiment, as it is a sensitive technique that determines the amount of a 
specific RNA in a sample and thus allows comparison of mRNAs. It is also a technique 
which is frequently used to map the 5' end of a transcript. In S1 nuclease analysis, end 
labelled single stranded DNA probe is hybridised to a measured amount of mRNA. 
Unhybridised RNA and DNA is digested away with enzymes and the resulting protected 
fragments analysed by PAGE.
In addition to KBa+b, HeLa and INT407 cells; A549 cells were included in this 
study to compare with HeLa as another semi-permissive cell line. 293 cells were also 
included; experiments conducted by Bailey et al, (1994) found these cells to be more
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permissive for Ad40 than KBa+b cells, it was therefore of interest as another permissive 
cell line. In brief, the experiment was as follows; cells grown on 50mm plates were 
infected with a lOOpl of a 1/10 dilution of Ad40 p9 and then incubated at 37°C. Infected 
and mock infected cells were grown in the absence or presence of cytosine arabinoside 
(ara-C) which inhibits DNA replication. This inhibitor was first added to plates after 
adsorption, to a final concentration of 40|ig/ml, and replenished every 12h thereafter. 
Cells were harvested at various timepoints for each cell type, when cytoplasmic RNA 
(see 3.3.3.) and nuclear DNA (see 3.3.2.) were extracted. The timepoints were chosen 
with reference to the northern blotting experiment described above, to look for early and 
late transcripts. Cytoplasmic RNA was treated with DNase I (see 3.4.) to remove possible 
DNA contamination and then hybridised to 2ng of probe 5-labelled with [32P] ATP. The 
probe used to detect Ad40 E1B 22S and 14S mRNA was a synthetic single stranded 
oligonucleotide which spanned the Ad40 14S splice acceptor site (oligo AB42 3049- 
3110nt). At the 3' end, 6nt were synthesised which were not of adenovirus origin, these 
were added in order to distinguish undigested probe from mRNA that bound to all of the 
probe Ad40 sequences (i.e. 22S). Panel A in Figure 4.5.4. shows the region spanned by 
the probe and the expected sizes of protected fragments for each species. A marker (not 
shown) comprising of labelled oligonucleotides of known sizes was run alongside the 
samples, to identify sizes of protected fragments. S1 analysis was carried out as described 
(see 3.13.) with 15|ig of cytoplasmic RNA. In parallel, DNA was recovered from cell 
nuclei (see 3.3.2.) and applied to nylon membranes using a slot blot (one twentieth 
harvest of a 50mm plate/slot). Membranes were probed with nick translated plasmid 
pAB106 containing the Ad40 E1B 55K region.
The DNA slot blots are shown in Fig 4.5.3. In the presence of ara-C, DNA 
replication from all cell types is inhibited. The timepoints span the expected onset of 
DNA replication in all the cell types with early and late timepoints. The onset of DNA 
replication for 293 and KBa+b cell lines is between 12-24h and for INT407 and A549 
cells is 24-30h. Interestingly the onset of DNA replication in HeLa cells is between 24- 
30h; earlier than observed in section 4.5.1.
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Figure 4.5.3. Inhibition of DNA Replication by ara-C in Ad40 Infected Cells.
Cells grown on 50mm plates were infected with a lOOpl of a 1/10 dilution of 
Ad40 p9, at the times indicated post infection. To inhibit DNA replication, half the plates 
were treated (after adsorption) with 120}ig of cytosine arabinoside (ara-C) which was 
added to plates every 12h thereafter. Cytoplasmic RNA was harvested and analysed by SI 
nuclease protection (see Figure 4.5.4.). DNA was extracted from cell nuclei and applied 
to nylon membranes using a slot blot (1/20 harvest of a 50mm plate/slot), blots were 
probed with a nick translated plasmid containing the Ad40 E1B 55K region (pAB106). 
The DNA blots were exposed to autoradiography film for 24h.
The pattern of E1B transcription in the presence and absence of DNA replication 
is shown in Panel B of Figure 4.5.4. In 293 cells, in the absence of ara-C, E1B 22S 
mRNA is first detected at 12h, 6h before 14S. For KBa+b cells no mRNA is detected 
until 24h and then both messages are detected. In these cells 22S and 14S levels are at 
their most abundant at 36h p.i., as was found in section 4.5.1. In INT407 cells, 22S is first 
seen at 24h and 14S at 30h. For both INT407 and 293 cells 22S increases steadily up to 
36h, 14S increases in a similar way but is more abundant in 293 cells than INT407. In 
A549 and HeLa cells, overall much lower levels of 14S are detected and they are first 
observed at 30h. Lower levels of 22S mRNA are detected in A549 and HeLa cells,, 
compared to the other cell lines especially at the 36h timepoint.
In the presence of ara-C in A549 and HeLa cells, no mRNA corresponding to 14S 
and 22S is detected. For the more permissive cell lines, a low amount of 22S mRNA is 
detected from 12 to 36h in 293 cells and 24 to 36h for both INT407 and KBa+b cells. A 
more dramatic decrease is seen with 14S mRNA, with extremely low amounts detected in 
the presence of ara-C in all cell types.
The fact that some probe was detected in all samples (Fig 4.5.4.), indicated that 
SI digestion was incomplete. In addition, certain samples were smeared and also 
appeared undigested (i.e. The samples were- in the absence of ara-C; 24h INT407, mi and 
12h HeLa; in the presence of ara-C; mi HeLa, 24h 293 and 12h A549 samples). These 
samples were repeated: for the mi and 12h samples no E1B mRNA was detected and for 
the two 24h samples similar amounts of 22S were detected as for the equivalent 30h 
timepoints.
A laddering effect was detected in all gels and again indicated incomplete 
digestion by SI nuclease. To optimise digestion conditions a control using tRNA instead 
of mRNA, was hybridised to the probe. Although complete digestion was achieved with 
the control, using these same conditions with the samples above still led to the laddering 
effect, even with mi mRNA. Alternatively this laddering could be an indication that the 
RNA was degraded. As there was insufficient RNA to run on a gel this was not tested 
further.
109
Figure 4.5.4. SI Analysis of Ad40 E1B Transcription in the Absence and Presence 
of ara-C in Permissive and Semi-Permissive Cells.
Panel A- The oligonucleotide AB42 spans the Ad40 14S splice acceptor site 
(3049-31 lOnt) and contains an additional 6nt of non adenoviral sequence at the 3' end 
(represented by the dashed line). Expected sizes of protected fragments for 22S and 14S 
mRNA are shown.
Panel B- Ad40 infected cells were grown in the absence and presence of ara-C 
for the times indicated. Cytoplasmic RNA was extracted and 15pg hybridised to 2ng of a 
5' labelled oligonucleotide (AB42) probe. Hybridisation was carried out at 55°C 
overnight, unhybridised DNA was removed by digestion with SI nuclease. Resulting 
protected fragments were run on 15% denaturing polyacrylamide gels, which were dried 
and exposed to autoradiography film for 3 days. A DNA marker was also run on gels 
(not shown).
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Interpretation was complicated by the appearance of the gel, with complete 
digestion of the probe variable both among cell types and across the timecourse and this 
in turn made quantitation difficult. However quantitation was attempted for the 36h 
timepoint using phosphorimage technology and is shown in Table 4.5.1.
The level of 14S is dramatically reduced in the presence of ara-C with an 
approximate 13-16 fold reduction observed in KBa+b, INT407 and 293 cell lines. No 
E1B mRNA is detected for both HeLa and A549 cells in the presence of ara-C at 36h. In 
the absence of ara-C the 22S transcript is most abundant in 293 cells, at levels approx. 3 
fold greater than seen in KBa+b and INT407 cells, while only a fraction of this amount is 
observed for HeLa and A549 cells. The level of 22S is the same for both INT407 and 
KBa+b in the absence of ara-C, and in the presence of ara-C comparable levels of 22S 
mRNA are observed in KBa+b, INT407 and 293 cells. The amount of 22S is also reduced 
in the presence of ara-C in these cell lines with an approximate 3 fold reduction in KBa+b 
and INT407 cells and an 8 fold difference in 293 cells.
4.5.3. Sum m ary.
Ad40 DNA replication was inhibited by the treatment of ara-C. In the absence of 
DNA replication E1B 22S mRNA could be detected in small amounts in 293, KBa+b and 
INT407 cells, but was not detected in HeLa or A549 cells. The level of 14S mRNA was 
dramatically reduced in the presence of ara-C. These results confirmed that E1B mRNA 
is made early in infection, albeit in small amounts, in the absence of DNA replication but 
only in permissive cells. The more permissive cell lines (KBa+b, INT407 and 293) show 
similar amounts of E1B mRNA in the absence of DNA replication, while no E1B mRNA 
is detected in HeLa and A549 cells. In the presence of DNA replication, E1B mRNA is 
most abundant in 293 cells, followed by KBa+b and then INT407 cells. In comparison, 
only small amounts of E1B mRNA were detected in HeLa and A549 cells. There was a 
large difference in the amount of E1B mRNA that was observed between the permissive 
and semi-permissive cell lines. Experiments were therefore carried out (see next section)
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Table 4.5.1. Comparison of E1B mRNA Levels at 36h p.i. in Ad40 Infected Cells 
in the Presence and Absence of ara-C.
Cells
ElBmRNA
- ara-C + ara-C
22S 14S 22S 14S
KBa+b 1041 « 8575 406 642
HeLa 46 509 nd b nd
INT407 1193 6964 386 501
293 3290 10749 429 681
A549 138 1930 nd nd
a these values were determined by scanning membranes on a phosphorimager 
and quantitated using Imagequant. 
b nd denotes not detected.
to investigate the EIB promoter function in permissive and semi-permissive cells, in 
order to see if this could explain the differences in expression of E1B transcripts.
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4.6. Analysis of the Ad40 E1B Promoter.
E1B mRNA are observed before the onset of DNA replication in both INT407 
and KBa+b cells, while in HeLa cells they are detected concurrent with the start of DNA 
replication. These results suggest that in HeLa cells the E1B promoter may be inactive at 
early times in infection.
The Ad2 (and Ad5) promoter is relatively simple consisting of a TATA box, 
(binding site for the TATA-binding protein or TBP) and a GC box sequence (binding site 
for the transcription factor Spl) (Wu et al., 1987; Parks et al., 1988). The GC box 
sequence is important for increasing the level of transcription above the basal level and an 
approximate 6 fold reduction in E1B mRNA production was observed with partial or 
complete deletion of the Spl binding site (Wu et al., 1987). This sequence element was 
found not to be involved in transactivation by E1A, as only mutations in the TATA box 
affected El A transactivation (Wu et al., 1987). Parks et al., (1988) have identified four 
protein binding sites upstream of the Ad5 E1B promoter and suggested that these could 
be involved in stimulating transcription in the absence of a functional GC box.
Figure 4.6.1. shows sequence comparison between the Ad40 E1B promoter and 
those of other adenovirus serotypes. A high degree of conservation is observed for both 
the TATA and GC boxes. The TATA box shows the highest degree of conservation and 
core sequences are identical, with the exception of 2 nucleotides in Ad 12. GC box 
sequences show more variability, but the Ad2 and Ad5 sequences are identical to the high 
affinity Spl binding site reported by Kadonaga et al., (1988). All the other GC box 
sequences approximate to the consensus sequence 5' (G/T)GGGCGG(G/A)2(C/T) 3', with
only slight variations from this consensus. The GC box sequence for Ad 12 is most 
similar to the putative Spl binding site for Ad40, with only 1 nucleotide difference 
between them. The spacing between the TATA and GC box sequences is identical for 
Ad40, 41 and 7 E1B promoters at 6nt, whereas this spacing is 8nt for both Ad2 and Ad5, 
and lOnt for Ad 12. Wu and Berk, (1988b) found that the Ad2 E1B promoter was 
constrained; increasing the distance between the two sequence elements led to a decrease 
in the level of transcription equivalent to the deletion of the Spl binding site. In Ad5, a
112
0 0 0 0 Eh < 0
0  0  Eh <  Eh Eh O
0 0 0 0 0 0 00 0 0 0 0 0 0
0 0 < <
0 0 0 Eh
S 5  2
A A A
S S
|  SEh Eh
Xo
t t
H
£
8 8 d - 80 0 0 < <J 0 0^ <  0  0  0  0  0< < Eh 0  < 0  0
<  <] Eh Eh <5 Eh 0
Eh Eh Eh Eh ^  0  0
Eh Eh 0  0  Eh Eh 0
CD g
Xo
«
U
o
e  s
Eh Eh 
0 0 Eh Eh 
0 0 
0 0
C Eh 
0 0 
Eh Eh 0  tn
8 £
8 §
Eh Eh
Eh
Eh
0Eh
Eh
Eh
0
Eh
Eh Eh 
0 0 
Eh Eh
I I
g  gs
8  80  Eh
<N
^  *8 ?  'd t) t)  
< < < < < < <
T>
i3
e3
£
<u
8
£
i-H
T3
O
<N
.3
<o43
fl
£o43on
t/3<D
>Co
<
H
U ^
£  <N
O  C/3
a a
2  §
*  s
CQ &
5 ip *
1 im D
«* 3cr
<D^  1/1
•S B
■4^  <P
I
VO
2Ph
PQ-
W
£
3d
>
o
(3d>Td
< bo
ld
).
decrease in spacing of 4nt also resulted in an impaired promoter (Personal 
communication A. Berk). It may therefore be likely that a decreased spacing, as described 
above for the Ad40 E1B promoter could also affect the level of E1B transcription.
4.6.1. Analysis of the Ad40 and Ad2 GC Box Sequences by Gel 
Retardation Assay.
The aims of the following experiments were to determine if the Ad40 E1B GC 
box sequence could indeed bind Spl protein, and if so to examine if there are differences 
in binding between the Ad2 Spl binding site and the Ad40 GC box. In addition the 
differences between INT407 and HeLa cell extracts in terms of protein binding to the 
Ad40 and Ad2 GC box sequences were investigated, in order to see if the differences in 
the E1B mRNA pattern were related to the amount of protein binding to the E1B GC box 
and hence affect promoter activity.
The nuclear extracts used were from HeLa and INT407 cells and these were 
prepared as described in section 3.17. In addition, Spl protein which had been partially 
purified by WGA affinity chromatography (see 3.18.), was also used in experiments to 
look at Spl binding to the two GC box sequences. All oligonucleotides sequences used 
are described in section 2.5. Two double stranded probes were used encompassing the 
Ad40 GC box (oligos RTR3&RTR4) and the Ad2 GC box (oligos RTR5&RTR6), both 
probes were 28bp long. The probes were designed to exclude the TATA box sequence as 
a large number of proteins in cell extracts have been reported to bind this site therefore 
inclusion of this site may have cloaked protein binding to the GC box sequence and 
adjacent sequences. Gel retardation assays were performed as described in section 3.19. 
For binding reactions, lng of probe was used with either 5pg of nuclear extract or 0.5pg 
of Spl partially purified extract. These reactions were performed at 25°C for 30min and 
retarded complexes separated from free unbound probe on 3.5% non denaturing gels.
The first experiment was conducted with all three extracts described above (i.e. 
INT407, HeLa and Spl) and examined the ability of the two probes and hence the two 
GC boxes to bind with protein from the extracts. The results of this experiment are shown
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in Figure 4.6.2. Both the Ad40 and Ad2 probes formed a single DNA-protein complex 
with the Spl extract. The major retarded complex (RC), from both INT407 and HeLa 
extracts, has a similar mobility to the complex formed with the Spl extract. The amount 
of complex (RC), is least with the INT407 extract whichever probe is used. In addition to 
the major complex a few minor bands which have a higher mobility, are also observed 
with the INT407 and HeLa extracts, but not with partially purified Spl. The Ad40 probe 
was labelled to a higher specific activity than the Ad2 probe, as observed from the 
difference in intensity of free probe (FP) in tracks without extract.
The amounts of the major retarded complex and free probe were quantitated by 
scanning gels using a phosphorimager (Molecular Dynamics) and analysing scans with 
Imagequant software, this data is shown in Table 4.6.1.
The Ad40 value for FP, in the sample without extract (which represented the 
amount of input probe), is approx. two fold higher than the RC+FP values for the other 
samples which contained Ad40 probe. This showed that a proportion of the probe is being 
lost, this could have arisen by pipetting errors and/or the presence of phosphatases in 
extracts, indeed smearing was observed in lanes (see Fig 4.6.2.).
Looking at the fraction of probe bound as a percentage of the total input probe 
takes into account the specific activities of the probes (see Table 4.6.1.). The greatest 
percentage of probe bound is 80% with Ad2 probe and Spl extract. Comparable levels of 
binding are also observed with Ad2 probe and HeLa extract (70%) and the least amount 
of binding with this probe is observed with INT407 nuclear extract. With the Ad40 probe 
the highest binding is detected with the HeLa extract (36%), whereas in comparison the 
percentage of probe bound to protein in the Spl extract is approximately 3 fold less. Only 
4.5% of Ad40 probe binds with the INT407 extract, and this is the lowest percentage 
detected.
In summary this preliminary experiment indicates that the Ad40 probe binds less 
protein than the Ad2 GC box probe, in addition less probe is bound with INT407 than 
HeLa extracts. Only one complex is detected with the partially purified Spl extract and 
this is most likely to be Spl protein.
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Probe: Ad2 Ad40
Extract:
Figure 4.6.2. Gel Retardation Analysis of Ad2 and Ad40 GC Box Sequences with 
Different Extracts.
Extracts were incubated with an end-labelled probe encompassing either the 
Ad40 GC box or the Ad2 GC box sequence. Binding was carried out at 25°C for 
30min with approx lng of probe and either 5|Hg of nuclear extract (HeLa or 
INT407) or 0.5pg of partially purified Spl extract. Free and bound probes were 
separated by electrophoresis on non-denaturing 3.5% acrylamide gels. Complexes 
were visualised by autoradiography, and are shown above. RC and FP represent 
major retarded complex and free unbound probe, respectively.
Table 4.6.1. Quantitation of Ad2 and Ad40 GC Box Binding to Different Cell Extracts.
Probe Extract RC a FP a RC + FP RC/RC+FP 
xlOO (% )*
None ndc 1,472,427 1,472,427 0.0
Ad2 HeLa 674,803 288,588 963,391 70.0
INT407 124,259 926,704 1,050,963 12.0
Spl 609,233 147,230 756,463 80.0
None ndc 4,318,274 4,318,274 0.0
Ad40 HeLa 572,019 1,028,327 1,600,346 36.0
INT407 107,846 2,305,895 2,413,741 4.5
Spl 255,271 1,901,308 2,156,579 12.0
a  these numbers represent pixel values which were determined by performing
volume integration with Imagequant software. 
b this represents the fraction of probe bound expressed as a percentage of the total. 
c  nd, not detected.
4.6.2. Gel Retardation Competition Assays of Ad40 and Ad2 GC Box 
Sequences.
The specificity of the Ad40 and Ad2 GC box sequence probes binding to protein 
was tested in competition binding assays. Oligonucleotides comprising the probes (Ad2 
and Ad40) above were used as competitors, but in an unlabelled form. In addition a 
hybrid competitor (Ad40m4) consisting of the core Ad2 GC box sequence with Ad40 
flanking sequences (oligos RTR11&12) was included. A nonspecific competitor 
consisting of the octamer/TAATGARAT motif (Oct 1) from the upstream promoter 
region of the HSV-1 IE gene 2 was also used and comprised of the oligos OCT27 and 
OCT28.
Competition experiments are outlined in more detail in section 3.19., but briefly 
the competitor DNAs were added to extracts for 15min at 25°C and after which probe was 
added, samples incubated for a further 30min at 25°C. Competitior DNAs corresponding 
to the Ad2, Ad40 and Ad40m4 GC box sequences were used at 50, 100 and 200 fold 
molar excess. The nonspecific competitor Oct 1 was used at 100 fold molar excess.
Competition binding assays using the Ad2 sequence as the labelled probe with 
INT407, HeLa and Spl extracts are shown in Figure 4.6.3. Using the homologous 
competitor (Ad2), complex formation (RC) is significantly reduced with all three 
extracts. The Ad40 sequence is the least effective competitor, but the amount of protein 
bound to probe decreased with the Ad40m4 DNA sequence i.e. less RC was detected. 
The hybrid competitor is more effective than Ad40, but Ad2 is still the best competitor.
A number of minor complexes were again observed with the INT407 and HeLa 
extracts. The competition indicates some of these minor bands are specific and others are 
non specific. These minor bands are not included in the quantitative analysis. The major 
retarded complex (RC) and free unbound probe (FP) were quantitated as described (see
4.6.1.) and the fraction of probe bound is shown in Table 4.6.2.
The fraction of probe bound by the Ad2 GC box sequence in the absence of 
competitor was almost identical to that detected previously (see Table 4.6.1) for each of 
the cell extracts. The values with the non specific competitor (Oct 1) are comparable to
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Figure 4.6.3. Competition of DNA-Protein Binding with the Ad2 Probe.
Gel retardation assays were carried out as described previously in section 3.19. 
Either 5pg of nuclear extract (HeLa or INT407) or 0.5pg of Spl extract was incubated 
with lng of end-labelled Ad2 probe. Competitor DNAs were added to extract (with all 
buffers) and incubated for 15min at 25°C. The competitors Ad40, Ad2 and Ad40m4 
were used at 50, 100 and 200 fold molar excess. Non-specific competitor Oct 1 was 
used at 100 fold molar excess. Probe was then added and samples incubated for a further 
30min at 25°C. Bound and free probes were then separated by electrophoresis on non- 
denaturing 3.5% acrylamide gels. Complexes were visualised by autoradiography, and 
are shown above. RC and FP represent major retarded complex and free unbound 
probe, respectively. N represents samples with no extract and no competitor i.e. probe 
and buffers alone. Samples with H, I and S had no competitors added i.e. probe (and 
buffers) with corresponding extract.

Table 4.6.2. The Quantitation of Ad2 Labelled Probe Binding to Different Cell 
Extracts in Competition Assays.
Competitor Extract a
(molar excess) HeLa INT407 Spl
None 67.90 12.30 78.80
Ad2 (x50) 10.60 0.10 3.00
Ad2 (xlOO) 0.60 0.05 1.10
Ad2 (x200) 0.60 0.04 0.70
Ad40 (x50) 35.90 6.30 56.30
Ad40 (xlOO) 23.30 5.60 49.70
Ad40 (x200) 14.50 2.70 35.40
Ad40m4 (x50) 12.60 1.90 22.90
Ad40m4 (xlOO) 7.80 0.80 12.40
Ad40m4 (x200) 2.40 0.40 8.00
Oct 1 (xlOO) 56.50 11.60 81.50
a values represent the fraction of probe bound to protein expressed as a percentage 
of the total radioactive signal i.e. RC/RC+FP xlOO.
values without competitor added, confirming that binding is specific. Relative affinities 
for this protein-DNA interaction were investigated using different concentrations of 
competitor DNAs. There is an approximate 5 fold difference between INT407 and HeLa 
extracts in the amount of probe that bound protein, although a similar pattern of 
competition is observed. When Ad2 competitor DNA is used at 100 or 200 fold molar 
excess with HeLa extract, probe binding is reduced to 0.6%, whereas using the Ad40 
competitor at 200 fold molar excess only reduces binding to 14.5 %, while the Ad40m4 
competitor at 200x excess gives an intermediate value of 2.4%. This implies that the 
Ad40 flanking sequences have an affect on probe binding to protein. A similar overall 
hierarchy is seen with both INT407 and Spl extracts; Ad2 is the best competitor for Ad2 
probe, next is Ad40m4 and the poorest is the Ad40 competitor. For the nonspecific 
competitor, Oct 1, the major retarded complex detected with both INT407 and Spl 
extracts appears to be specific, as there is little difference with or without Oct 1. However 
with HeLa extract there is a small reduction in the amount of RC detected with Oct 1, this 
could be due to an excess of DNA added or indicate that the complex is non specific. As 
this small reduction is only a fraction of that observed with the other competitors, the RC 
is most likely a specific complex.
Similar competition binding assays were carried out using the Ad40 GC box as 
probe with the extracts and competitors described above, the gels are shown in Figure 
4.6.4. Minor bands are again detected with HeLa and INT407 extracts. Using the Ad40 
competitor with HeLa and Spl extracts, a similar pattern of competition is observed 
where there is a reduction in the amount of RC observed over the three concentrations of 
competitor. However small amounts of complex are still detected even with the x200 
concentration. With the INT407 extract and Ad40 competitor there is a more dramatic 
decrease in complex and no RC is observed with 200 fold molar excess of competitor. 
Using Ad2 as a competitor, no RC is detected with all three extracts even at 50 fold molar 
excess. With the hybrid competitor Ad40m4 and the HeLa and INT407 extracts a pattern 
more similar to the Ad2 competitor is observed for RC with no complex detected even at 
the highest concentration. However the pattern of minor bands more resembles the Ad40 
competitor. Small amounts of RC are detected with the Spl extract and Ad40m4
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Figure 4.6.4. Competition of DNA-Protein Binding with the Ad40 Probe.
Gel retardation assays were carried out as described previously in section 3.19. 
Either 5|ig of nuclear extract (HeLa or INT407) or 0.5|ig of Spl extract was incubated 
with lng of end-labelled Ad40 probe. Competitor DNAs were added to extract (with all 
buffers) and incubated for 15min at 25°C. The competitors Ad40, Ad2 and Ad40m4 
were used at 50, 100 and 200 fold molar excess. Non-specific competitor Oct 1 was 
used at 100 fold molar excess. Probe was then added and samples incubated for a further 
30min at 25°C. Bound and free probes were then separated by electrophoresis on non- 
denaturing 3.5% acrylamide gels. Complexes were visualised by autoradiography, and 
are shown above. RC and FP represent major retarded complex and free unbound 
probe, respectively. N represents samples with no extract and no competitor i.e. probe 
and buffers alone. Samples with H, I and S had no competitors added i.e. probe (and 
buffers) with corresponding extract.

competitor at xSO and xlOO fold molar excess but not at x200. The major retarded 
complex (RC) and free probe (FP) were quantitated as described previously (see section
4.6.1.) and the percentage of probe bound is shown in Table 4.6.3.
Approximately equivalent levels of Ad40 probe bound are observed with HeLa 
and Spl extracts when there is no competitor present. There is a 6 to 7 fold less difference 
with the INT407 extract compared to the other two extracts. The percentage ratio of probe 
bound with the INT407 extract (without competitors) was the same as that observed 
previously (see Table 4.6.1.). However there is some variability in the amount of RC 
detected with the HeLa and Spl extracts compared to the previous experiment (see Table
4.6.1.). The pattern of competition is very similar for HeLa and Spl extracts, with all 
competitors very effective in reducing the fraction of probe bound. The INT407 extract 
bound only 4.5% of probe and all competitors were very effective in reducing this 
fraction.
Overall competitors even at highest dilutions (50x molar excess) were very effective at 
reducing binding to 2% or less. To measure differences in affinity it would be necessary 
to use lower levels of competitors (e.g. x5, xlO etc.). For the non-specific competitor Oct 
1, no difference is observed with INT407 extract and Ad40 probe indicating that this 
binding is specific. For HeLa and Spl extracts a reduction in complex is detected with 
Oct 1, however this is very small compared to the effect of the other competitors used, 
and the RC is most likely specific.
4.6.3. Summary.
Less RC was detected with the Ad40 GC box than the Ad2 GC box for all three 
extracts and with INT407 extract less probe was bound compared to HeLa and Spl 
extracts. The major retarded complex is most likely formed with Spl protein as the 
mobility of RC corresponded to the only complex detected with the Spl extract. The RC 
observed with Ad2 GC box probe was efficiently competed with unlabelled Ad2 GC box 
sequence but less so by unlabelled Ad40 GC sequence. The hybrid sequence Ad40m4 
was an intermediate competitor indicating that the sequences flanking the Ad40 GC box
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Table 4.6.3. The Quantitation of Ad40 Labelled Probe Binding to Different Cell 
Extracts in Competition Assays.
Competitor Extract a
(molar excess) HeLa INT407 Spl
None 24.80 4.50 25.30
Ad40 (x50) 1.70 0.20 2.10
Ad40 (xlOO) 0.40 0.10 0.80
Ad40 (x200) 0.20 0.05 0.50
Ad2 (x50) 0.20 0.10 0.80
Ad2 (xlOO) 0.20 0.10 0.80
Ad2 (x200) 0.10 0.10 0.05
Ad40m4 (x50) 0.20 0.06 0.20
Ad40m4 (xlOO) 0.10 0.05 0.10
Ad40m4 (x200) 0.30 0.07 0.01
Oct 1 (xlOO) 19.90 4.60 17.70
a values represent the fraction of probe bound to protein expressed as a percentage 
of the total radioactive signal i.e. RC/RC+FP xlOO.
may also have an affect on protein binding. With Ad40 probe, the Ad2 and Ad40m4 
competitors were very effective and reduced binding to below 1% with all three extracts. 
The Ad40 competitor was also effective at reducing the amount of RC observed and 
binding was reduced to 2% or less at x50 fold molar excess.
118
5. DISCUSSION.
5.1. INT407 Cells are Permissive for Ad40.
The El region was first implicated with the fastidious growth of the enteric 
adenoviruses when it was shown that these viruses grew on 293 cells which are HEK 
cells transformed with the Ad5 El region (Takiff et al, 1981). The E1B region was later 
shown to be specifically involved, as Ad40 could grow in cell lines expressing the Ad2 
E1B region (KBb, KBa+b cells), but not the E1A region (KBa) alone (Mautner et al,
1989). Furthermore complementation assays with adenovirus E1B mutants demonstrated 
that it was the expression or function of the Ad40 E1B 55K protein that was impaired 
(Mautner et al, 1989). Thus far, permissive cell lines used to successfully propagate 
Ad40 were transformed with either the EIB or El regions of adenovirus (293, KBb, 
KBa+b); what effect these endogenous proteins had in Ad40 gene expression and DNA 
replication was unknown. At this time, in a preliminary experiment, the INT407 cell line 
was shown to support Ad40 growth, albeit at reduced levels compared to KBa+b cells 
(Steinthorsdottir, 1991). Therefore a detailed timecourse of Ad40 DNA replication on 
INT407, KBa+b and the semi-permissive cell line HeLa was undertaken (section 4.1.). 
This experiment revealed that the time of onset and yield of DNA was similar on KBa+b 
and INT407 cells, although the DNA yield from KBa+b cells was higher than INT407 
cells. In HeLa cells, the onset of DNA replication was later and the final virus yield much 
lower than the other two cell lines. This confirmed that Ad40 could grow in cells which 
had not been transformed with the El region and were not known to express adenovirus 
proteins. The eclipse phase prior to DNA replication for Ad40 (see Fig 4.1.1.) on both 
KBa+b and INT407 cells lasts at least 24h, and these results are comparable to Mautner et 
al, (1989) where the eclipse phase for Ad40 was determined to be of similar duration. On 
HeLa cells the eclipse phase for the virus was 6h longer than for both KBa+b and INT407
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cells. In comparison the eclipse phase of Ad5 grown on KBa+b cells lasts approx. 8h 
(Mautner et al, 1989), and demonstrates that Ad40 grows more slowly than Ad5 even on 
the permissive cells lines KBa+b and INT407.
Two possible explanations why INT407 cells are able to support the growth of 
Ad40 are that either E1B 55K is complemented by a cellular factor in INT407 which has 
ElB-like properties or the requirement for 55K may vary in these cells. INT407 cells 
could support the growth of Ad40, therefore some adenovirus mutants were investigated 
to determine if this cell line could complement the growth of E1B adenovirus mutants or 
whether the effect was specific to Ad40. INT407 complemented the Ad5/2 E1B 19K 
mutant pml722 to wild type (dl309) levels and partially complemented the Ad5/2 E1B 
55K mutant dll520 (Fig 4.2.3.). This implies that the mechanism by which the Ad40 E1B 
55K defect is overcome in INT407 cells may also be used for other adenovirus 55K 
mutants, although some virus specificity is exhibited i.e. d ll520 was only partially 
complemented.
Other researchers have also reported the growth of enteric adenoviruses on cell 
lines which have no endogenous El complementary proteins. Gomes et al, (1992) have 
shown that Ad40 (Dugan) can be propagated on the HRT-18 cell line which is derived 
from human rectal adenocarcinoma. In these cells Ad40 grew better than the EIB 55K 
mutant d ll520 from analyses of Hirt extracted DNAs; this was similar to the pattern 
observed in section 4.2. where dll520 is partially complemented in INT407 cells. 
Interestingly in coinfections with Ad40 and dll520 in HRT 18 or 293 cells (Gomes et al, 
1992) no DNA was detected for both viruses. This was not in agreement with Mautner et 
al, (1989) in which DNA was detected by slot blot hybridisation for both viruses in a 
coinfection assay conducted on HeLa cells. Hashimoto et al, (1991) has shown the A549 
(derived from lung carcinoma) cell line can support Ad40 (Sapporo strain) growth. These 
authors also reported the production of plaques on these cell lines at 18 days post 
infection. During work carried out for this thesis a plaque assay using A549 cells and 
Ad40 (Dugan strain) was conducted but no plaques were observed, even with the same 
experimental conditions as those used by Hashimoto et al, (1991). Indeed Grabow et al,
(1993) using A549 cells in a plaque assay with Ad40 (Hovi-X strain) also failed to obtain
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plaques. The A549 cell line was also used by Steinthorsdottir et al., (1991) to look at 
Ad40 (Dugan strain) growth in comparison to the INT407 and KBa+b cell line It was 
shown to be less permissive than INT407 cells which were in turn less permissive than 
KBa+b cells. In contrast Hashimoto et al., (1991) reported that A549 cells are more 
permissive for Ad40 than KBb cells. As Mautner et al., (1990) have shown that KBa+b 
and KBb cells are equally permissive for Ad40 growth, it is not known if differences 
between these results are affected by the presence of El A in KBa+b cells. Different 
strains of Ad40 are used in these studies and different laboratory conditions may well 
account for some of the differences in these results as has been well documented by de 
Jong et al, (1983). In this thesis (sections 4.2., 4.3. and 4.5.), A549 is also shown to be 
less permissive for Ad40 than INT407 cells particularly in terms of the growth of the 
virus and El transcription.
Other cell lines which can support Ad40 and Ad41 with variable degrees of 
success are: colonic carcinoma cell line CaCo-2 (Pinto et al, 1994); Chang conjunctival 
cells (Kidd and Madeley, 1981); Hep-2 cells (Pieniazek et al., 1990a); PLC/PRF/5 
hepatoma cell line (Grabow et al., 1992); primary rhesus monkey Kidney cells 
transformed with Ad3 or Ad5 El sequences (Nascimento et al., 1990). Ad40 grows in 
some of these cell lines, but it is uncertain if similar functions to INT407 cells are 
supplied or if there is something else in these cells that complements Ad40. Ad40 growth 
in these cell lines warrants further investigation.
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5.2. Ad40 Growth in Permissive Cells Shows One Hit Kinetics.
It was shown that the yield of Ad40 obtained from INT407 cells was considerably 
greater than that on HeLa cells. Explanations to account for this difference were sought, 
primarily through viral infectivity assays. The work described in section 4.3. was an 
attempt to define the growth kinetics of Ad40 in cells showing different degrees of 
permissiveness. An indirect fluorescence focus assay was employed to monitor Ad40 
infected cells in relation to virus dilution. In KBa+b and INT407 cells a pattern of one hit 
kinetics was obtained, while in A549 and HeLa cells a two hit pattern was observed.
A one hit pattern has been described for many viruses (for review see Cooper, 
1961), although in most of these studies a plaque assay was employed to examine virus 
infectivity. This pattern of infection has been described for many adenoviruses; Ad4 and 
Ad5 on HeLa cells (Kjell6n, 1961), also for Adi and Ad7 on Grivet monkey kidney cells 
(Tytell et al., 1962) and Ad41 on the permissive cell line 293 (Tiemessen and Kidd,
1990). An example of another virus that displays the one hit pattern is that of 
poliomyelitis virus (Dulbecco and Vogt, 1953).
A pattern where two virus particles are required to infect a cell has also been 
described. The most notable example is that of adeno-associated viruses; these viruses 
only replicate in cells that are infected by an adenovirus or herpesvirus (Atchison et al., 
1965; Blacklow et al., 1967). Another example is the defective SV40-Ad7 hybrid particle 
which is complemented by Ad7 in African green monkey kidney cells (Boeye et al., 
1966). In the examples where two particles are required, the particles are distinct and one 
particle appears to have the role of a helper. HeLa and A549 cells on the other hand are 
infected by two Ad40 particles and no helper appears to be present. Tiemessen and Kidd
(1990) showed that Ad41 exhibits a two hit pattern in coinfections with Ad2 and a 
multiple hit pattern in single infections on Chang conjunctival cells. A possible 
explanation put forward by these authors for the multiple hit pattern was that multiple 
infecting genomes were required to overcome a limiting concentration of some essential 
product in these cells. For HeLa and A549 cells it is not clear if the requirement of two
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Ad40 genomes overcomes an essential but scarce product in these cells, which may be 
present in INT407 cells.
In the absence of a reliable plaque assay with Ad40, the enumeration of virus 
infectivity was carried out using the data from the indirect fluorescent focus assay in 
order to compare Ad40 titres on different cell lines. Titres obtained (see Table 4.3.5.) 
were comparable to those previously reported by Gomes et al., (1992) (2.4 x 105 FFU/ml) 
on HeLa cells and the permissive HRT-18 cell line (1.4 x 106 FFU/ml). The particle to 
infectivity ratios for Ad40 are high; 1:103 for KBa+b & INT407 and 1:104 for HeLa & 
A549 cells (from Table 4.3.5.). Brown et al., (1992) found that the particle to infectious 
unit (IU) ratios for Ad40 (where infectivity was measured by endpoint dilution method) 
were between xlO3 to xlO6 on HeLa cells and xlO4 to xlO5 for 293 cells. Moreover these 
authors showed that a similar yield of Ad5, Ad40 and Ad41 particles was produced from 
infected cells, but the particle to infectious unit ratios were approx. 100-1000 fold less for 
Ad40 and Ad41. This ratio is high and one possible contributor could be the poor growth 
of these viruses in cell culture. A higher particle to infectivity ratio compared to other 
adenoviruses is also an indication of the presence of defective virus particles, probably 
resulting from a failure at some stage in the lytic cycle. It was apparent from these 
studies, as well as others that complementation of E1B function only partially corrected 
the defective growth phenotype of Ad40. Therefore an investigation of the early events 
during the Ad40 replicative cycle (i.e. attachment and internalisation) was initiated to 
determine if any defects at this stage might contribute to the growth phenotype of Ad40.
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5.3. Ad40 Entry into Cells.
The first event in adenovirus entry into cells is virus to cell recognition. For 
adenovirus types 2 and 5 this has been shown to occur via attachment of the distal part of 
the fibre protein 'knob', (Philipson et al, 1968; Defer et al, 1990; Henry et al, 1994; 
Louis et al, 1994), followed by penton base interaction with cell surface integrin proteins 
(Wickham et al, 1993) which is essential for internalisation of the virus.
The amount of Ad40 virus that attached to HeLa and INT407 cells was examined 
(see 4.4.1.), to investigate why the number of HeLa cells infected with Ad40 is much 
reduced compared to INT407 cells (see 4.3.). In this study approximately 10% of the viral 
input attaches to cells and of this bound virus 21-31% is actually internalised. This is 
consistent with findings by Brown et al, (1992) who found that 10% of HeLa cells can 
support a lytic cycle. This may explain the high particle to infectivity ratio observed for 
Ad40 (Table 4.3.5.), although the molecular mechanism behind it is unknown. However 
this did not explain the difference in Ad40 permissivity between INT407 and HeLa cells, 
as slightly more Ad40 particles attach to HeLa cells than to INT407 cells. Was there a 
difference in the amount of virus that was taken up by the two cell types? In order to 
address this, internalisation of Ad40 was investigated in INT407 and HeLa cells (see
4.4.2.). More virus is internalised in HeLa cells than INT407 cells. This again can not 
account for the difference observed in the later onset of DNA replication (see 4.1.) and 
reduced yield of virus in HeLa cells (see 4.3.) compared to INT407 cells.
In a parallel experiment attachment and internalisation of dl309 was examined on 
INT407 and HeLa cells; approximately 10% of virus attaches to both these cell types and 
of this 33-41% of bound virus is internalised. The amount of Ad40 virus that attached and 
internalised in HeLa cells was comparable to dl309. In this study the percentage of bound 
virus that was internalised was considerably less compared to other studies for Ad2; 60% 
in Wickham et al, (1993) and 50% in Varga et al, (1991). In both these studies the cell 
cultures used were in suspension as opposed to monolayers used in this study. This may 
in part account for the reduced amount of dl309 that was internalised compared to these 
studies, but Greber et al, (1993) have observed 80% of attached Ad2 virus internalised in
KB monolayers. It is unclear what could account for the differences in the amount of 
internalisation. However it should be noted that virus receptor sites for both dl309 and 
Ad40 on HeLa and INT407 cells are not saturated, as no plateau is observed (section
4.1.1.). Philipson et al, (1968) reported that there are 104 Ad2 receptors on HeLa cells, in 
this study 3xl03 particles/cell for dl309 and 7X103 particles/cell for Ad40 were used, 
which would be insufficient to saturate receptor sites. Presumably with a higher moi an 
increase in internalisation (& attachment) may be seen. Whether this approaches the 
amount reported for Ad2 remains to be determined.
The attachment of dl309 was significantly inhibited by Ad2 fibre indicating that 
attachment is mediated by the fibre protein, and is consistent with previous reports for 
adenovirus (Philipson et al., 1968). Internalisation of Ad2, 3, 4 and 12 is mediated by 
penton base which binds to cell surface av integrin proteins via their RGD sequence (Bai 
et al., 1993; Wickham et al., 1993; Mathias et al., 1994). However Ad40 does not have 
an RGD sequence. Instead an RGA motif is present, and it is unclear whether Ad40 also 
uses this mechanism or whether another mechanism is involved. Another virus which has 
no RGD sequence is FAV-10 (Sheppard and Trist, 1992).
Other viruses that possess an RGD sequence include foot-and-mouth disease virus 
and coxsackievirus A9. The foot and mouth disease virus RGD motif present on a capsid 
protein can bind a vP3 integrins on monkey cells and is essential for cell attachment
(Berinstein et al, 1995 and references therein). Deletion of the RGD sequence renders the 
virus non infectious and unable to bind cells. Coxsackievirus A9 (CAV-9) can also bind 
a vp3 integrins via an RGD sequence present on capsid protein VP1, this interaction
mediates virus attachment to cells (Roivainen et al., 1994). Hughes et al., (1995) have 
shown that CAV-9 mutants lacking the RGD motif can bind cells and are infectious. 
These results indicate that CAV-9 can use an RGD-independent pathway for entry into 
cells. Ad40 may also use an RGD-independent pathway that does not involve integrin 
binding, but some integrins can bind non-RGD sequences i.e. a2pl, a4Pi, a xP2 (Hynes,
1992). Therefore an integrin-mediated internalisation step cannot be fully ruled out for 
Ad40.
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Ad40 (and Ad41) contains two types of fibre, one type extending from each 
vertex of the capsid, how this relates to attachment is not clear. Avian adenovirus CELO 
also has two types of fibre, but in contrast to enteric adenoviruses, both types of fibre 
protrude from each vertex (Laver et al., 1971; Hess et al., 1995). Whether the two Ad40 
fibres bind to the same cell receptor or two different receptors one for attachment and one 
for internalisation is not known. The lack of homology between the two head domains of 
adenovirus subgroup F fibres (Kidd et al., 1993) may indicate that these viruses bind to 
two different receptors.
In this study attachment and internalisation of Ad40 was comparable to dl309, 
indicating that the Ad40 entry process was as efficient as that of dl309, which has one 
type of fibre. The amount of Ad40 virus internalised in HeLa cells was higher than in 
INT407 and was not a determinant as to why INT407 cells are more permissive than 
HeLa cells. There could be a failure at some other stage in the lytic cycle and the next 
stage investigated was El gene expression.
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5.4. Ad40 El Gene Expression,
In this study the major mRNAs from the Ad40 E1B region correspond to the Ad2 
22S and 14S mRNAs (see Fig 4.5.1.). This was consistent with the species of mRNA 
produced from the Ad40 E1B promoter characterised by Steinthorsdottir and Mautner,
(1991). Both in terms of appearance and abundance of mRNA, the pattern of E1B gene 
expression in INT407 cells more closely follows the pattern in KBa+b cells than HeLa 
cells. However the amount of E1B mRNA produced in Ad40 is reported to be 5 fold less 
than in Ad5 at a modest moi (Mautner et al., 1990). In this study E1B 22S mRNA is 
observed at early times, before the onset of DNA replication, in KBa+b and INT407 cells, 
albeit at low levels. This is the first time E1B mRNA has been detected before the onset 
of DNA replication and is contrary to previous reports, where no Ad40 mRNA was seen 
at early times (Mautner et al, 1990; Steinthorsdottir, 1991). Possible explanations to 
account for this difference may be from the use of a higher titre vims in this study 
compared to Mautner et al, (1990) or a different extraction method for mRNA compared 
to Steinthorsdottir, (1991) or quite possibly a combination of these factors. In HeLa cells, 
mRNA is detected coincident with the onset of DNA replication, however as both mRNA 
and DNA first appear at the same time, it is unclear if there is an increase in either E1B 
mRNA or DNA replication first. El A is also observed before the onset of DNA 
replication in permissive cells but not in semi permissive cells. It is not clear if El A is 
produced before E1B as times between 12-18h were not investigated. However for both 
Ad40 El A and E1B regions mRNA is delayed compared to Ad5 (Ad5 El A is detected at 
2h p.i. and Ad5 E1B is seen at 3.5h) (Glenn and Ricciardi, 1988). Ad40 E1A has been 
shown to have a low transactivation activity which could explain its late detection. In 
addition the Ad40 El A promoter has been shown to be weak compared with Ad5 and 
Ad 12 El A (Ishino et al, 1988). The low transactivation and promoter activity may play a 
role in the replication of the vims and thus contribute to a poor viral yield. However the 
later detection of Ad40 El A is unlikely to account for the differences in E1B gene 
expression observed among cell types, as Ad40 could not be complemented in cells 
which express adenovims El A gene products, and could complement a Ad2 El A mutant
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indicating there was no gross defect in this region (Mautner et al., 1989: Hashimoto et al, 
1991).
To confirm that E1B mRNA was detected at early times, infection was carried out 
in the presence and absence of cytosine arabinoside (ara-C), which inhibits DNA 
replication, allowing the accumulation of early mRNA. The mRNA was analysed by SI 
nuclease protection (Fig 4.5.4.). The 22S transcript is detected in the presence of ara-C in 
293, KBa+b and INT407 cells. The amount of 22S mRNA was reduced in the presence of 
ara-C (Table 4.5.1.) (approx. 2-3 fold in INT407 and KBa+b cells, and 7.6 fold in 293 
cells at 36h p.i.), but the reduction in 14S was considerably greater at approx. 13-16 fold 
less for these cell types. This is consistent with reports by Bailey et al, (1993, 1994) 
where the 55K protein is detected in approx. similar levels in the presence and absence of 
ara C in 293 and KBa+b cells, but the expression of the 19K protein is inhibited in the 
presence of ara C. Furthermore this correlates with the low levels of 19K protein detected 
at early times in infection (Bailey et al., 1993) and implies that for efficient 19K 
expression progression into the later stages of infection is needed. For HeLa and A549 
cells infected with Ad40, E1B mRNA is not detected when DNA replication is inhibited 
by ara-C. A possible explanation for this is that the E1B region is only transcribed on 
newly replicated DNA. This would be consistent with the detection of DNA and RNA at 
approx. 36h and the increased replication thereafter (Fig 4.5.1.). Alternatively E1B 
transcription is inefficient in these cells and as such not observed until after the onset of 
DNA replication after which an increase in template results in a detectable transcription 
level.
In Adl2 the pattern of E1B gene expression is similar to Ad40 with a 14S 
transcript detected by cDNA cloning (Virtanen et al, 1982), and no 13S mRNA is 
observed. The amino acid sequence of Ad40 E1B proteins are more closely related to 
Adl2 than Ad2 (Ishino et al, 1988). Moreover Ad40 and Adl2 display similar DNA 
replication profiles with onset occurring between 20-30h p.i. (Brieding et al., 1988; 
Mautner et al, 1990) compared with 10-12h for Ad5.
The 55K protein is not essential for DNA replication in Ad5 (Babiss and 
Ginsberg, 1984), but it has been found to be necessary for Ad 12 DNA replication
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(Shiroki et al., 1986; Brieding et al., 1988; Zhang et al., 1992b). It appears that the ability 
of Ad40 to replicate in the permissive cell line may correlate with the expression of 55K 
at early times, which in turn most likely effects the efficiency of DNA replication. 
Consistent with this idea is the finding that semi-permissive cells require more than one 
infectious particle to infect a cell, and it may be that there is a need for a minimum 
amount of the EIB 55K protein for DNA replication to proceed. Therefore the presence 
of more genomes may make up for poor E1B gene expression.
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5.5. The Ad40 E1B Promoter,
A possible explanation for the lack of Ad40 early E1B mRNA and protein (Bailey 
et al, 1993, 1994) in semi permissive cells, is that transcription from the E1B promoter is 
inefficient or absent early in infection. Even in permissive cells Ad40 E1B mRNA 
transcription is poor compared to Ad5 (Mautner et al, 1990) which may indicate 
inefficient promoter usage.
The activity of the Ad40 E1B promoter was compared to Ad5 by Bailey et al,
(1994). Two recombinant viruses were used for this study and were constructed from Ad5 
(dl309) with the Ad40 E1B region in place of the Ad5 equivalent under the control of 
either the Ad40 (sub40P) or Ad5 (sub5P) promoter. This enabled study of the expression 
from the Ad40 E1B region in a well characterised adenovirus system. In 293 and KBa+b 
cells, expression from the Ad40 promoter as measured at the RNA level was respectively 
10 and 20 fold lower compared to the Ad5 promoter, in HeLa cells a 80 fold reduction 
was detected. Results indicated that the Ad40 E1B promoter was less active than the Ad5 
E1B promoter. The pattern of E1B mRNA processing was the same for both 
recombinants with the 14S mRNA as the predominant species. The amount of E1B 
mRNA was much less in sub40P infected cells and the low expression in HeLa cells 
paralleled Ad40 E1B expression in these cells. This suggested the activity of the Ad40 
E1B promoter was a likely cause for the poor expression of E1B mRNA in HeLa cells 
(see section 4.5.). Furthermore CAT assays were conducted where the CAT gene replaced 
the Ad40 E1B coding region in the recombinants sub40P and sub5P (Mautner et al, 
1995). Results confirmed previous studies with the Ad40 E1B promoter showing 
significantly lower activity than the Ad5 E1B promoter. In addition the amount of activity 
of the E1B promoter was shown to vary depending on the cell type used; with the highest 
activity in 293, intermediate in INT407 and lowest activity in HeLa cells. This mirrored 
the levels of Ad40 E1B mRNA and virus yields among these cell types in this study.
What could account for the lower promoter activity?. Differences in E1B gene 
expression between Ad40 and other serotypes are not obvious from direct comparison of 
the sequence of promoter elements (see Fig 4.6.1.). In Ad5, the E1B promoter is
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transactivated by El A which acts through the TATA, while the Spl binding site is 
essential for efficient transcription from the EIB promoter but does not affect E1A- 
mediated transactivation (Wu et al., 1987; Parks et al., 1988). The TATA box sequence is 
identical to Ad2/5 and various other TAT As (Fig 4.6.1.). The Ad40 E1B promoter was 
shown to respond to the VZV 140K protein which acts through the TATA box 
(Steinthorsdottir, 1991) although the response is weaker compared to Ad5 E1B promoter. 
This indicates that the TATA box sequence is not a likely cause of the low promoter 
activity. It was not clear if the GC box in the Ad40 E1B promoter was a functional Spl 
binding site. Did weak binding of Spl to the site result in lower activity of the promoter. 
Indeed mutations in the Spl binding site in the Ad2 E1B promoter do result in a decrease 
in activity (Wu etal., 1987).
In section 4.6. it was shown in gel retardation assays that the Ad40 GC box 
sequence will bind recombinant Spl protein (Jackson et al., 1990), but less efficiently 
than the Ad2 (Ad5) GC box sequence, and that the flanking sequences as well as the GC 
box core sequence have an influence on Spl binding. To look at the differences between 
permissive and semi permissive cells, INT407 and HeLa extracts were used. In INT407 
extracts less protein (Spl) bound both GC box sequences than from HeLa extracts. The 
amount of Spl in cell extracts was not quantitated, and it is not certain if there are 
decreased levels of this protein in INT407 cells. Whether this was a contributory factor in 
the amount of Spl-DNA complexes observed with INT407 cells is unclear.
Alternatively there may be other transcription factors that complement Spl or 
replace Spl in INT407 cells. Spl related proteins have been reported (i.e. Sp2, Sp3 & 
Sp4) (Hagen et al, 1992), the existence of which indicates that Spl is a member of a 
multigene family of transcriptional regulatory proteins. One of these proteins, Sp3, can 
have an activating or inhibitory role in transcription (Dennig et al, 1996 and references 
therein). Looking at the Ad40 promoter, does the fact that more Spl bind from HeLa 
extracts actually have a negative regulatory effect. The spacing between the TATA box 
and Spl binding site in Ad40 is reduced compared to Ad2 (Ad5). How this affects 
binding to TAF110 and thus transcriptional activation is unknown, but a possibility that 
the decreased spacing may lead to an altered interaction of Spl with TAF110 and TBP,
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compared with Ad2 cannot be over looked. The spacing of the Spl binding site and 
TATA box is important in the Ad2 E1B promoter (Wu and Berk, 1988a; Segal and Berk,
1991). Increasing the spacing by 30bp is equivalent to the deletion of the Spl site, and 
insertion of a half turn of DNA helix is more detrimental than a full turn. These results 
indicate that the position and spacing of Spl and TBP are important for interaction. In 
Ad2 a reduction in the spacing between these promoter elements has also been reported to 
reduce E1B transcription (Personal communication A. Berk). In this respect the reduced 
spacing in Ad40 may also be important. However it must be noted that the Ad7 E1B 
promoter has a similar spacing between its promoter elements (see Fig 4.6.1.) and does 
not appear to have a gross defect in this region.
132
5.6. Future.
The detailed characterisation of Ad40 has only been possible since the discovery 
of cell lines such as KBa+b that the virus can grow in efficiently. This has now been 
extended to include INT407 cells which are not known to have endogenous adenovirus 
proteins but are permissive for the virus. The work presented in this thesis and by other 
workers have shown there are still many unanswered questions and several lines of 
interesting study.
Previously the comparison of infectivity among different serotypes compared to 
Ad40 could not be looked at easily because Ad40 did not plaque. Most comparison was 
done by comparing DNA yields. However, the indirect immunofluorescent assay could 
be extended to compare the infectivity of other adenovirus serotypes in comparison to 
Ad40 using the cell lines detailed in this study, and thus compare particle to infectivity 
ratios.
In this study monolayers were used in the examination of viral entry. However 
spinner cultures could be used to increased the numbers of particles attaching to cells. 
Indeed initial experiments carried out with spinner HeLa cells increased the amount of 
attached virus 2 fold. Therefore extending this assay with spinner cultures of INT407 
cells would be advantageous in an attempt to increase the amount of virus internalised.
The amount of Ad40 that is internalised and/or attached is similar in both HeLa 
and INT407 cells and appears to be comparable to dl309. However Ad40 does not 
contain the RGD motif which has been found to be important for cell entry in many other 
adenovirus serotypes. The question of whether integrins are involved in Ad40 entry into 
cells or is an alternate pathway used remains to be answered. Also what role do the two 
types of fibres present on Ad40 have in attachment and do they have different receptors. 
Does this relate to the number of Ad40 receptors on INT407 cells, which in turn also 
needs to be determined. Characterisation of the proteins that bind the Ad40 fibres, could 
also be explored. Are there differences in the number and types of cellular proteins that 
bind?.
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Studies on E1B gene expression in this thesis and elsewhere would indicate that 
Ad40 needs the E1B 22S mRNA and hence the 55K protein to be expressed early for 
efficient growth. The ability of Ad40 to replicate in some cells lines and not others may 
depend on the extent to which 55K can be expressed at early times. It is predicted that 
cells in which E1B mRNA can be expressed early would be suitable hosts for replication 
of Ad40 in tissue culture. This could account for the reported growth of Ad40 in some 
cell lines not expressing endogenous El proteins. Although the 22S mRNA was detected 
in infected INT407 cells, the presence of 55K has still to be confirmed. The question of 
whether the Ad40 55K protein is actually functional is another area requiring 
investigation.
Adl2 55K mutants resemble Ad40 more than Ad5 55K mutants, and it may 
therefore be useful to compare Adl2 to Ad40 as well as Ad5 in future investigations. An 
area not addressed in this thesis is that of the presence of cotranscripts-counterparts 
previously detected in Ad40 infected KBa+b cells. What is the function of these mRNAs 
and their importance in viral replication?.
Why does less Spl bind the Ad40 GC box with INT407 extracts than HeLa? By 
binding to HeLa is the Spl protein acting in an inhibitory capacity by masking a site for 
TAFs or the general transcription machinery and thus if less binds in INT407 does this 
lead to increased promoter activity? The actual amount of Spl still remains to be 
determined in INT407 cells. In addition further analysis of the whole Ad40 promoter by 
DNase I analysis has yet to be carried out.
In this thesis and the literature many different cell lines have been used to 
characterise Ad40 with varying degrees of success. The permissive cell lines presented in 
this thesis have been very successful in detecting, propagating and studying Ad40, but 
yields of virus have never achieved the levels of viral growth seen for other adenovirus 
subgroups. A cell system which is more like the natural host environment (i.e. an 
intestinal cell line) would be a better way to explore the growth requirements of Ad40, 
ideally producing higher levels of the virus for study and comparison with other 
serotypes.
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